Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,A1BG,Alpha-1B-glycoprotein,19738,73,0.71 [0.20-2.50],0.597115423390338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AAMDC,Mth938 domain-containing protein,19209,70,0.90 [0.59-1.39],0.6391337164759067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,22532,81,1.50 [1.08-2.08],0.016401717296617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABCA2,ATP-binding cassette sub-family A member 2,19109,70,0.56 [0.28-1.11],0.0989336500346569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABHD14B,Protein ABHD14B,22407,81,1.11 [0.79-1.56],0.5356373938902499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABL1,Tyrosine-protein kinase ABL1,22532,81,0.86 [0.63-1.17],0.3396520015742877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABO,Histo-blood group ABO system transferase,19711,71,1.01 [0.86-1.18],0.9391515282847488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABRAXAS2,BRISC complex subunit Abraxas 2,19109,70,0.85 [0.59-1.21],0.3581766352051018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22124,81,0.99 [0.78-1.26],0.9217007932993508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19329,70,1.04 [0.78-1.40],0.7752983512183222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19709,73,0.78 [0.59-1.01],0.0605586504375256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAN,Aggrecan core protein,22428,78,1.71 [0.84-3.51],0.1408455401567565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE,Angiotensin-converting enzyme,19711,71,1.62 [0.68-3.83],0.2732836431326596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE2,Angiotensin-converting enzyme 2,22232,80,1.24 [0.86-1.80],0.2505085989647148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACHE,Acetylcholinesterase,19296,70,1.18 [0.59-2.35],0.6446400061380859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOT13,Acyl-coenzyme A thioesterase 13,19608,71,0.83 [0.68-1.01],0.0664616067069623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22636,82,0.61 [0.40-0.94],0.0253533538147679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19160,71,1.24 [0.78-1.98],0.3656630889150161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP5,Tartrate-resistant acid phosphatase type 5,22743,81,1.27 [0.70-2.30],0.428421993586543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP6,Lysophosphatidic acid phosphatase type 6,22798,83,0.97 [0.73-1.29],0.8476220801880495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRBP,Acrosin-binding protein,19602,71,0.53 [0.27-1.03],0.0599029260914001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRV1,Acrosomal protein SP-10,19160,71,0.96 [0.50-1.84],0.9054775592322044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19109,70,1.11 [0.64-1.93],0.7088117412428471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTA2,"Actin, aortic smooth muscle",22232,80,1.10 [0.71-1.70],0.6822286825319221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN2,Alpha-actinin-2,19109,70,1.14 [0.77-1.70],0.5094722236918473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN4,Alpha-actinin-4,22210,82,0.93 [0.49-1.78],0.8348740723131942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACVRL1,Serine/threonine-protein kinase receptor R3,22451,81,0.57 [0.24-1.37],0.2097476228321369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY1,Aminoacylase-1,22636,82,1.14 [0.83-1.57],0.4234781457873913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19109,70,0.75 [0.48-1.16],0.1939297436006534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACYP1,Acylphosphatase-1,19213,70,1.08 [0.77-1.52],0.6599979811021055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA,Adenosine deaminase,22885,83,0.97 [0.55-1.70],0.910421723266038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA2,Adenosine deaminase 2,22479,82,0.98 [0.61-1.57],0.9259662424455198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19160,71,1.67 [1.14-2.45],0.0082534898722113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22232,80,1.01 [0.53-1.95],0.9650130538213898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22486,81,1.10 [0.62-1.96],0.7370054252541614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22885,83,0.83 [0.49-1.40],0.475945552104014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22793,80,1.20 [0.59-2.46],0.6191259734555117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19608,71,0.97 [0.44-2.10],0.9306538669451148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19160,71,1.25 [0.65-2.41],0.5072677816945527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22905,81,1.12 [0.47-2.65],0.8052730091926605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22532,81,0.73 [0.50-1.06],0.0936137797562908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22232,80,1.24 [0.72-2.11],0.4412071625819189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19160,71,0.56 [0.28-1.11],0.0974872621934785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22705,82,1.88 [1.21-2.93],0.0053047024779559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL2,ADAMTS-like protein 2,19705,73,0.94 [0.45-1.95],0.8592041093326452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL4,ADAMTS-like protein 4,19209,70,0.78 [0.29-2.12],0.6242796198573005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL5,ADAMTS-like protein 5,19709,73,0.81 [0.45-1.44],0.4719269799546575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22124,81,1.12 [0.70-1.79],0.6476809879124817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADD1,Alpha-adducin,19296,70,1.00 [0.73-1.39],0.9861049865275768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRB3,Adhesion G protein-coupled receptor B3,22451,81,1.15 [0.64-2.08],0.63872357252203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRD1,Adhesion G-protein coupled receptor D1,19296,70,0.97 [0.51-1.82],0.9185707124570048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE1,Adhesion G protein-coupled receptor E1,19608,71,1.01 [0.66-1.53],0.9793706560843108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE2,Adhesion G protein-coupled receptor E2,22739,82,1.19 [0.58-2.40],0.6372817876660833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE5,Adhesion G protein-coupled receptor E5,22798,81,1.06 [0.55-2.06],0.8617535115529127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRF5,Adhesion G protein-coupled receptor F5,19709,73,1.00 [0.47-2.11],0.9942193385630884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG1,Adhesion G-protein coupled receptor G1,22532,81,1.14 [0.83-1.57],0.4060670669349913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG2,Adhesion G-protein coupled receptor G2,22636,82,0.96 [0.46-2.01],0.9210733955556308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRV1,Adhesion G-protein coupled receptor V1,19101,70,0.93 [0.67-1.31],0.6971417478156117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH1B,All-trans-retinol dehydrogenase,19296,70,0.90 [0.65-1.24],0.5019179266979952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22232,80,1.09 [0.87-1.38],0.4467867027857092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADIPOQ,Adiponectin,19738,73,1.02 [0.73-1.43],0.9105628827104656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADM,Pro-adrenomedullin,22837,83,0.60 [0.29-1.23],0.1658025557483256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADRA2A,Alpha-2A adrenergic receptor,19109,70,1.17 [0.90-1.53],0.2490175913895155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFAP1,Actin filament-associated protein 1,19296,70,0.90 [0.68-1.20],0.4813452217400402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFM,Afamin,19738,73,1.57 [0.47-5.18],0.460161227372309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFP,Alpha-fetoprotein,22424,81,1.08 [0.81-1.44],0.5828237701294463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGBL2,Cytosolic carboxypeptidase 2,19101,70,0.98 [0.76-1.26],0.8871488403886748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGER,Advanced glycosylation end product-specific receptor,22587,82,1.01 [0.62-1.65],0.9593281262591876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR2,Anterior gradient protein 2 homolog,21875,78,0.96 [0.78-1.17],0.661370926024733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR3,Anterior gradient protein 3,22084,81,0.91 [0.64-1.28],0.5709000422731639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRN,Agrin,22739,82,0.81 [0.44-1.50],0.4972598413184829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRP,Agouti-related protein,22885,83,1.03 [0.71-1.49],0.8658110620890422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGT,Angiotensinogen,19711,71,2.03 [0.93-4.42],0.0750225541858214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGXT,Serine--pyruvate aminotransferase,22636,82,0.96 [0.74-1.25],0.7721849575798886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHCY,Adenosylhomocysteinase,22636,82,0.87 [0.65-1.16],0.3386519588142655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK,Neuroblast differentiation-associated protein AHNAK,19209,70,0.76 [0.35-1.62],0.4707132488130469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK2,Protein AHNAK2,19209,70,1.00 [0.44-2.27],0.9935341787108282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19602,71,0.84 [0.58-1.23],0.3702931902036787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSG,Alpha-2-HS-glycoprotein,19711,71,1.54 [0.67-3.57],0.3105249432734926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,22606,79,1.46 [1.17-1.82],0.0006786709883465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIDA,"Axin interactor, dorsalization-associated protein",19160,69,0.94 [0.71-1.26],0.6880593547139466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1,Allograft inflammatory factor 1,22124,81,0.74 [0.51-1.08],0.1179497896917527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1L,Allograft inflammatory factor 1-like,19209,70,0.90 [0.59-1.39],0.6396804489187363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22487,81,0.94 [0.77-1.13],0.4972014374005408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK1,Adenylate kinase isoenzyme 1,22636,82,1.19 [0.89-1.59],0.2328724184463054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK2,"Adenylate kinase 2, mitochondrial",19668,71,0.87 [0.70-1.08],0.2155853089066071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKAP12,A-kinase anchor protein 12,19296,70,1.42 [0.59-3.42],0.4350446549927943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B1,Aldo-keto reductase family 1 member B1,22124,81,0.87 [0.67-1.13],0.2904187829177104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B10,Aldo-keto reductase family 1 member B10,19160,69,0.78 [0.51-1.18],0.2352092901616483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1C4,Aldo-keto reductase family 1 member C4,22232,80,1.04 [0.74-1.47],0.8076403093090283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19160,71,1.05 [0.76-1.44],0.7742518470494302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT1S1,Proline-rich AKT1 substrate 1,22073,79,0.97 [0.72-1.31],0.8677978254071386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,19678,72,0.83 [0.69-0.99],0.0358852327197701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT3,RAC-gamma serine/threonine-protein kinase,22015,80,0.72 [0.50-1.04],0.0795548136981431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALCAM,CD166 antigen,22905,81,1.52 [0.55-4.19],0.4202358146966887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,22641,79,1.74 [1.29-2.34],0.0003143242385608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH2,"Aldehyde dehydrogenase, mitochondrial",19602,71,1.01 [0.66-1.55],0.9476827281287824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22564,82,0.89 [0.65-1.23],0.4926380589183878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19678,72,0.79 [0.47-1.32],0.3657790198966589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALMS1,Alstrom syndrome protein 1,19329,70,0.94 [0.56-1.57],0.8152080791232048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPI,Intestinal-type alkaline phosphatase,19160,71,0.94 [0.77-1.13],0.5036033525033969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",22532,81,1.22 [1.01-1.48],0.0378607942077706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBN,Ameloblastin,22210,82,1.50 [0.97-2.31],0.065418400155363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBP,Protein AMBP,22804,83,0.67 [0.25-1.79],0.4187640454570125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19705,73,1.63 [0.67-3.96],0.2798609802452729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMFR,E3 ubiquitin-protein ligase AMFR,22073,79,1.02 [0.75-1.38],0.9062028680094796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO1,Amphoterin-induced protein 1,19160,69,1.22 [0.84-1.79],0.2995610046739779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO2,Amphoterin-induced protein 2,22532,81,0.44 [0.19-1.03],0.0591986688091308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMN,Protein amnionless,22210,82,1.34 [0.92-1.97],0.1321263539811188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,19296,70,2.09 [1.27-3.43],0.0035028267633282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOTL2,Angiomotin-like protein 2,19544,71,1.02 [0.64-1.62],0.9386820474080996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,19668,71,1.43 [1.07-1.92],0.0151356225908182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18440,66,0.78 [0.47-1.30],0.3425859984817907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2A,Pancreatic alpha-amylase,21736,78,0.86 [0.56-1.32],0.4910448827244981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2B,Alpha-amylase 2B,21082,77,0.87 [0.56-1.34],0.5190283676490269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANG,Angiogenin,22553,82,0.60 [0.33-1.10],0.0990590550876564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT1,Angiopoietin-1,22557,82,0.90 [0.72-1.13],0.3849924784412193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT2,Angiopoietin-2,22837,83,0.80 [0.47-1.36],0.411189583593298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL1,Angiopoietin-related protein 1,22332,82,1.02 [0.52-2.00],0.9509906440914812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL2,Angiopoietin-related protein 2,22671,81,1.30 [0.80-2.12],0.2854215582508403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL3,Angiopoietin-related protein 3,22621,82,1.10 [0.64-1.90],0.721192659466172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,22700,82,1.73 [1.12-2.66],0.0133491536688434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL7,Angiopoietin-related protein 7,22837,83,1.18 [0.70-2.00],0.5351707224039355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANK2,Ankyrin-2,19109,70,0.92 [0.66-1.29],0.6293051437855769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19160,71,0.74 [0.55-1.00],0.0504808170364151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,19016,71,0.60 [0.38-0.94],0.0268622708896368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRD54,Ankyrin repeat domain-containing protein 54,22124,81,1.28 [0.98-1.67],0.0738987024583778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19209,70,1.06 [0.64-1.77],0.8185477317977751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANPEP,Aminopeptidase N,22657,82,1.33 [0.68-2.61],0.3984875531370061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA1,Annexin A1,19171,70,1.03 [0.62-1.71],0.899998776567971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA10,Annexin A10,22073,79,0.90 [0.70-1.17],0.4286369514529837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA11,Annexin A11,22566,81,0.95 [0.71-1.26],0.7042207308245263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA2,Annexin A2,18917,69,0.97 [0.70-1.36],0.8646692768091712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA3,Annexin A3,22793,80,0.96 [0.73-1.27],0.7691214330117331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA4,Annexin A4,22520,82,0.91 [0.69-1.20],0.5124197281768441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA5,Annexin A5,22013,79,1.02 [0.53-1.99],0.9434236208685818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22210,82,1.14 [0.85-1.53],0.3697684369001035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC3,Membrane primary amine oxidase,22698,82,1.73 [0.90-3.32],0.0975348359184541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP1G2,AP-1 complex subunit gamma-like 2,19602,71,0.82 [0.61-1.11],0.201378890841633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP2B1,AP-2 complex subunit beta,19160,69,0.86 [0.52-1.42],0.5476037033978853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3B1,AP-3 complex subunit beta-1,19608,71,0.80 [0.59-1.09],0.1642799236675463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3S2,AP-3 complex subunit sigma-2,19668,71,0.75 [0.45-1.26],0.282342724690423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22532,81,0.88 [0.56-1.39],0.5804228795516215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APCS,Serum amyloid P-component,19555,71,0.79 [0.42-1.48],0.4599844648037223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22764,83,1.16 [0.85-1.58],0.3376004818659388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APLP1,Amyloid-like protein 1,22636,82,0.99 [0.68-1.45],0.9652447465969364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA1,Apolipoprotein A-I,19738,73,1.26 [0.61-2.63],0.5337661182736626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA2,Apolipoprotein A-II,19711,71,1.15 [0.72-1.83],0.5586743325770548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA4,Apolipoprotein A-IV,19738,73,0.68 [0.35-1.35],0.2713623604380852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOB,Apolipoprotein B-100,19711,71,2.02 [0.73-5.60],0.177920032590083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOBR,Apolipoprotein B receptor,19209,70,1.26 [0.72-2.19],0.4199870484491504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOC1,Apolipoprotein C-I,19693,72,1.18 [0.65-2.16],0.5859821136625103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOD,Apolipoprotein D,18823,68,0.77 [0.40-1.47],0.4220390240623987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOE,Apolipoprotein E,19738,73,1.05 [0.80-1.39],0.7090819654507103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOF,Apolipoprotein F,19711,71,0.66 [0.33-1.32],0.2380608277656859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOH,Beta-2-glycoprotein 1,22641,79,1.44 [0.87-2.38],0.1589242210152425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOL1,Apolipoprotein L1,19711,71,1.01 [0.71-1.44],0.9589821128451866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOM,Apolipoprotein M,22661,82,1.03 [0.49-2.16],0.9337746047385546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APP,Amyloid-beta precursor protein,22606,78,0.89 [0.66-1.20],0.4383734010259814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APPL2,DCC-interacting protein 13-beta,19296,70,0.86 [0.70-1.05],0.1409690667790451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APRT,Adenine phosphoribosyltransferase,22456,81,1.04 [0.69-1.56],0.8564358975539325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARAF,Serine/threonine-protein kinase A-Raf,19329,70,1.04 [0.75-1.44],0.8187822317230361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AREG,Amphiregulin,22532,81,0.99 [0.64-1.53],0.9770851175064332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARF6,ADP-ribosylation factor 6,19608,71,0.90 [0.73-1.11],0.3109127841501763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARFIP1,Arfaptin-1,19678,72,0.88 [0.63-1.23],0.4597004342557298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,22541,82,1.49 [1.04-2.13],0.0302885445631846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG2,"Arginase-2, mitochondrial",19602,71,0.81 [0.46-1.43],0.4683367733831995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP1,Rho GTPase-activating protein 1,22124,81,0.94 [0.61-1.44],0.7743317060136523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP25,Rho GTPase-activating protein 25,22124,81,0.95 [0.68-1.34],0.7907190602826497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP30,Rho GTPase-activating protein 30,19329,70,0.74 [0.36-1.51],0.4042218302464599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,19296,70,0.75 [0.56-1.00],0.0462215089786443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP5,Rho GTPase-activating protein 5,19016,71,0.84 [0.60-1.17],0.3008707350936274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF1,Rho guanine nucleotide exchange factor 1,19668,71,0.88 [0.68-1.13],0.3062541881069039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF10,Rho guanine nucleotide exchange factor 10,19678,72,0.83 [0.64-1.06],0.1315761334019878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF12,Rho guanine nucleotide exchange factor 12,22597,82,0.90 [0.75-1.09],0.2830467683693518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF5,Rho guanine nucleotide exchange factor 5,19101,70,0.92 [0.67-1.28],0.6242783663836192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID3A,AT-rich interactive domain-containing protein 3A,19101,70,1.50 [0.94-2.42],0.0918245520370515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID4B,AT-rich interactive domain-containing protein 4B,22073,79,1.00 [0.63-1.59],0.9924615566749998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL13B,ADP-ribosylation factor-like protein 13B,19109,70,0.82 [0.58-1.17],0.2762383222493281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19109,70,0.73 [0.41-1.32],0.3007526391908579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARMCX2,Armadillo repeat-containing X-linked protein 2,19101,70,0.89 [0.60-1.32],0.5577878756343558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNT,Aryl hydrocarbon receptor nuclear translocator,22210,82,0.81 [0.46-1.45],0.4834474477762555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19109,70,1.31 [0.95-1.81],0.0953559759655301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSA,Arylsulfatase A,22641,79,1.26 [0.81-1.96],0.296663517092414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSB,Arylsulfatase B,22532,81,0.81 [0.56-1.17],0.263902925514242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART3,Ecto-ADP-ribosyltransferase 3,22698,82,1.06 [0.58-1.93],0.8596370328963507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART5,Ecto-ADP-ribosyltransferase 5,19101,70,0.90 [0.61-1.34],0.6141031890307371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARTN,Artemin,22210,82,1.02 [0.67-1.55],0.9402634983167336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH1,Acid ceramidase,19521,72,0.59 [0.34-1.02],0.0571016538383555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH2,Neutral ceramidase,22486,81,1.53 [1.00-2.34],0.0509028088232154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR1,Asialoglycoprotein receptor 1,22486,81,1.49 [0.77-2.89],0.2382603289731279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR2,Asialoglycoprotein receptor 2,19711,71,1.81 [0.78-4.21],0.1671869278968643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPN,Asporin,19709,73,0.60 [0.25-1.45],0.2596990146598649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPSCR1,Tether containing UBX domain for GLUT4,19678,72,0.93 [0.67-1.30],0.6726219821856156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19209,70,0.89 [0.71-1.12],0.3264067642320989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASS1,Argininosuccinate synthase,19109,70,1.04 [0.78-1.39],0.7998839980197433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22073,79,0.89 [0.64-1.25],0.5139407101871099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19016,71,1.25 [0.68-2.28],0.4763024454159399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG16L1,Autophagy-related protein 16-1,19608,71,0.84 [0.64-1.10],0.2054978517184732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,22124,81,1.43 [1.06-1.93],0.0190378097376847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATOX1,Copper transport protein ATOX1,22705,82,0.88 [0.67-1.15],0.3612232852035302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19109,70,1.12 [0.75-1.68],0.5778753023734371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19109,70,0.70 [0.32-1.53],0.3648987175392221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19109,70,0.74 [0.38-1.43],0.3678539965191424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B4,Protein ATP1B4,19016,71,0.85 [0.48-1.51],0.576201077073667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19109,70,0.98 [0.68-1.42],0.93371859763455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19109,70,1.04 [0.70-1.56],0.8319140329538642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5IF1,"ATPase inhibitor, mitochondrial",22739,82,0.88 [0.74-1.05],0.1511388539999915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5PO,"ATP synthase subunit O, mitochondrial",22073,79,1.14 [0.74-1.76],0.555873750214463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6AP2,Renin receptor,22124,81,1.26 [0.85-1.86],0.2552676572611635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1D,V-type proton ATPase subunit D,22532,81,1.21 [0.60-2.46],0.5992874419312026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1F,V-type proton ATPase subunit F,22025,79,0.98 [0.72-1.32],0.8715566822999272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G1,V-type proton ATPase subunit G 1,19209,70,0.90 [0.65-1.24],0.5243417652518848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G2,V-type proton ATPase subunit G 2,19109,70,0.98 [0.77-1.23],0.8363754420306764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRAID,All-trans retinoic acid-induced differentiation factor,19608,71,0.53 [0.21-1.33],0.1736772921766885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRN,"Attractin, Isoform 2",19738,73,1.92 [0.49-7.51],0.3487340891148126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,22073,79,0.74 [0.58-0.95],0.0189454534717758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2,Ataxin-2,19101,70,0.87 [0.69-1.10],0.2568139378971038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2L,Ataxin-2-like protein,19678,72,1.15 [0.74-1.80],0.5251505820035053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN3,Ataxin-3,19668,71,1.25 [0.89-1.78],0.2013149001810106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXIN1,Axin-1,22597,82,0.85 [0.69-1.05],0.1298103983646766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXL,Tyrosine-protein kinase receptor UFO,22698,82,0.63 [0.31-1.31],0.2175469615702318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZI2,5-azacytidine-induced protein 2,19678,72,0.85 [0.56-1.30],0.4517170361306573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZU1,Azurocidin,21914,78,1.09 [0.86-1.38],0.4836855146490063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B2M,Beta-2-microglobulin,19738,73,1.00 [0.49-2.02],0.9934279555374728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19109,70,1.34 [0.47-3.80],0.5839594906737697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19209,70,0.80 [0.43-1.50],0.4894205057743078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",22739,82,2.45 [1.22-4.89],0.0115180638057468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GAT1,"Beta-1,4-glucuronyltransferase 1",22641,79,1.89 [0.85-4.24],0.1196827434558877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BABAM1,BRISC and BRCA1-A complex member 1,19160,71,0.52 [0.21-1.27],0.152945230499296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BACH1,Transcription regulator protein BACH1,22597,82,0.88 [0.67-1.16],0.3750766123066488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG3,BAG family molecular chaperone regulator 3,22451,81,0.83 [0.52-1.33],0.4371384154303546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG4,BAG family molecular chaperone regulator 4,19160,71,0.80 [0.48-1.31],0.3713136427941589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG6,Large proline-rich protein BAG6,22232,80,0.97 [0.56-1.70],0.9276681716879666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22124,81,1.17 [0.86-1.58],0.3126552603891409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAMBI,BMP and activin membrane-bound inhibitor homolog,22124,81,0.74 [0.37-1.50],0.4096484057919507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BANK1,B-cell scaffold protein with ankyrin repeats,22597,82,0.84 [0.71-1.01],0.0621176023036269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAP18,Chromatin complexes subunit BAP18,19668,71,1.05 [0.77-1.44],0.7463974712225115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BATF,Basic leucine zipper transcriptional factor ATF-like,19160,69,0.97 [0.73-1.27],0.8077135385172239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAX,Apoptosis regulator BAX,22043,79,1.01 [0.80-1.27],0.9341050995188752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAM,Basal cell adhesion molecule,22641,79,2.16 [1.00-4.68],0.0514309454243902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAN,Brevican core protein,22486,81,1.00 [0.56-1.80],0.9931175058074652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19709,73,1.15 [0.57-2.32],0.7029629763428594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19101,70,0.94 [0.61-1.46],0.797572777466955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCHE,Cholinesterase,19338,70,0.85 [0.39-1.86],0.682030186957443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,19608,71,0.50 [0.28-0.87],0.0137666810462665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L1,Bcl-2-like protein 1,19668,71,0.88 [0.71-1.11],0.2871204360799811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22597,82,0.54 [0.38-0.76],0.0003925559480538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L15,Bcl-2-like protein 15,19160,71,1.12 [0.78-1.60],0.544765782291053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19016,71,1.17 [0.86-1.59],0.304462324581856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19602,71,0.85 [0.49-1.47],0.558662617909247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCR,Breakpoint cluster region protein,22597,82,0.85 [0.69-1.06],0.1412540314972547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BDNF,Brain-derived neurotrophic factor,19705,73,0.82 [0.63-1.06],0.1312626020872433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BECN1,Beclin-1,19209,70,1.06 [0.74-1.54],0.7413375383889682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BEX3,Protein BEX3,19016,71,1.13 [0.73-1.75],0.570029906185552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGLAP,Osteocalcin,19705,73,0.97 [0.75-1.24],0.8021173802737805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGN,Biglycan,22085,81,0.95 [0.81-1.12],0.5706888281715267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHLHE40,Class E basic helix-loop-helix protein 40,19101,70,0.70 [0.48-1.03],0.0679666474652236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19109,70,1.38 [0.57-3.34],0.4729724892857755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BID,BH3-interacting domain death agonist,22597,82,1.13 [0.86-1.49],0.3828353219611417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIN2,Bridging integrator 2,22641,79,0.85 [0.68-1.06],0.1549006286025019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIRC2,Baculoviral IAP repeat-containing protein 2,22124,81,0.90 [0.66-1.24],0.5248125851085736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLMH,Bleomycin hydrolase,22905,81,0.92 [0.50-1.69],0.7916539312620254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLNK,B-cell linker protein,19160,71,0.64 [0.32-1.27],0.2021259165256117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19101,70,0.90 [0.65-1.26],0.550266974467992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19668,71,0.60 [0.32-1.13],0.1120767028487536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,22641,79,1.52 [1.19-1.96],0.0009197318436646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP10,Bone morphogenetic protein 10,19296,70,0.69 [0.32-1.52],0.3605771029696318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP4,Bone morphogenetic protein 4,22451,81,0.86 [0.54-1.36],0.51080550689929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,22196,80,0.65 [0.43-0.99],0.0464668209892721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMPER,BMP-binding endothelial regulator protein,19296,70,0.60 [0.21-1.70],0.3331201742504954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19709,73,0.74 [0.37-1.49],0.4034546009909927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19160,71,0.79 [0.45-1.37],0.3961669743988373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOC,Brother of CDO,22232,80,0.70 [0.30-1.64],0.414999335684429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA1,BolA-like protein 1,19101,70,0.90 [0.59-1.39],0.6478453806426121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA2_BOLA2B,BolA-like protein 2,19209,70,1.31 [0.87-1.97],0.1940470677282299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFA2,BPI fold-containing family A member 2,18527,68,1.02 [0.82-1.27],0.8464134258708529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB1,BPI fold-containing family B member 1,22577,81,1.22 [0.88-1.68],0.2255791805557524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB2,BPI fold-containing family B member 2,19675,73,1.12 [0.82-1.54],0.4738586608533748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRAP,BRCA1-associated protein,19438,71,0.85 [0.69-1.04],0.11599863669887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD1,Bromodomain-containing protein 1,19329,70,1.38 [0.74-2.57],0.3128238163165808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD2,Bromodomain-containing protein 2,19101,70,1.51 [0.95-2.40],0.0804882131282013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD3,Bromodomain-containing protein 3,19109,70,1.10 [0.72-1.69],0.644337189561261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRDT,Bromodomain testis-specific protein,19109,70,0.71 [0.37-1.36],0.3002537682859558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,22073,79,0.58 [0.36-0.93],0.0244458546195781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRME1,Break repair meiotic recombinase recruitment factor 1,19101,70,0.66 [0.34-1.27],0.2146751150356854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRSK2,Serine/threonine-protein kinase BRSK2,19678,72,0.71 [0.38-1.33],0.2831572308978564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSG,Basigin,22845,83,0.86 [0.33-2.20],0.7463714316122714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSND,Barttin,19016,71,0.76 [0.36-1.62],0.4812274883641371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22833,80,1.11 [0.71-1.75],0.6414239265575036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST2,Bone marrow stromal antigen 2,22833,80,1.08 [0.75-1.55],0.6779706807999162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTC,Probetacellulin,22124,81,0.89 [0.67-1.17],0.4039700641445078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTD,Biotinidase,19738,73,1.20 [0.41-3.53],0.7370352890459287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTLA,B- and T-lymphocyte attenuator,19016,71,0.89 [0.65-1.21],0.4648569877808457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,19567,71,1.51 [1.15-1.97],0.0029040845861208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN2A1,Butyrophilin subfamily 2 member A1,22739,82,0.76 [0.34-1.67],0.4887707142965161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN3A2,Butyrophilin subfamily 3 member A2,22597,82,1.31 [0.79-2.16],0.2908671069822203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTNL10,Butyrophilin-like protein 10,19016,71,1.24 [0.79-1.92],0.3465192192291738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C19orf12,Protein C19orf12,22073,79,1.14 [0.85-1.52],0.3860182060209026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1GALT1C1,C1GALT1-specific chaperone 1,19109,70,0.82 [0.39-1.74],0.6070193251699738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QA,Complement C1q subcomponent subunit A,22766,81,0.89 [0.37-2.13],0.788449734029131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19678,72,0.82 [0.54-1.23],0.3300707759744552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QL2,Complement C1q-like protein 2,19160,71,0.97 [0.57-1.63],0.8974765206977359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22698,82,1.45 [0.95-2.22],0.0827656331069627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19296,70,0.55 [0.33-0.91],0.018758813538393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19678,72,1.29 [0.70-2.39],0.4159909675463967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19254,70,1.23 [0.75-2.03],0.4111276955712059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1R,Complement C1r subcomponent,19738,73,1.12 [0.37-3.40],0.8356831512999707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1RL,Complement C1r subcomponent-like protein,19706,73,0.64 [0.21-1.94],0.4334821568265583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1S,Complement C1s subcomponent,19738,73,1.12 [0.38-3.32],0.8387209060812966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,22661,82,2.64 [1.01-6.91],0.0480347305761155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2CD2L,Phospholipid transfer protein C2CD2L,22025,79,1.20 [0.79-1.81],0.3995382402144333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2orf69,UPF0565 protein C2orf69,19160,69,0.76 [0.47-1.21],0.2460472795493592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C3,Complement C3,18729,67,0.88 [0.50-1.55],0.6618400146031712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C4BPB,C4b-binding protein beta chain,22705,82,0.85 [0.52-1.37],0.4974499011592013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C5,Complement C5,19738,73,2.49 [0.82-7.60],0.1092463326005114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7,Complement component C7,19260,70,1.30 [0.61-2.76],0.4986026847207635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7orf50,Uncharacterized protein C7orf50,19668,71,1.02 [0.40-2.62],0.9679191379654084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C8B,Complement component C8 beta chain,19738,73,1.08 [0.52-2.24],0.8412210175838725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9,Complement component C9,19711,71,0.70 [0.45-1.08],0.1062916146793005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,19608,71,1.43 [1.12-1.84],0.0046635054418927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,22103,81,1.47 [1.09-1.98],0.0123420986245688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA11,Carbonic anhydrase-related protein 11,22124,81,0.87 [0.45-1.69],0.6803601102772143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA12,Carbonic anhydrase 12,22532,81,0.97 [0.52-1.82],0.9253353037080618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,22398,82,0.82 [0.69-0.98],0.0304644147234394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA14,Carbonic anhydrase 14,22837,83,1.00 [0.56-1.77],0.9906080267398192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,22565,79,1.46 [1.13-1.88],0.0038527883561449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,22866,81,1.43 [1.07-1.91],0.0151622923030506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA4,Carbonic anhydrase 4,22905,81,0.69 [0.30-1.61],0.3938214324626635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA5A,"Carbonic anhydrase 5A, mitochondrial",22232,80,1.10 [0.89-1.36],0.3774628705791634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA6,Carbonic anhydrase 6,22569,79,1.06 [0.77-1.46],0.7095503248040984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA7,Carbonic anhydrase 7,19329,70,1.20 [0.67-2.15],0.5361709508798431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA8,Carbonic anhydrase-related protein,19160,71,1.10 [0.51-2.37],0.8085141232679842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA9,Carbonic anhydrase 9,22837,83,1.05 [0.69-1.62],0.8109861471529902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CABP2,Calcium-binding protein 2,19160,69,0.98 [0.69-1.39],0.900739058175074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19101,70,0.90 [0.43-1.86],0.7707453285136425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19109,70,0.91 [0.59-1.39],0.6595085411240937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19101,70,0.82 [0.54-1.25],0.3574021913571203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19678,72,0.79 [0.60-1.03],0.0811803484563089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACYBP,Calcyclin-binding protein,19253,70,0.82 [0.66-1.02],0.0760970041804069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CADPS,Calcium-dependent secretion activator 1,19160,69,1.10 [0.68-1.78],0.6869676011426731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB1,Calbindin,22532,81,1.36 [0.84-2.21],0.2124563438298222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB2,Calretinin,22073,79,0.70 [0.35-1.40],0.3156608037903808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCA,Calcitonin,22438,81,1.11 [0.78-1.58],0.552117206578578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCB,Calcitonin gene-related peptide 2,19668,71,0.65 [0.33-1.29],0.2167857490379012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22764,83,0.93 [0.77-1.12],0.4256699478649499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19209,70,0.88 [0.65-1.19],0.4090906042848458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALY,Neuron-specific vesicular protein calcyon,19109,70,0.55 [0.26-1.18],0.1264196267764424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22124,81,0.58 [0.35-0.96],0.0326886084517688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19160,69,0.68 [0.42-1.12],0.1276196319378842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19678,72,0.92 [0.75-1.14],0.4575618461139233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CANT1,Soluble calcium-activated nucleotidase 1,22570,82,2.57 [0.98-6.73],0.0546225857256257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPG,Macrophage-capping protein,22482,81,1.08 [0.78-1.50],0.6566850891432319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPN3,Calpain-3,19602,71,1.12 [0.64-1.96],0.6931062663749851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPS,Calcyphosin,19668,71,0.83 [0.61-1.14],0.2519910293615222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,22073,79,1.55 [1.11-2.16],0.0102733609682416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASC3,Protein CASC3,19160,69,0.70 [0.39-1.28],0.252408612322714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP1,Caspase-1,22073,79,0.92 [0.68-1.24],0.5828213006892081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP10,Caspase-10,22073,79,1.03 [0.77-1.36],0.8599599355539631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP2,Caspase-2,22597,82,0.83 [0.61-1.11],0.2121994938265314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP3,Caspase-3,22905,81,0.83 [0.67-1.03],0.0929138607542992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP4,Caspase-4,19329,70,1.11 [0.99-1.25],0.0698325062398021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,19668,71,0.73 [0.55-0.96],0.0222651349223109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP8,Caspase-8,22765,83,1.00 [0.74-1.36],0.9780366459914368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP9,Caspase-9,19160,71,0.81 [0.55-1.19],0.285925566851651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASQ2,Calsequestrin-2,19109,70,0.63 [0.33-1.17],0.1423322750367752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,19406,68,1.72 [1.20-2.45],0.003063772658596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLIF,Cobalamin binding intrinsic factor,22602,82,1.00 [0.77-1.30],0.9934301064139502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN1,Cerebellin-1,19101,70,1.17 [0.99-1.40],0.0731800796263925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN4,Cerebellin-4,22837,83,0.82 [0.44-1.54],0.5433485272797879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBS,Cystathionine beta-synthase,19209,70,0.80 [0.49-1.31],0.3714594401119273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBX2,Chromobox protein homolog 2,19109,70,1.17 [0.73-1.88],0.522155011902204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22486,81,1.15 [0.89-1.48],0.3009854263592422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCAR2,Cell cycle and apoptosis regulator protein 2,19668,71,1.05 [0.72-1.53],0.8046267388465349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC134,Coiled-coil domain-containing protein 134,19602,71,0.82 [0.51-1.33],0.4173534387032855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC28A,Coiled-coil domain-containing protein 28A,19160,69,1.02 [0.46-2.26],0.961511420246172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC50,Coiled-coil domain-containing protein 50,19678,72,0.77 [0.55-1.10],0.1507650770215705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC80,Coiled-coil domain-containing protein 80,22636,82,0.95 [0.54-1.67],0.867783939884562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19209,70,0.98 [0.68-1.44],0.9361319208801384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL11,Eotaxin,22885,83,1.13 [0.67-1.89],0.6471255180713628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL13,C-C motif chemokine 13,22845,83,0.97 [0.73-1.28],0.8355090274807946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL14,C-C motif chemokine 14,22553,82,0.99 [0.60-1.64],0.9588786948732828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL15,C-C motif chemokine 15,22905,81,1.11 [0.71-1.74],0.6482900892110477
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL16,C-C motif chemokine 16,22905,81,1.43 [0.94-2.17],0.0931570856250916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL17,C-C motif chemokine 17,22604,82,0.97 [0.78-1.20],0.79071202795032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL18,C-C motif chemokine 18,22289,82,0.88 [0.66-1.19],0.4185831946909352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL19,C-C motif chemokine 19,22833,80,1.04 [0.91-1.20],0.5405872958142808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL2,C-C motif chemokine 2,22451,81,0.99 [0.68-1.43],0.9482382558695812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL20,C-C motif chemokine 20,22885,83,1.07 [0.87-1.31],0.5246094672048466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL21,C-C motif chemokine 21,22739,82,0.96 [0.60-1.54],0.8692315568073361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL22,C-C motif chemokine 22,22413,82,1.17 [0.81-1.70],0.3947163351272713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL23,C-C motif chemokine 23,22739,82,1.25 [0.78-2.01],0.3579522566056904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL24,C-C motif chemokine 24,22700,82,1.18 [0.94-1.48],0.1542012582713607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL25,C-C motif chemokine 25,22885,83,0.87 [0.58-1.29],0.4841130892027784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL26,C-C motif chemokine 26,22597,82,1.05 [0.85-1.29],0.6621910100482051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,22636,82,1.54 [1.11-2.15],0.0103092923699697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL28,C-C motif chemokine 28,22522,82,0.86 [0.60-1.21],0.3849791218741224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL3,C-C motif chemokine 3,22597,82,1.04 [0.73-1.49],0.8189260862685992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL4,C-C motif chemokine 4,22671,82,1.00 [0.76-1.33],0.9774458021682736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL5,C-C motif chemokine 5,22698,82,0.86 [0.71-1.04],0.1260826686048534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL7,C-C motif chemokine 7,22597,82,0.91 [0.64-1.29],0.6042355849767982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL8,C-C motif chemokine 8,22804,83,0.91 [0.67-1.25],0.5713055066080317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN1,CCN family member 1,22492,81,1.12 [0.86-1.45],0.4039323155032106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN2,CCN family member 2,22627,82,0.86 [0.61-1.21],0.390242113473601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN3,CCN family member 3,22872,81,1.03 [0.57-1.86],0.9269504504514586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN4,CCN family member 4,22837,83,0.79 [0.48-1.30],0.3587910310824139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,22641,79,1.63 [1.01-2.65],0.0472316566467887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCND2,G1/S-specific cyclin-D2,19329,70,0.89 [0.49-1.61],0.6902742289882333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCNE1,G1/S-specific cyclin-E1,19160,71,1.00 [0.78-1.27],0.9807448445149198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCS,Copper chaperone for superoxide dismutase,22486,81,1.24 [0.84-1.84],0.2770520741559071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCT5,T-complex protein 1 subunit epsilon,22124,81,1.11 [0.72-1.70],0.6424487628662167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD101,Immunoglobulin superfamily member 2,19608,71,1.04 [0.61-1.76],0.8818635856673646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD109,CD109 antigen,22641,79,1.82 [1.00-3.33],0.0507734062870977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD14,Monocyte differentiation antigen CD14,22134,80,0.94 [0.58-1.54],0.8185672910288606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD160,CD160 antigen,22885,83,0.83 [0.54-1.28],0.398288154982459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22698,82,0.86 [0.54-1.37],0.5160006626514213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164,Sialomucin core protein 24,22641,79,1.25 [0.66-2.37],0.4907204665967025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164L2,CD164 sialomucin-like 2 protein,19160,69,0.92 [0.49-1.75],0.8042543242992866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD177,CD177 antigen,22612,79,1.02 [0.87-1.19],0.7998845593739293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD1C,T-cell surface glycoprotein CD1c,22705,82,1.65 [0.71-3.86],0.2453121574658944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2,T-cell surface antigen CD2,19109,70,0.74 [0.37-1.48],0.3915531648232377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200,OX-2 membrane glycoprotein,22597,82,1.31 [0.61-2.82],0.4954179522609769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200R1,Cell surface glycoprotein CD200 receptor 1,22529,82,0.81 [0.45-1.46],0.4916336489739841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD207,C-type lectin domain family 4 member K,22140,81,1.22 [0.72-2.04],0.4580025375519534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD209,CD209 antigen,22682,81,1.00 [0.60-1.66],0.998712366390242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD22,B-cell receptor CD22,22885,83,0.91 [0.56-1.50],0.7197234489841107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD226,CD226 antigen,19160,71,0.65 [0.37-1.13],0.126275644905247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD244,Natural killer cell receptor 2B4,22885,83,0.78 [0.38-1.61],0.4996036788265612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD248,Endosialin,19705,73,1.37 [0.78-2.39],0.2697045815511033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD27,CD27 antigen,22705,82,1.46 [0.90-2.36],0.1264008053604605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD274,Programmed cell death 1 ligand 1,22486,81,1.35 [0.79-2.31],0.2784926154872533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD276,CD276 antigen,22630,82,1.19 [0.68-2.09],0.5419866389963577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD28,T-cell-specific surface glycoprotein CD28,22124,81,1.20 [0.71-2.03],0.4958816838010247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2AP,CD2-associated protein,22636,82,1.15 [0.86-1.55],0.3449195952106392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300A,CMRF35-like molecule 8,19296,70,1.12 [0.51-2.44],0.7830861713924333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300C,CMRF35-like molecule 6,22833,80,0.87 [0.48-1.57],0.6350647770078179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300E,CMRF35-like molecule 2,22758,83,1.21 [0.74-1.96],0.4530276321516705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LF,CMRF35-like molecule 1,22837,83,0.93 [0.68-1.28],0.6584111952491158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LG,CMRF35-like molecule 9,22641,79,1.05 [0.61-1.79],0.8683976534281304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD302,CD302 antigen,22532,81,0.90 [0.45-1.80],0.774460211398537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD33,Myeloid cell surface antigen CD33,22705,82,1.13 [0.88-1.45],0.3407461889225858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD34,Hematopoietic progenitor cell antigen CD34,22751,80,1.11 [0.49-2.52],0.8084362723809515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD36,Platelet glycoprotein 4,19160,71,0.64 [0.37-1.12],0.1216323811716455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22532,81,0.89 [0.46-1.71],0.7267301437864193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3D,T-cell surface glycoprotein CD3 delta chain,19101,70,1.12 [0.59-2.09],0.7326969195879994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19329,70,0.76 [0.37-1.60],0.476445427779954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3G,T-cell surface glycoprotein CD3 gamma chain,19160,71,0.93 [0.70-1.22],0.5817207930523257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD4,T-cell surface glycoprotein CD4,22555,82,1.28 [0.72-2.26],0.4008847889950028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40,Tumor necrosis factor receptor superfamily member 5,22632,82,0.70 [0.46-1.07],0.1008085464478216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40LG,CD40 ligand,22885,83,0.90 [0.70-1.15],0.3937641113210911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD46,Membrane cofactor protein,22471,81,0.67 [0.32-1.40],0.2874349569975447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD48,CD48 antigen,22700,82,0.62 [0.32-1.21],0.1584686747560093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5,T-cell surface glycoprotein CD5,22804,83,1.06 [0.59-1.93],0.8374660376905845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD55,Complement decay-accelerating factor,21825,80,0.78 [0.35-1.76],0.5505360950685365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD58,Lymphocyte function-associated antigen 3,22596,82,0.36 [0.12-1.03],0.0579101630434193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD59,CD59 glycoprotein,21798,79,0.60 [0.22-1.63],0.3154756365833513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5L,CD5 antigen-like,19620,72,1.14 [0.70-1.86],0.5877084569633582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD6,T-cell differentiation antigen CD6,22845,83,1.06 [0.74-1.53],0.7406369796641081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD63,CD63 antigen,22451,81,0.92 [0.63-1.34],0.6653385517317354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD69,Early activation antigen CD69,22539,82,0.87 [0.70-1.08],0.2056538573861381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD7,T-cell antigen CD7,19121,71,0.59 [0.34-1.04],0.0694441217769122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD70,CD70 antigen,22597,82,1.11 [0.69-1.79],0.6559833875541663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD72,B-cell differentiation antigen CD72,19296,70,1.40 [0.81-2.43],0.2251866398862387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD74,HLA class II histocompatibility antigen gamma chain,22833,80,1.01 [0.57-1.81],0.9696620335425324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD79B,B-cell antigen receptor complex-associated protein beta chain,22885,83,1.39 [0.90-2.17],0.1413029531407557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD80,T-lymphocyte activation antigen CD80,19709,73,1.03 [0.52-2.04],0.9319938585154102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD82,CD82 antigen,19329,70,1.07 [0.64-1.80],0.7844934100653636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD83,CD83 antigen,22597,82,1.06 [0.58-1.92],0.8520116172799965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD84,SLAM family member 5,22597,82,0.54 [0.29-1.01],0.0531794602633747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD86,T-lymphocyte activation antigen CD86,19608,71,0.71 [0.33-1.50],0.3704620297080704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD8A,T-cell surface glycoprotein CD8 alpha chain,22833,80,1.10 [0.74-1.65],0.6409017554502551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD93,Complement component C1q receptor,21751,81,1.10 [0.58-2.10],0.7757791741804214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99,CD99 antigen,22641,79,0.94 [0.33-2.68],0.909406259665512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99L2,CD99 antigen-like protein 2,22641,79,1.22 [0.52-2.87],0.6425494339639805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDA,Cytidine deaminase,19668,73,1.19 [0.77-1.84],0.4348004055239374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDAN1,Codanin-1,19668,71,1.69 [0.91-3.13],0.0976245218158663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC123,Cell division cycle protein 123 homolog,19016,71,0.98 [0.69-1.40],0.916370329063946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC25A,M-phase inducer phosphatase 1,19016,71,0.94 [0.53-1.67],0.8429134016971489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC26,Anaphase-promoting complex subunit CDC26,19580,71,0.75 [0.53-1.05],0.0927900363256278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC27,Cell division cycle protein 27 homolog,22124,81,0.98 [0.70-1.36],0.8936297434177551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC37,Hsp90 co-chaperone Cdc37,22705,82,0.95 [0.75-1.20],0.6630577109676462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC42BPB,Serine/threonine-protein kinase MRCK beta,19608,71,0.82 [0.65-1.04],0.1026866212542711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDCP1,CUB domain-containing protein 1,22486,81,1.04 [0.69-1.56],0.847583812879072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH1,Cadherin-1,21851,81,1.17 [0.73-1.86],0.5094371304661696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH15,Cadherin-15,22785,80,1.18 [0.78-1.79],0.4213781059155387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH17,Cadherin-17,22636,82,0.95 [0.71-1.28],0.7535306373380083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH2,Cadherin-2,22636,82,1.53 [0.88-2.69],0.1346996587718985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH22,Cadherin-22,19329,70,1.35 [0.70-2.62],0.3761636751106726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH23,Cadherin-23,19668,71,1.49 [0.69-3.25],0.3115712266765485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,22833,80,1.70 [1.03-2.82],0.0392046562677097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH4,Cadherin-4,19101,70,0.94 [0.57-1.54],0.8000673468174844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH5,Cadherin-5,22905,81,1.26 [0.66-2.40],0.4753389284003604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH6,Cadherin-6,22636,82,1.47 [0.88-2.46],0.1418352774930081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,22073,79,1.50 [1.06-2.13],0.0218378550849515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,22532,81,1.31 [1.01-1.69],0.0404479189146989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR5,Cadherin-related family member 5,22636,82,0.87 [0.53-1.43],0.5791828359676172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK1,Cyclin-dependent kinase 1,19016,71,1.29 [0.70-2.37],0.4078797058523914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19678,72,0.75 [0.49-1.15],0.1948262889922947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKL5,Cyclin-dependent kinase-like 5,19101,70,1.10 [0.75-1.62],0.6171148722560051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN1A,Cyclin-dependent kinase inhibitor 1,22532,81,0.84 [0.69-1.01],0.0659429778057946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22532,81,0.87 [0.71-1.06],0.1788094498423829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDNF,Cerebral dopamine neurotrophic factor,22532,81,0.67 [0.36-1.28],0.2244260543577458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22672,82,0.73 [0.35-1.51],0.3921404502482071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDSN,Corneodesmosin,22805,83,1.02 [0.65-1.60],0.9463283927989596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22666,81,1.80 [0.68-4.80],0.2376602695989109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19608,71,0.90 [0.67-1.19],0.4559409663969876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19329,70,0.68 [0.42-1.08],0.1045132357046305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19608,71,0.78 [0.44-1.40],0.4089081321641599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19329,70,0.74 [0.41-1.32],0.3053971078089862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22597,82,0.97 [0.77-1.22],0.7741978745285047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22124,81,1.28 [0.90-1.81],0.1699873779230019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21821,80,1.28 [0.96-1.71],0.0970367443363721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19705,73,1.27 [0.72-2.24],0.4073763856412281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22232,80,1.11 [0.75-1.66],0.5944125083292975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPA,CCAAT/enhancer-binding protein alpha,19160,71,0.77 [0.37-1.59],0.4733551588695945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPB,CCAAT/enhancer-binding protein beta,22232,80,1.10 [0.66-1.83],0.7067496617859229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA2A,Chymotrypsin-like elastase family member 2A,19705,73,0.89 [0.61-1.30],0.5413794528052691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA3A,Chymotrypsin-like elastase family member 3A,22867,81,1.08 [0.76-1.54],0.6624013802210879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19296,70,0.59 [0.35-1.00],0.0507619002431057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,19160,71,1.75 [1.30-2.35],0.0002182837751979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEND1,Cell cycle exit and neuronal differentiation protein 1,19101,70,0.79 [0.49-1.28],0.333160558969388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPF,Centromere protein F,19329,70,1.32 [0.92-1.88],0.1343996535906692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPJ,Centromere protein J,19329,70,0.90 [0.64-1.27],0.5485340273041008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP112,Centrosomal protein of 112 kDa,19109,70,0.98 [0.58-1.65],0.9305201679696596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP152,Centrosomal protein of 152 kDa,19016,71,1.02 [0.61-1.73],0.9289008276178554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,22210,82,1.25 [1.00-1.56],0.0472348030881386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP170,Centrosomal protein of 170 kDa,19209,70,0.94 [0.69-1.28],0.6944301623803045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP20,Centrosomal protein 20,22124,81,1.02 [0.78-1.34],0.8573139495682368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP290,Centrosomal protein of 290 kDa,19329,70,0.60 [0.35-1.04],0.0666630475270319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP350,Centrosome-associated protein 350,19016,71,1.41 [0.86-2.33],0.1743763603720045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP43,Centrosomal protein 43,22055,79,0.85 [0.63-1.14],0.2763103449799551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP85,Centrosomal protein of 85 kDa,22124,81,1.15 [0.85-1.57],0.3582158869732013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CERT,Ceramide transfer protein,22073,79,0.83 [0.60-1.16],0.272607346313906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES1,Liver carboxylesterase 1,22680,81,1.06 [0.82-1.36],0.6548143041989005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES2,Cocaine esterase,22532,81,0.93 [0.64-1.35],0.7142443909458805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES3,Carboxylesterase 3,22532,81,1.04 [0.78-1.38],0.7840770732807848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,22073,79,0.70 [0.51-0.97],0.0299673529719148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN3,Centrin-3,19608,71,0.83 [0.61-1.12],0.2160848125665702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFB,Complement factor B,19361,71,0.82 [0.41-1.66],0.5859431489729955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFC1,Cryptic protein,22124,81,0.92 [0.59-1.45],0.7275255763946324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFD,Complement factor D,19738,73,1.20 [0.39-3.73],0.7535641184639955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFH,Complement factor H,18565,63,0.42 [0.15-1.19],0.1029414267544696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR2,Complement factor H-related protein 2,19596,73,0.95 [0.65-1.38],0.7779502011452566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR4,Complement factor H-related protein 4,19707,73,1.02 [0.75-1.38],0.9017450871027872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR5,Complement factor H-related protein 5,19444,70,0.76 [0.46-1.26],0.2914440508560564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFI,Complement factor I,19738,73,0.83 [0.27-2.53],0.7441287756263485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFP,Properdin,19738,73,1.37 [0.62-3.03],0.4339229601264854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGA,Glycoprotein hormones alpha chain,22641,79,1.18 [0.92-1.51],0.1879061260545381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19711,71,1.34 [1.03-1.74],0.0315813661435133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,19160,69,1.47 [1.00-2.15],0.049849614950449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGREF1,Cell growth regulator with EF hand domain protein 1,22636,82,0.99 [0.62-1.59],0.9729706828138096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22124,81,1.18 [0.88-1.59],0.2698271151684688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAD,Chondroadherin,19296,70,1.02 [0.66-1.57],0.9442706190641416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19668,71,0.89 [0.48-1.64],0.7041293681155336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD6,MICOS complex subunit MIC25,19602,71,0.44 [0.17-1.17],0.0987901024775498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHEK2,Serine/threonine-protein kinase Chk2,22232,80,1.29 [0.74-2.23],0.3697677653396481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGA,Chromogranin-A,19705,73,0.86 [0.65-1.13],0.2724976374281526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGB,Secretogranin-1,22742,80,0.76 [0.46-1.26],0.2857123111925403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHI3L1,Chitinase-3-like protein 1,22108,80,1.08 [0.83-1.40],0.5803948586263658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHIT1,Chitotriosidase-1,22726,81,0.97 [0.86-1.10],0.648821818720188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHL1,Neural cell adhesion molecule L1-like protein,22661,82,1.16 [0.63-2.14],0.6421308374641842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHM,Rab proteins geranylgeranyltransferase component A 1,19160,69,0.75 [0.51-1.13],0.1687297779793045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP1A,Charged multivesicular body protein 1a,22486,81,0.94 [0.73-1.20],0.6048114975239849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP6,Charged multivesicular body protein 6,19709,73,0.76 [0.51-1.14],0.1847700144589721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHP1,Calcineurin B homologous protein 1,19101,70,0.80 [0.56-1.14],0.2191949684705521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL1,Chordin-like protein 1,22700,82,0.69 [0.36-1.32],0.2612561642515175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL2,Chordin-like protein 2,22636,82,0.82 [0.57-1.19],0.2978341663814726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRM1,Muscarinic acetylcholine receptor M1,19160,69,1.47 [0.93-2.34],0.099181379082536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIAPIN1,Anamorsin,22705,82,0.99 [0.73-1.34],0.9300721117856008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CILP,Cartilage intermediate layer protein 1,19705,73,0.87 [0.58-1.30],0.4876227682600654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CINP,Cyclin-dependent kinase 2-interacting protein,19329,70,0.92 [0.54-1.58],0.7681826562240014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIRBP,Cold-inducible RNA-binding protein,19608,71,0.88 [0.70-1.12],0.3013023423276831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIT,Citron Rho-interacting kinase,19160,69,1.42 [0.93-2.17],0.1055157753348486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKAP4,Cytoskeleton-associated protein 4,22777,83,1.43 [0.70-2.92],0.3312759406317039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKB,Creatine kinase B-type,19705,73,0.83 [0.57-1.20],0.3237825027332418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22556,82,0.88 [0.70-1.12],0.3041847617549358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLASP1,CLIP-associating protein 1,19016,71,0.91 [0.65-1.28],0.5967687964904884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLC,Galectin-10,22601,82,1.10 [0.82-1.46],0.523338891353767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC10A,C-type lectin domain family 10 member A,22486,81,0.99 [0.56-1.73],0.9620516712057566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC11A,C-type lectin domain family 11 member A,22593,79,1.12 [0.74-1.70],0.5898019540191912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC12A,C-type lectin domain family 12 member A,19160,71,1.23 [0.42-3.59],0.706223417335146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC14A,C-type lectin domain family 14 member A,22641,79,0.89 [0.47-1.69],0.7128302773938977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1A,C-type lectin domain family 1 member A,22232,80,0.98 [0.53-1.82],0.9521753725410184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1B,C-type lectin domain family 1 member B,22833,80,0.84 [0.69-1.04],0.1074196009926984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC2L,C-type lectin domain family 2 member L,19160,69,1.20 [0.82-1.76],0.3559623009945104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC3B,Tetranectin,19262,70,0.86 [0.29-2.55],0.7808730391602523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4A,C-type lectin domain family 4 member A,22597,82,0.81 [0.46-1.42],0.4538181098775929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4C,C-type lectin domain family 4 member C,22597,82,0.97 [0.64-1.49],0.9065790521255294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4D,C-type lectin domain family 4 member D,22597,82,1.11 [0.80-1.53],0.5351456186603696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4G,C-type lectin domain family 4 member G,22597,82,0.68 [0.37-1.24],0.207698651740419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4M,C-type lectin domain family 4 member M,19666,73,0.93 [0.59-1.48],0.7652145050629015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC5A,C-type lectin domain family 5 member A,22569,82,1.32 [0.67-2.60],0.429262315060379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,22124,81,1.58 [1.07-2.34],0.0201617269757297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC7A,C-type lectin domain family 7 member A,22885,83,0.89 [0.67-1.19],0.4475945256623179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLGN,Calmegin,19160,69,0.86 [0.50-1.47],0.5710901134205606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIC5,Chloride intracellular channel protein 5,19160,69,1.31 [0.73-2.37],0.3708240682662931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLINT1,Clathrin interactor 1,19016,71,0.86 [0.50-1.47],0.5786310356335967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIP2,CAP-Gly domain-containing linker protein 2,22597,82,0.88 [0.74-1.04],0.1434440231388455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLMP,CXADR-like membrane protein,22837,83,0.61 [0.23-1.63],0.3244673290521128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLNS1A,Methylosome subunit pICln,19160,69,1.68 [0.93-3.04],0.0868472901865985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22438,81,0.91 [0.74-1.12],0.3706500786733357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPS,Colipase,22606,79,1.33 [0.99-1.78],0.0545315069664145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSPN,Claspin,22025,79,1.22 [0.75-2.01],0.4233840876927611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN1,Calsyntenin-1,22073,79,0.78 [0.51-1.19],0.2431399756372432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN2,Calsyntenin-2,22885,83,0.61 [0.36-1.06],0.0802672197029248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN3,Calsyntenin-3,19668,71,0.79 [0.37-1.68],0.5335481595896358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLTA,Clathrin light chain A,22232,80,0.83 [0.53-1.29],0.4070190774931289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLU,Clusterin,19738,73,0.86 [0.38-1.94],0.7231947136535113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLUL1,Clusterin-like protein 1,22603,80,0.92 [0.59-1.42],0.7041605486776453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,19709,73,0.74 [0.58-0.96],0.0235084932506243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMIP,C-Maf-inducing protein,19602,71,0.80 [0.61-1.06],0.1260709686135713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNDP1,Beta-Ala-His dipeptidase,22698,82,1.32 [0.84-2.08],0.2344518967750466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19101,70,0.97 [0.63-1.49],0.8779476207281852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19171,69,0.89 [0.67-1.20],0.4485148561539984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY2,Protein canopy homolog 2,22232,80,0.68 [0.44-1.04],0.0762006815342286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,22532,81,0.75 [0.58-0.97],0.030985711545957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNST,Consortin,22636,82,0.91 [0.76-1.09],0.2912902468344391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTF,Ciliary neurotrophic factor,19101,70,1.02 [0.52-1.99],0.961593958989294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN1,Contactin-1,22905,81,0.96 [0.47-1.95],0.902930422659322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN2,Contactin-2,22837,83,0.76 [0.49-1.18],0.2200449277283505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN3,Contactin-3,22641,79,1.00 [0.56-1.80],0.9914381279019524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN4,Contactin-4,22641,79,1.47 [0.64-3.38],0.3581757435413576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN5,Contactin-5,22685,80,1.41 [0.84-2.39],0.1960684803997815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP2,Contactin-associated protein-like 2,22597,82,0.97 [0.59-1.59],0.915968239542568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP4,Contactin-associated protein-like 4,19160,69,1.09 [0.90-1.33],0.377317583344712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COCH,Cochlin,19709,73,1.11 [0.69-1.79],0.6616817084701692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL15A1,Collagen alpha-1(XV) chain,19705,73,0.55 [0.23-1.31],0.1757596939107606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL18A1,Collagen alpha-1(XVIII) chain,22729,81,1.02 [0.43-2.42],0.9567884143998924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL1A1,Collagen alpha-1(I) chain,22905,81,1.04 [0.49-2.20],0.9131479806516464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL24A1,Collagen alpha-1(XXIV) chain,19608,71,0.80 [0.54-1.20],0.2886709015370512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL28A1,Collagen alpha-1(XXVIII) chain,19160,69,1.01 [0.73-1.40],0.9473720760582672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL2A1,Collagen alpha-1(II) chain,19209,70,1.09 [0.83-1.44],0.5413087004119955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL3A1,Collagen alpha-1(III) chain,19705,73,1.99 [0.80-4.90],0.1369326955004322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A1,Collagen alpha-1(IV) chain,22636,82,1.17 [0.71-1.92],0.5402643543943519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A4,Collagen alpha-4(IV) chain,19298,70,0.98 [0.64-1.51],0.9286530544921294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL5A1,Collagen alpha-1(V) chain,19296,70,0.96 [0.53-1.72],0.8825842644770234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL6A3,Collagen alpha-3(VI) chain,22905,81,0.83 [0.45-1.53],0.5585461570773557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A1,Collagen alpha-1(IX) chain,22597,82,1.06 [0.71-1.58],0.7606097546585537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A2,Collagen alpha-2(IX) chain,19329,70,0.93 [0.56-1.57],0.7954531794108609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COLEC12,Collectin-12,22630,82,0.91 [0.42-2.02],0.825167168939869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD1,COMM domain-containing protein 1,19209,70,0.71 [0.48-1.05],0.0850054064885987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD9,COMM domain-containing protein 9,19602,71,0.68 [0.36-1.30],0.2473373463593847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMP,Cartilage oligomeric matrix protein,22371,82,0.98 [0.54-1.76],0.9350389549988044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMT,Catechol O-methyltransferase,21996,79,0.99 [0.78-1.26],0.9453503220933476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPB2,Coatomer subunit beta',19109,70,0.69 [0.39-1.22],0.204297975930501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,22073,79,1.50 [1.14-1.97],0.0041496694874122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19209,70,1.06 [0.65-1.75],0.8082205974855633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO1A,Coronin-1A,22149,79,0.97 [0.77-1.21],0.7804879721260473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO6,Coronin-6,19101,70,1.39 [0.82-2.37],0.2249085891198305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22532,81,0.78 [0.58-1.05],0.1073789491459173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX6B1,Cytochrome c oxidase subunit 6B1,19709,73,0.53 [0.25-1.11],0.0936518728577095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA1,Carboxypeptidase A1,22905,81,1.19 [0.85-1.66],0.3113632756784229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA2,Carboxypeptidase A2,22747,80,1.14 [0.85-1.54],0.381933899083299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA4,Carboxypeptidase A4,18905,69,1.12 [0.65-1.93],0.6927152679225503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB1,Carboxypeptidase B,22905,81,1.10 [0.78-1.54],0.6040387593717854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB2,Carboxypeptidase B2,19693,72,1.15 [0.42-3.16],0.7795445571576483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPE,Carboxypeptidase E,22675,83,0.71 [0.45-1.11],0.1322260178159806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPLX2,Complexin-2,19016,71,0.67 [0.30-1.51],0.3337883620711229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPM,Carboxypeptidase M,22726,80,1.10 [0.62-1.97],0.7392468757992423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19160,71,0.93 [0.40-2.12],0.8547582147696178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPPED1,Serine/threonine-protein phosphatase CPPED1,22833,80,1.29 [0.97-1.72],0.0752888958163799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPQ,Carboxypeptidase Q,19663,73,1.04 [0.54-2.00],0.9139485935906848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPTP,Ceramide-1-phosphate transfer protein,19109,70,0.88 [0.48-1.61],0.6788459456461224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,22809,83,0.64 [0.42-0.98],0.0379275755071621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM1,Probable carboxypeptidase X1,22705,82,0.89 [0.67-1.18],0.4169204473429273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM2,Inactive carboxypeptidase-like protein X2,19709,73,0.88 [0.36-2.17],0.7807418792114308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR1,Complement receptor type 1,19630,71,0.89 [0.47-1.69],0.7188919411773456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR2,Complement receptor type 2,22698,82,0.85 [0.56-1.30],0.4549733746213813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22124,81,1.08 [0.87-1.35],0.4844188107099284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRADD,Death domain-containing protein CRADD,22438,81,1.01 [0.78-1.31],0.9371455660558348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREB3,Cyclic AMP-responsive element-binding protein 3,19016,71,0.92 [0.61-1.40],0.7017979637178409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREBZF,CREB/ATF bZIP transcription factor,19016,71,1.29 [0.58-2.87],0.5316664549758017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREG1,Protein CREG1,22336,80,1.35 [0.80-2.29],0.2649648248998037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD1,Protein disulfide isomerase CRELD1,19296,70,0.82 [0.44-1.51],0.5166286199501686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,22700,82,0.62 [0.42-0.91],0.0158398959791566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRH,Corticoliberin,22083,81,1.16 [0.93-1.46],0.1941557431878846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHBP,Corticotropin-releasing factor-binding protein,22630,82,1.10 [0.54-2.22],0.7942976353578908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHR1,Corticotropin-releasing factor receptor 1,22232,80,0.96 [0.70-1.33],0.8269518957590519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIM1,Cysteine-rich motor neuron 1 protein,22739,82,1.41 [0.54-3.69],0.489360755666716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIP2,Cysteine-rich protein 2,22486,81,1.28 [0.78-2.08],0.3276606624888201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP2,Cysteine-rich secretory protein 2,22837,83,0.88 [0.65-1.20],0.4236565075042028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP3,Cysteine-rich secretory protein 3,19531,71,0.80 [0.35-1.85],0.604262953096357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRKL,Crk-like protein,22666,82,0.91 [0.76-1.09],0.2936164518759776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRLF1,Cytokine receptor-like factor 1,22739,82,1.03 [0.48-2.23],0.930957825136392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRNN,Cornulin,21994,81,1.05 [0.78-1.42],0.7366731068358461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAC1,Cartilage acidic protein 1,22905,81,0.59 [0.32-1.12],0.1079667270132852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAM,Cytotoxic and regulatory T-cell molecule,22486,81,0.87 [0.58-1.30],0.4971842119784466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAP,Cartilage-associated protein,19160,69,1.03 [0.65-1.63],0.9118901633048876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRX,Cone-rod homeobox protein,22232,80,0.99 [0.83-1.19],0.9258301273854704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,19709,73,0.64 [0.44-0.92],0.0154883423697787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB2,Beta-crystallin B2,19668,71,0.96 [0.67-1.37],0.8303907205788641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYGD,Gamma-crystallin D,19668,71,1.00 [0.79-1.26],0.9868783245388164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,19101,70,1.27 [1.02-1.58],0.035073422106006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYZL1,Quinone oxidoreductase-like protein 1,19209,70,0.86 [0.67-1.10],0.2322967724451299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSDE1,Cold shock domain-containing protein E1,19109,70,1.02 [0.84-1.23],0.8734256474221761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1,Macrophage colony-stimulating factor 1,22739,82,1.59 [0.78-3.22],0.201607738040793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1R,Macrophage colony-stimulating factor 1 receptor,19711,71,0.99 [0.55-1.77],0.962809602342106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2,Granulocyte-macrophage colony-stimulating factor,19109,70,0.77 [0.39-1.52],0.4494954144009256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22486,81,0.60 [0.43-0.84],0.0033090147488125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RB,Cytokine receptor common subunit beta,19160,71,1.02 [0.61-1.73],0.9290096894034752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3,Granulocyte colony-stimulating factor,22210,82,1.19 [0.80-1.78],0.3840590060979941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3R,Granulocyte colony-stimulating factor receptor,19160,71,1.46 [0.74-2.88],0.2756914119328771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,19711,71,1.48 [1.14-1.91],0.0031106458851876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,19160,71,0.65 [0.43-0.99],0.0455218701771125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK2A1,Casein kinase II subunit alpha,19678,72,0.89 [0.54-1.47],0.646397756947666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG4,Chondroitin sulfate proteoglycan 4,19705,73,1.16 [0.59-2.31],0.6657915985039401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG5,Chondroitin sulfate proteoglycan 5,19101,70,0.76 [0.45-1.29],0.3141414304659289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSRP3,Cysteine and glycine-rich protein 3,19109,70,1.01 [0.79-1.28],0.9637800058934524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST1,Cystatin-SN,17102,65,1.10 [0.86-1.40],0.4413792341276938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST3,Cystatin-C,22665,82,0.99 [0.48-2.03],0.9795050847163542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST5,Cystatin-D,22255,81,1.23 [0.87-1.75],0.2433411047178817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST6,Cystatin-M,22061,81,1.09 [0.71-1.66],0.7002418755023685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST7,Cystatin-F,22671,82,0.95 [0.76-1.18],0.64341527068005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSTB,Cystatin-B,22320,78,1.10 [0.68-1.77],0.6952189545078019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTAG1A_CTAG1B,Cancer/testis antigen 1,19286,70,1.26 [0.85-1.88],0.2549948544595956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTBS,Di-N-acetylchitobiase,19417,71,1.72 [0.71-4.12],0.2271529602437555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTF1,Cardiotrophin-1,22232,80,0.84 [0.66-1.07],0.1623452608591946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTHRC1,Collagen triple helix repeat-containing protein 1,19705,73,1.00 [0.45-2.25],0.9946962491919444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTLA4,Cytotoxic T-lymphocyte protein 4,19705,73,0.59 [0.27-1.26],0.1712593357141707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTNNA1,Catenin alpha-1,19101,70,1.31 [0.80-2.14],0.287261146871006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRB1,Chymotrypsinogen B,22641,79,1.00 [0.69-1.46],0.990486321698077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRC,Chymotrypsin-C,22639,82,1.16 [0.85-1.59],0.348908821317225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRL,Chymotrypsin-like protease CTRL-1,19668,71,1.06 [0.75-1.50],0.7366444476934657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSB,Cathepsin B,22653,81,1.17 [0.82-1.67],0.3909241903416891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSC,Dipeptidyl peptidase 1,22595,82,1.22 [0.78-1.90],0.3792399193559364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSD,Cathepsin D,21114,80,0.83 [0.48-1.43],0.5003970199884611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSE,Cathepsin E,19296,70,0.98 [0.62-1.53],0.915764013263682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSF,Cathepsin F,22705,82,1.47 [0.91-2.38],0.1166220084028606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSH,Pro-cathepsin H,22170,80,0.89 [0.67-1.17],0.392551337763029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSL,Cathepsin L1,22636,82,1.11 [0.49-2.52],0.7949219314255496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,22885,83,2.13 [1.18-3.85],0.0118011566166973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSS,Cathepsin S,17770,60,1.47 [0.53-4.08],0.4599116476935985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSV,Cathepsin L2,22778,83,1.42 [0.93-2.17],0.1085882623232156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSZ,Cathepsin Z,22619,82,1.26 [0.67-2.37],0.4771429585284833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19160,69,1.29 [0.75-2.21],0.3588461230734212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CWC15,Spliceosome-associated protein CWC15 homolog,19490,71,0.94 [0.65-1.38],0.7709061504069898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CX3CL1,Fractalkine,22486,81,0.81 [0.45-1.48],0.4954907651609829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXADR,Coxsackievirus and adenovirus receptor,22597,82,1.16 [0.81-1.65],0.4089089109027587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL1,Growth-regulated alpha protein,22596,82,1.05 [0.86-1.27],0.6397304905578031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL10,C-X-C motif chemokine 10,22739,82,1.13 [0.86-1.48],0.3896933959181496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL11,C-X-C motif chemokine 11,22833,80,1.04 [0.82-1.33],0.7472109820944972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL12,Stromal cell-derived factor 1,22210,82,1.06 [0.66-1.72],0.8010657624529156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,22833,80,1.39 [1.14-1.70],0.0009949328525199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL14,C-X-C motif chemokine 14,22210,82,0.94 [0.66-1.32],0.7051874941631276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL16,C-X-C motif chemokine 16,22866,81,1.22 [0.53-2.84],0.6388101362230824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL17,C-X-C motif chemokine 17,22885,83,0.98 [0.61-1.57],0.9234723967576732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL3,C-X-C motif chemokine 3,22632,82,0.91 [0.74-1.12],0.3848289897513232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,22563,82,0.83 [0.71-0.99],0.033673926536707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL6,C-X-C motif chemokine 6,22885,83,0.83 [0.65-1.07],0.1547397674966924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL8,Interleukin-8,22462,83,1.04 [0.79-1.37],0.7965062167485909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL9,C-X-C motif chemokine 9,22739,82,1.17 [0.89-1.53],0.2599871996677124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5A,Cytochrome b5,19016,71,0.89 [0.63-1.25],0.5058409092935494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,19365,70,0.63 [0.40-0.97],0.0376210302144857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19109,70,1.10 [0.87-1.38],0.4273533134039786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTH3,Cytohesin-3,19016,71,1.18 [0.91-1.53],0.206245363660818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTL1,Cytokine-like protein 1,19705,73,1.31 [0.50-3.44],0.5835900509987478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAAM1,Disheveled-associated activator of morphogenesis 1,19296,70,0.89 [0.68-1.18],0.4333240478425977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAB2,Disabled homolog 2,22837,83,0.89 [0.75-1.06],0.2007598309494105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAG1,Dystroglycan,22739,82,0.77 [0.51-1.17],0.2234858196681518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAND5,DAN domain family member 5,19160,71,0.82 [0.53-1.26],0.3621122917957056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPK2,Death-associated protein kinase 2,19160,71,1.06 [0.72-1.57],0.7537837832967705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22597,82,0.88 [0.76-1.03],0.1092057151597462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22438,81,0.84 [0.65-1.10],0.2055567334679629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBH,Dopamine beta-hydroxylase,19670,71,0.95 [0.78-1.16],0.6078933004304659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBI,Acyl-CoA-binding protein,22542,79,0.83 [0.64-1.08],0.1648340914230873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBN1,Drebrin,19160,71,0.68 [0.42-1.10],0.1188157641195325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBNL,Drebrin-like protein,22739,82,0.89 [0.72-1.09],0.2671497728095247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22705,82,2.24 [1.28-3.93],0.0048011043689876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCC,Netrin receptor DCC,19160,69,1.18 [0.48-2.85],0.7210522445600602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCDC2C,Doublecortin domain-containing protein 2C,19016,71,1.05 [0.74-1.48],0.7828639082563715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCLRE1C,Protein artemis,19016,71,1.22 [0.62-2.41],0.565832637625165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCN,Decorin,22232,80,0.55 [0.22-1.37],0.2002099759528753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTD,Deoxycytidylate deaminase,19296,70,0.81 [0.63-1.02],0.0762936309502358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN1,Dynactin subunit 1,22837,83,1.03 [0.77-1.38],0.8388320443667717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN2,Dynactin subunit 2,22532,81,0.97 [0.78-1.19],0.746463796000107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN6,Dynactin subunit 6,22073,79,0.99 [0.74-1.31],0.932496669108834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTPP1,dCTP pyrophosphatase 1,22636,82,0.82 [0.43-1.56],0.5462826103417958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D1,DCN1-like protein 1,19101,70,1.00 [0.74-1.35],0.9940916788087468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D2,DCN1-like protein 2,19016,71,1.20 [0.95-1.50],0.1210407258743315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCXR,L-xylulose reductase,22705,82,1.20 [0.84-1.72],0.3143706771894004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDA1,DET1- and DDB1-associated protein 1,19109,70,1.06 [0.62-1.82],0.8198622825830217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22532,81,0.69 [0.43-1.11],0.1250533022610597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDC,Aromatic-L-amino-acid decarboxylase,22602,82,0.93 [0.62-1.40],0.7316670526739232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDHD2,Phospholipase DDHD2,19678,72,0.81 [0.57-1.14],0.2170041244891934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,19296,70,1.45 [1.11-1.89],0.0060438279226151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDR1,Epithelial discoidin domain-containing receptor 1,22833,80,1.80 [0.79-4.08],0.1628880308862284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDT,D-dopachrome decarboxylase,19705,73,1.50 [0.94-2.39],0.0855548021897467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX1,ATP-dependent RNA helicase DDX1,19608,71,0.94 [0.59-1.49],0.7950422241137244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX25,ATP-dependent RNA helicase DDX25,19160,69,1.15 [0.67-1.96],0.6164780107276613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX39A,ATP-dependent RNA helicase DDX39A,19160,71,0.82 [0.28-2.38],0.7190422149833807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX4,Probable ATP-dependent RNA helicase DDX4,19160,71,0.97 [0.63-1.49],0.888788375937017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX53,Probable ATP-dependent RNA helicase DDX53,19160,69,1.25 [0.67-2.32],0.4823640255782094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX58,Antiviral innate immune response receptor RIG-I,22124,81,0.81 [0.56-1.19],0.2840567056845385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22597,82,0.91 [0.74-1.11],0.3473807889060661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFA1_DEFA1B,Neutrophil defensin 1,22154,79,1.10 [0.76-1.59],0.6227775327908676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,19008,71,1.49 [1.10-2.02],0.0097165760979995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB104A_DEFB104B,Beta-defensin 104,19101,70,1.17 [0.82-1.69],0.3873850562265559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB116,Beta-defensin 116,19101,70,1.14 [0.89-1.46],0.3151904674303371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB118,Beta-defensin 118,19101,70,1.00 [0.68-1.48],0.9994072073209204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB4A_DEFB4B,Beta-defensin 4A,22327,81,1.12 [0.98-1.27],0.0990787529319178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENND2B,DENN domain-containing protein 2B,19109,70,1.13 [0.77-1.65],0.5352587145047116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENR,Density-regulated protein,19160,71,0.87 [0.57-1.32],0.5081101953962288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DFFA,DNA fragmentation factor subunit alpha,22885,83,0.91 [0.68-1.21],0.4982353375256912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,19101,70,1.52 [1.17-1.97],0.0018307384720974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKA,Diacylglycerol kinase alpha,19160,71,0.88 [0.57-1.35],0.5582748362050824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKZ,Diacylglycerol kinase zeta,22210,82,0.99 [0.57-1.73],0.9749061990124476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHODH,Dihydroorotate dehydrogenase,19109,70,1.02 [0.64-1.61],0.9479920060130544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHPS,Deoxyhypusine synthase,19602,71,0.88 [0.49-1.59],0.6727689564126776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19668,71,0.52 [0.29-0.93],0.0285699990254196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIABLO,"Diablo homolog, mitochondrial",22569,82,0.90 [0.75-1.07],0.2307669733953475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK1C,Divergent protein kinase domain 1C,19160,69,1.38 [0.90-2.13],0.1419382927472651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK2B,Divergent protein kinase domain 2B,19296,70,1.18 [0.50-2.79],0.7088418207711797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK1,Dickkopf-related protein 1,22833,80,0.90 [0.65-1.25],0.5286581534814883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK3,Dickkopf-related protein 3,22905,81,1.07 [0.55-2.09],0.8322941015250209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK4,Dickkopf-related protein 4,22455,81,0.77 [0.49-1.22],0.2652382703682933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKKL1,Dickkopf-like protein 1,22532,81,1.01 [0.80-1.26],0.9561867680817336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLG4,Disks large homolog 4,19668,71,0.87 [0.62-1.22],0.4187342456370182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLGAP5,Disks large-associated protein 5,19678,72,1.21 [0.88-1.66],0.2438586771774284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLK1,Protein delta homolog 1,22905,81,1.01 [0.70-1.46],0.9696009438921496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL1,Delta-like protein 1,22705,82,1.37 [0.70-2.68],0.3652100783701576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL4,Delta-like protein 4,19209,70,1.12 [0.93-1.36],0.2399916736935225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMD,Dystrophin,19209,70,1.01 [0.64-1.58],0.978642741586322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMP1,Dentin matrix acidic phosphoprotein 1,19209,70,1.07 [0.74-1.56],0.7205648357919718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA1,DnaJ homolog subfamily A member 1,19016,71,1.30 [0.89-1.90],0.1676157680133986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA2,DnaJ homolog subfamily A member 2,22817,83,0.96 [0.76-1.21],0.7229764027373691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA4,DnaJ homolog subfamily A member 4,19668,71,1.27 [0.95-1.71],0.1084419730126799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB1,DnaJ homolog subfamily B member 1,22532,81,1.17 [0.93-1.46],0.1773836339286825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB14,DnaJ homolog subfamily B member 14,19608,71,0.93 [0.65-1.32],0.6815424982679179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB2,DnaJ homolog subfamily B member 2,19296,70,1.36 [0.91-2.01],0.1314021556376233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB6,DnaJ homolog subfamily B member 6,19105,70,0.84 [0.64-1.10],0.2088360364453443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB8,DnaJ homolog subfamily B member 8,22232,80,0.93 [0.65-1.32],0.6829737050331846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC21,DnaJ homolog subfamily C member 21,19668,71,0.81 [0.43-1.50],0.495526106260659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19209,70,0.90 [0.68-1.19],0.4703397927826325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC9,DnaJ homolog subfamily C member 9,19608,71,0.96 [0.72-1.29],0.7873299870829525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNER,Delta and Notch-like epidermal growth factor-related receptor,22598,82,1.01 [0.45-2.27],0.971238156191428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNLZ,DNL-type zinc finger protein,19101,70,1.14 [0.93-1.39],0.2074189960533217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,19608,71,0.76 [0.63-0.92],0.0049655640899436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,19678,72,0.49 [0.30-0.81],0.004899786600345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNMBP,Dynamin-binding protein,22486,81,0.91 [0.65-1.26],0.5648254118028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPEP,Aspartyl aminopeptidase,19668,71,1.14 [0.77-1.69],0.4987136459189194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22705,82,1.48 [1.04-2.10],0.0309254752652557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOC2B,Double C2-like domain-containing protein beta,19160,69,0.97 [0.50-1.87],0.9218412774588338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOCK9,Dedicator of cytokinesis protein 9,19101,70,1.00 [0.82-1.21],0.9698004258746216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK1,Docking protein 1,19668,71,0.86 [0.74-1.01],0.0707812971118597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK2,Docking protein 2,22636,82,0.90 [0.76-1.06],0.1970859686498362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP1,Dipeptidase 1,22438,81,0.72 [0.50-1.03],0.0745057865724135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP2,Dipeptidase 2,22532,81,0.93 [0.46-1.89],0.850904417174017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP10,Inactive dipeptidyl peptidase 10,22597,82,1.30 [0.76-2.25],0.340812050240002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP4,Dipeptidyl peptidase 4,22189,81,0.80 [0.40-1.56],0.5075793555472771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP6,Dipeptidyl aminopeptidase-like protein 6,22532,81,1.31 [0.72-2.39],0.3736529294381738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP7,Dipeptidyl peptidase 2,22448,82,1.21 [0.87-1.69],0.2570622220283085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPT,Dermatopontin,22905,81,0.76 [0.37-1.56],0.4493948102633956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPY30,Protein dpy-30 homolog,22764,83,0.85 [0.61-1.20],0.367649046461708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRAXIN,Draxin,22486,81,0.90 [0.56-1.42],0.6398141023946238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRG2,Developmentally-regulated GTP-binding protein 2,22532,81,0.78 [0.54-1.12],0.1729136156457105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSC2,Desmocollin-2,22394,77,1.17 [0.63-2.17],0.6082537897964091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSCAM,Down syndrome cell adhesion molecule,19678,72,1.14 [0.60-2.15],0.696776067668922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG2,Desmoglein-2,22641,79,0.84 [0.40-1.77],0.6424841895320172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG3,Desmoglein-3,22769,83,0.97 [0.54-1.73],0.9053746190686636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG4,Desmoglein-4,22452,81,1.10 [0.74-1.62],0.6402165996091074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTD1,D-aminoacyl-tRNA deacylase 1,19296,70,0.83 [0.63-1.08],0.169236570298481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTNB,Dystrobrevin beta,19574,71,0.97 [0.55-1.70],0.9168347651637077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19160,69,0.85 [0.57-1.25],0.4014944229174452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22532,81,0.98 [0.42-2.27],0.961953466512534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTYMK,Thymidylate kinase,19709,73,1.03 [0.75-1.41],0.8710852163712703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUOX2,Dual oxidase 2,22232,80,1.08 [0.84-1.39],0.5663613851383509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP13,Dual specificity protein phosphatase 13 isoform A,19602,71,0.82 [0.46-1.48],0.5173702323789955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP29,Dual specificity phosphatase 29,19160,69,1.15 [0.85-1.55],0.3553496702577792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP3,Dual specificity protein phosphatase 3,22073,79,0.94 [0.74-1.20],0.6279142563031299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19608,71,0.87 [0.69-1.08],0.2096934668725804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DXO,Decapping and exoribonuclease protein,19668,71,1.13 [0.69-1.84],0.6238198114511158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19602,71,1.01 [0.63-1.61],0.9747108596566332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT1,Dynein light chain Tctex-type 1,19160,69,1.03 [0.78-1.35],0.851069524505436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT3,Dynein light chain Tctex-type 3,19602,71,0.78 [0.45-1.34],0.3627479713687529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22486,81,0.90 [0.73-1.11],0.3296438510981057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBI3_IL27,Interleukin-27,22798,83,1.08 [0.57-2.05],0.8173584205038001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECE1,Endothelin-converting enzyme 1,22073,79,1.20 [0.69-2.10],0.5218922181624133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19709,73,0.96 [0.71-1.31],0.8191677543371804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19209,70,0.77 [0.60-0.98],0.0344702464934078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECI2,Enoyl-CoA delta isomerase 2,19109,70,0.79 [0.53-1.20],0.2692939843258036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECM1,Extracellular matrix protein 1,19172,70,0.65 [0.37-1.15],0.1382966310267911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECSCR,Endothelial cell-specific chemotaxis regulator,19101,70,0.81 [0.48-1.36],0.4205828764432443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDA2R,Tumor necrosis factor receptor superfamily member 27,22837,83,0.86 [0.48-1.54],0.6198656759396034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDAR,Tumor necrosis factor receptor superfamily member EDAR,22597,82,0.93 [0.75-1.15],0.5249902559717279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDDM3B,Epididymal secretory protein E3-beta,19602,71,0.81 [0.46-1.43],0.4662408739190408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19109,70,1.10 [0.61-1.99],0.7545860995278333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDF1,Endothelial differentiation-related factor 1,19678,72,0.88 [0.62-1.25],0.4804595522225208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22232,80,1.23 [0.70-2.17],0.4665857096376887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDN1,Endothelin-1,19209,70,0.58 [0.26-1.30],0.1845062265745154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDNRB,Endothelin receptor type B,19160,71,1.18 [0.77-1.81],0.4538261144715776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EEF1D,Elongation factor 1-delta,19709,73,0.92 [0.72-1.18],0.5275018636764555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB14,EF-hand calcium-binding domain-containing protein 14,19608,71,0.70 [0.28-1.74],0.4398037965020988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB2,Dynein regulatory complex protein 8,19329,70,1.12 [0.60-2.11],0.7216949668764655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22659,82,0.93 [0.49-1.78],0.8278980912804013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFHD1,EF-hand domain-containing protein D1,19678,72,0.67 [0.33-1.37],0.2729324500122003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA1,Ephrin-A1,22607,79,0.99 [0.47-2.12],0.9875253694899452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA4,Ephrin-A4,22451,81,0.92 [0.45-1.88],0.8152069523028183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNB2,Ephrin-B2,19160,69,1.14 [0.80-1.61],0.4762445678194857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGF,Pro-epidermal growth factor,22600,82,0.87 [0.73-1.05],0.1499779223364045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFL7,Epidermal growth factor-like protein 7,22124,81,1.29 [0.82-2.03],0.2717446890848081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFLAM,Pikachurin,19608,71,0.62 [0.28-1.37],0.2400565742002075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFR,Epidermal growth factor receptor,22905,81,0.80 [0.24-2.69],0.7183566448844696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGLN1,Egl nine homolog 1,22597,82,0.95 [0.66-1.37],0.7736987399677476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,19709,73,0.72 [0.53-0.99],0.045187838221156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,19209,70,0.83 [0.68-1.00],0.0472210463021994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19668,71,1.01 [0.67-1.51],0.9733515235664104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19540,71,0.86 [0.70-1.07],0.1836779497498298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19109,70,0.81 [0.55-1.18],0.273942582901146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19209,70,1.00 [0.58-1.74],0.9886197739426424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4B,Eukaryotic translation initiation factor 4B,22486,81,0.92 [0.66-1.27],0.60516751527622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4E,Eukaryotic translation initiation factor 4E,19160,71,0.94 [0.73-1.21],0.6379046237674609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22636,82,1.24 [0.93-1.64],0.1414344619966459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22885,83,0.98 [0.81-1.19],0.8435829265454349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19678,72,0.86 [0.60-1.23],0.406724426065073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5,Eukaryotic translation initiation factor 5,19109,70,1.06 [0.65-1.74],0.8135252311215061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5A,Eukaryotic translation initiation factor 5A-1,22210,82,1.42 [0.77-2.61],0.2580156032762069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAC1,Zinc phosphodiesterase ELAC protein 1,19678,72,0.80 [0.62-1.04],0.095296699544325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAVL4,ELAV-like protein 4,19101,70,0.97 [0.74-1.28],0.8334163806788906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELN,Elastin,19709,73,1.21 [0.64-2.29],0.5556397174127311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOA,Elongin-A,22532,81,1.15 [0.84-1.57],0.3962322466669976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOB,Elongin-B,19109,70,0.63 [0.32-1.25],0.1881366687921148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENAH,Protein enabled homolog,22210,82,0.83 [0.54-1.27],0.3869204794655972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENDOU,Poly(U)-specific endoribonuclease,18205,69,1.51 [1.00-2.28],0.0511288021761221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENG,Endoglin,22905,81,1.03 [0.32-3.28],0.9596205017006436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO1,Alpha-enolase,22600,80,0.81 [0.64-1.04],0.0996935196545914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO2,Gamma-enolase,22833,80,0.86 [0.64-1.17],0.3450989466782754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO3,Beta-enolase,19209,70,1.02 [0.68-1.54],0.923707622272002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOPH1,Enolase-phosphatase E1,19602,71,1.14 [0.83-1.57],0.4095220839521836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19109,70,0.95 [0.41-2.23],0.9128590849897248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPEP,Glutamyl aminopeptidase,19109,70,1.04 [0.64-1.68],0.8814826127562762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22905,81,1.64 [0.86-3.09],0.1301340338412237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22739,82,1.01 [0.63-1.63],0.9509697910974751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19209,70,0.67 [0.36-1.23],0.1957724830204774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21936,78,1.22 [0.97-1.53],0.0953728329589406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENSA,Alpha-endosulfine,19602,71,1.09 [0.72-1.64],0.676827793393397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22124,81,1.16 [0.75-1.80],0.5088330268802144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22232,80,0.56 [0.22-1.42],0.2203998407782793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22232,80,0.96 [0.47-1.98],0.9158876136712456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTR1,Endosome-associated-trafficking regulator 1,19209,70,1.25 [0.87-1.80],0.2284296153159804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EP300,Histone acetyltransferase p300,19160,71,0.87 [0.41-1.86],0.7259477515972229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPB41L5,Band 4.1-like protein 5,19160,69,1.03 [0.72-1.47],0.8885345606463942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPCAM,Epithelial cell adhesion molecule,22634,82,1.01 [0.83-1.22],0.9460683389502758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPGN,Epigen,19602,71,1.06 [0.68-1.67],0.7973366604488118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA1,Ephrin type-A receptor 1,22705,82,1.58 [0.88-2.86],0.1250747050118263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA10,Ephrin type-A receptor 10,22073,79,0.79 [0.55-1.14],0.2121546790493392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA2,Ephrin type-A receptor 2,21829,79,0.92 [0.46-1.84],0.8152936554003051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA4,Ephrin type-A receptor 4,19296,70,1.18 [0.52-2.68],0.6850055120710608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB4,Ephrin type-B receptor 4,22905,81,1.11 [0.49-2.51],0.8029554865938873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB6,Ephrin type-B receptor 6,22438,81,1.63 [0.86-3.07],0.1327309150004066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHX2,Bifunctional epoxide hydrolase 2,22232,80,0.80 [0.55-1.16],0.2316660888721228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPN1,Epsin-1,19329,70,1.23 [0.81-1.88],0.3284273383065961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPO,Erythropoietin,22597,82,1.01 [0.78-1.31],0.9227539566632952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPPK1,Epiplakin,19209,70,0.97 [0.71-1.34],0.8689834216807628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22803,83,0.75 [0.38-1.46],0.3952802167289753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB2,Receptor tyrosine-protein kinase erbB-2,22705,82,1.52 [0.67-3.45],0.3191107542793671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB3,Receptor tyrosine-protein kinase erbB-3,22570,82,1.39 [0.50-3.84],0.5289115724065978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB4,Receptor tyrosine-protein kinase erbB-4,22705,82,0.93 [0.41-2.12],0.8634793136771945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBIN,Erbin,22532,81,0.87 [0.72-1.05],0.1567480776081987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERC2,ERC protein 2,19160,69,1.04 [0.78-1.39],0.7770075621211092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERCC1,DNA excision repair protein ERCC-1,19016,71,1.12 [0.60-2.09],0.7320084897985742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EREG,Proepiregulin,22438,81,0.84 [0.65-1.09],0.1919167541975672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERI1,3'-5' exoribonuclease 1,19329,70,0.97 [0.49-1.90],0.9243792961338452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERMAP,Erythroid membrane-associated protein,19160,71,0.87 [0.52-1.46],0.6075154267266837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19602,71,0.90 [0.50-1.65],0.7407119939372236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP29,Endoplasmic reticulum resident protein 29,19296,70,0.83 [0.68-1.01],0.0574788429903931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP44,Endoplasmic reticulum resident protein 44,22492,81,0.64 [0.29-1.39],0.2573980867368956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19109,70,1.24 [0.83-1.87],0.2998920803677084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESAM,Endothelial cell-selective adhesion molecule,22905,81,0.58 [0.30-1.12],0.1073511818392593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESM1,Endothelial cell-specific molecule 1,22630,82,1.17 [0.66-2.09],0.5938948230742698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESPL1,Separin,19016,71,1.24 [0.91-1.69],0.1734204295804317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESR1,Estrogen receptor,19160,71,0.83 [0.53-1.32],0.4354860428465322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESYT2,Extended synaptotagmin-2,19668,71,0.88 [0.66-1.18],0.3961628536077852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI2B,Protein EVI2B,19016,71,0.92 [0.51-1.66],0.7875135999442004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI5,Ecotropic viral integration site 5 protein homolog,19160,71,0.83 [0.64-1.08],0.1713773648604379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVPL,Envoplakin,19329,70,1.02 [0.52-1.99],0.9550861777436374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXOSC10,Exosome component 10,19109,70,0.98 [0.66-1.43],0.9004440940163316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXTL1,Exostosin-like 1,19109,70,1.09 [0.70-1.69],0.7067188910011122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EZR,Ezrin,22833,80,1.31 [0.58-2.98],0.5153007028015908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F10,Coagulation factor X,19711,71,0.75 [0.31-1.80],0.5142822505294351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11,Coagulation factor XI,19449,71,0.93 [0.43-2.00],0.8450104311609734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11R,Junctional adhesion molecule A,22641,79,0.82 [0.57-1.18],0.2858631283193171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F12,Coagulation factor XII,19738,73,0.80 [0.48-1.33],0.3856822262569673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F13B,Coagulation factor XIII B chain,19620,72,0.55 [0.24-1.30],0.1742265702256659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2,Prothrombin,19738,73,2.31 [0.52-10.36],0.2735988148657038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2R,Proteinase-activated receptor 1,22700,82,0.72 [0.50-1.01],0.0598773686643398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F3,Tissue factor,22701,82,0.85 [0.42-1.74],0.6632743993788508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F7,Coagulation factor VII,22669,82,1.42 [0.73-2.78],0.3051394578421553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F9,Coagulation factor IX,22661,82,1.06 [0.35-3.19],0.9158679820763812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP1,"Fatty acid-binding protein, liver",22630,82,0.94 [0.76-1.17],0.6002841957530409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP2,"Fatty acid-binding protein, intestinal",22636,82,0.81 [0.62-1.06],0.1272112039342161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP3,"Fatty acid-binding protein, heart",19709,73,0.99 [0.62-1.60],0.9782772900559222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",22905,81,0.60 [0.39-0.92],0.0197779097378328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP5,Fatty acid-binding protein 5,22766,80,0.84 [0.63-1.13],0.2531713499361885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP6,Gastrotropin,22199,80,0.97 [0.67-1.40],0.8775328933008297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP9,Fatty acid-binding protein 9,22597,82,0.78 [0.55-1.12],0.1766875367292711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FADD,FAS-associated death domain protein,22636,82,0.86 [0.67-1.12],0.2686324424872804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM13A,Protein FAM13A,19608,71,0.95 [0.67-1.34],0.7634385309852066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171A2,Protein FAM171A2,19678,72,1.01 [0.88-1.16],0.8869159700657255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171B,Protein FAM171B,19602,71,1.49 [0.79-2.83],0.2197587091624242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM172A,Cotranscriptional regulator FAM172A,19209,70,0.83 [0.57-1.21],0.3215755883735338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,19709,73,0.42 [0.19-0.94],0.0352549189246102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3B,Protein FAM3B,22532,81,0.92 [0.52-1.63],0.7799046433374436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3C,Protein FAM3C,22602,82,0.79 [0.40-1.55],0.4854418331269298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3D,Protein FAM3D,19608,71,0.87 [0.66-1.16],0.3478462485448624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAP,Prolyl endopeptidase FAP,22905,81,0.95 [0.46-1.99],0.899214620555148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FARSA,Phenylalanine--tRNA ligase alpha subunit,19160,69,0.80 [0.55-1.17],0.2543862214508116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAS,Tumor necrosis factor receptor superfamily member 6,22837,81,1.11 [0.63-1.95],0.7179532254199203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FASLG,Tumor necrosis factor ligand superfamily member 6,22885,83,0.77 [0.46-1.28],0.3072755546665038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBLN2,Fibulin-2,19705,73,0.82 [0.39-1.74],0.6042449656384132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBN2,Fibrillin-2,19160,69,1.04 [0.71-1.54],0.8303340316769175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBP1,"Fructose-1,6-bisphosphatase 1",22636,82,0.87 [0.66-1.14],0.3043618065147145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19709,73,1.11 [0.81-1.52],0.5075050543292664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAR,Immunoglobulin alpha Fc receptor,22597,82,1.06 [0.70-1.60],0.7945928336746146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19678,72,1.16 [0.46-2.95],0.7483886077275327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER2,Low affinity immunoglobulin epsilon Fc receptor,22641,79,1.28 [0.84-1.96],0.2546866056835835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22522,82,1.19 [0.83-1.71],0.3472724302427533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22124,81,0.75 [0.53-1.07],0.1133382124216808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22630,82,1.05 [0.71-1.56],0.8073962958845194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN1,Ficolin-1,19670,71,1.13 [0.73-1.73],0.5863864503729044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN2,Ficolin-2,22508,81,0.86 [0.54-1.38],0.5386197655114991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL1,Fc receptor-like protein 1,22636,82,1.12 [0.71-1.75],0.6274490781496819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL2,Fc receptor-like protein 2,22778,83,1.35 [0.91-1.99],0.1349738905534631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL3,Fc receptor-like protein 3,22210,82,0.92 [0.64-1.31],0.6294713120553335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,22641,79,1.87 [1.32-2.66],0.0004410401951817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL6,Fc receptor-like protein 6,22597,82,1.06 [0.80-1.42],0.6811297177175892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRLB,Fc receptor-like B,22124,81,1.28 [0.96-1.71],0.0863909225540996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX1,"Adrenodoxin, mitochondrial",19109,70,0.84 [0.56-1.26],0.3912614287826955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX2,"Ferredoxin-2, mitochondrial",19109,70,0.93 [0.61-1.41],0.7188800649230398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FEN1,Flap endonuclease 1,22124,81,1.12 [0.87-1.44],0.3883664639960349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FES,Tyrosine-protein kinase Fes/Fps,22124,81,0.91 [0.59-1.41],0.686791482442861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FETUB,Fetuin-B,22661,82,1.06 [0.59-1.90],0.8417083339199958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGA,Fibrinogen alpha chain,19266,69,0.65 [0.31-1.39],0.2705774065731313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19678,72,0.85 [0.64-1.14],0.2779258838652596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF12,Fibroblast growth factor 12,19160,71,1.18 [0.81-1.71],0.3979224705561081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF16,Fibroblast growth factor 16,19160,71,0.65 [0.37-1.14],0.1353515305711518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF19,Fibroblast growth factor 19,22739,82,0.99 [0.77-1.27],0.9210819914143636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF2,Fibroblast growth factor 2,22597,82,0.80 [0.59-1.09],0.1528307508220641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF20,Fibroblast growth factor 20,19160,71,1.27 [0.87-1.87],0.2212703077638898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF21,Fibroblast growth factor 21,22798,83,0.87 [0.73-1.03],0.1050599877558792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF23,Fibroblast growth factor 23,22804,82,0.86 [0.59-1.24],0.4138891646329807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF3,Fibroblast growth factor 3,19160,71,0.75 [0.32-1.78],0.5169454565555438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF5,Fibroblast growth factor 5,22210,82,1.09 [0.60-1.99],0.7761615694565811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF6,Fibroblast growth factor 6,19160,71,0.84 [0.46-1.55],0.5825515967236015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF7,Fibroblast growth factor 7,19016,71,0.93 [0.69-1.26],0.6516737443801517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF9,Fibroblast growth factor 9,18978,71,1.56 [0.91-2.68],0.1073779871649664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP1,Fibroblast growth factor-binding protein 1,22705,82,0.73 [0.39-1.35],0.311333257443391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP2,Fibroblast growth factor-binding protein 2,19705,73,1.52 [1.00-2.33],0.0524021396169944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP3,Fibroblast growth factor-binding protein 3,19668,71,0.86 [0.46-1.59],0.6226953068683895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR2,Fibroblast growth factor receptor 2,22705,82,1.15 [0.46-2.88],0.7693049177891731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR4,Fibroblast growth factor receptor 4,19296,70,0.88 [0.57-1.36],0.5669380943570486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGL1,Fibrinogen-like protein 1,19711,71,0.93 [0.66-1.33],0.7079523527445312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGR,Tyrosine-protein kinase Fgr,22073,79,1.13 [0.84-1.51],0.4221469569482485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FH,"Fumarate hydratase, mitochondrial",19101,70,0.95 [0.72-1.26],0.737463671728357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19109,70,1.24 [0.85-1.81],0.2619495449122606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIT,Bis(5'-adenosyl)-triphosphatase,22073,79,1.16 [0.89-1.52],0.2785095691404906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FIS1,Mitochondrial fission 1 protein,22637,82,0.96 [0.75-1.24],0.7759171089719813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19678,72,0.82 [0.65-1.02],0.0791202565789379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22703,82,0.90 [0.75-1.08],0.2510279779362629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22486,81,1.12 [0.73-1.74],0.6009890222100489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22486,81,0.86 [0.70-1.05],0.1382296279089616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22025,79,0.72 [0.44-1.18],0.1963532704311165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBPL,FK506-binding protein-like,19608,71,1.00 [0.68-1.47],0.99672430945131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLI1,Friend leukemia integration 1 transcription factor,22124,81,0.95 [0.79-1.14],0.5561819624597646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22486,81,0.57 [0.28-1.16],0.1190771486576308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT1,Vascular endothelial growth factor receptor 1,22492,81,1.77 [0.91-3.44],0.0941883249252312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3,Receptor-type tyrosine-protein kinase FLT3,22124,81,0.58 [0.29-1.16],0.1241308211264687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3LG,Fms-related tyrosine kinase 3 ligand,22885,83,1.21 [0.67-2.21],0.5257975052864783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT4,Vascular endothelial growth factor receptor 3,22705,82,0.74 [0.42-1.31],0.3011460065428476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMNL1,Formin-like protein 1,22073,79,1.20 [0.95-1.52],0.1269770794091094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMR1,Synaptic functional regulator FMR1,22124,81,0.72 [0.40-1.27],0.2547395615546243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FN1,Fibronectin,19738,73,0.53 [0.23-1.26],0.1513692302797482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNDC1,Fibronectin type III domain-containing protein 1,19668,71,0.69 [0.43-1.13],0.140635861867834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19602,71,0.68 [0.33-1.38],0.2841203924726361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLH1,Glutamate carboxypeptidase 2,19160,71,0.98 [0.78-1.22],0.8264166666471968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR1,Folate receptor alpha,22598,82,1.10 [0.54-2.22],0.796276890956047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR2,Folate receptor beta,22833,80,0.62 [0.31-1.23],0.1713944609825744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR3,Folate receptor gamma,22631,81,0.96 [0.85-1.07],0.4459276131084683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOS,Proto-oncogene c-Fos,18978,71,1.59 [0.90-2.82],0.1109352134955801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,22073,79,1.51 [1.10-2.07],0.0117726391833408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXJ3,Forkhead box protein J3,19160,71,0.96 [0.57-1.62],0.8784587678502455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,22597,82,0.79 [0.62-1.00],0.049679569477724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO3,Forkhead box protein O3,22124,81,0.99 [0.81-1.22],0.9516324092987212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD4B,FERM domain-containing protein 4B,19109,70,0.77 [0.53-1.10],0.1498166680797576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD7,FERM domain-containing protein 7,19160,69,0.75 [0.37-1.50],0.4104630819644672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRZB,Secreted frizzled-related protein 3,22410,80,0.60 [0.29-1.21],0.1526783802725736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSHB,Follitropin subunit beta,19209,70,1.02 [0.73-1.43],0.8948133748204258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,22700,82,1.44 [1.00-2.07],0.0488929169764261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL1,Follistatin-related protein 1,19209,70,0.56 [0.20-1.56],0.2661227569042436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL3,Follistatin-related protein 3,22597,82,0.86 [0.45-1.66],0.6561986815495342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FTCD,Formimidoyltransferase-cyclodeaminase,19640,71,1.03 [0.78-1.34],0.8553871235833594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUCA1,Tissue alpha-L-fucosidase,22777,80,0.96 [0.76-1.21],0.7161964177307126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUOM,Fucose mutarotase,19296,70,0.92 [0.64-1.32],0.6442111787684486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FURIN,Furin,22705,82,1.21 [0.68-2.16],0.5227937869828239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUS,RNA-binding protein FUS,22092,80,1.29 [0.81-2.05],0.2871886315955818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19286,70,0.89 [0.60-1.31],0.5440668271475897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22833,80,1.37 [0.88-2.12],0.160518579730967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT8,"Alpha-(1,6)-fucosyltransferase",22486,81,0.86 [0.61-1.21],0.3940370738282976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXN,"Frataxin, mitochondrial",22837,83,1.01 [0.78-1.32],0.9130945359916636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXYD5,FXYD domain-containing ion transport regulator 5,22210,82,0.94 [0.69-1.28],0.6844912859439449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FYB1,FYN-binding protein 1,22606,79,0.83 [0.67-1.03],0.0907116365652115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD10,Frizzled-10,19160,69,1.02 [0.71-1.49],0.8971240147560886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD8,Frizzled-8,19101,70,1.17 [0.73-1.85],0.5159890269318764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAP,Gamma-aminobutyric acid receptor-associated protein,19602,71,0.91 [0.56-1.47],0.6990088431649226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19329,70,1.13 [0.83-1.52],0.4470079741257461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19101,70,1.06 [0.76-1.48],0.7352261399098278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD1,Glutamate decarboxylase 1,19016,71,1.62 [0.69-3.83],0.2687612795359289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD2,Glutamate decarboxylase 2,19160,71,0.99 [0.60-1.62],0.9616488915959912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19329,70,1.07 [0.70-1.63],0.7429878265853951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19209,70,0.69 [0.43-1.11],0.1276167566373775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAGE2A,G antigen 2A,19016,71,1.14 [0.84-1.55],0.4087822169136034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAL,Galanin peptides,22739,82,0.99 [0.72-1.35],0.93876253999823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22532,81,2.29 [1.17-4.46],0.0150695762609518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22837,83,1.35 [0.63-2.89],0.4329352488690835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22210,82,1.13 [0.71-1.80],0.613485993858824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19709,73,1.84 [0.87-3.91],0.1113013227958633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT7,N-acetylgalactosaminyltransferase 7,22532,81,0.87 [0.34-2.22],0.7715510119780256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAMT,Guanidinoacetate N-methyltransferase,19109,70,0.63 [0.29-1.35],0.2355524287039181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18874,69,0.80 [0.43-1.49],0.4836538541012799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GART,Trifunctional purine biosynthetic protein adenosine-3,19678,72,0.93 [0.39-2.23],0.877645495644402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS2,Growth arrest-specific protein 2,19329,70,1.17 [0.81-1.70],0.3929244430160981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS6,Growth arrest-specific protein 6,22758,81,0.58 [0.26-1.25],0.1641617180259266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GASK1A,Golgi-associated kinase 1A,19109,70,0.84 [0.49-1.43],0.514761177436701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAST,Gastrin,19668,71,0.93 [0.77-1.11],0.4138853824495917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19016,71,0.66 [0.28-1.57],0.3489158191328562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19209,70,0.72 [0.52-0.99],0.0403121592912119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBA,Lysosomal acid glucosylceramidase,19160,69,1.13 [0.75-1.71],0.5443584042497743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP1,Guanylate-binding protein 1,19631,71,1.09 [0.77-1.54],0.6161607909086865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP2,Guanylate-binding protein 2,22210,82,0.88 [0.63-1.23],0.4416958551941689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP4,Guanylate-binding protein 4,22073,79,0.75 [0.49-1.17],0.2058611086120291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP6,Guanylate-binding protein 6,19109,70,0.69 [0.37-1.30],0.2532096770604817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GC,Vitamin D-binding protein,19738,73,0.91 [0.39-2.12],0.8222683234757674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCC1,GRIP and coiled-coil domain-containing protein 1,19668,71,0.87 [0.71-1.07],0.1874364255257591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCG,Pro-glucagon,22124,81,1.03 [0.88-1.21],0.6737992763462344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18827,68,1.21 [0.80-1.83],0.3584678420939866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCLM,Glutamate--cysteine ligase regulatory subunit,19109,70,0.99 [0.62-1.60],0.9788816566952836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22532,81,0.89 [0.50-1.58],0.6816249206170815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF15,Growth/differentiation factor 15,22905,81,1.37 [0.92-2.04],0.1184515710266299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF2,Growth/differentiation factor 2,22636,82,0.71 [0.41-1.24],0.2297788265753293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDNF,Glial cell line-derived neurotrophic factor,22073,79,1.01 [0.60-1.72],0.9667026451797242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GET3,ATPase GET3,19709,73,1.13 [0.78-1.63],0.5190648286946323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFAP,Glial fibrillary acidic protein,22087,80,0.91 [0.59-1.40],0.66670254211682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFER,FAD-linked sulfhydryl oxidase ALR,22124,81,0.85 [0.61-1.17],0.3106174232437546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22124,81,1.05 [0.91-1.21],0.5348387616348416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA1,GDNF family receptor alpha-1,22798,83,0.62 [0.30-1.28],0.1986953190139806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,22532,81,0.36 [0.16-0.83],0.0167250512294271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA3,GDNF family receptor alpha-3,22420,81,0.59 [0.29-1.21],0.153040935268775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRAL,GDNF family receptor alpha-like,19077,69,1.09 [0.75-1.58],0.6409216563343059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGA1,ADP-ribosylation factor-binding protein GGA1,22073,79,0.86 [0.62-1.20],0.3756497277606109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGACT,Gamma-glutamylaminecyclotransferase,19709,73,0.86 [0.62-1.18],0.3383722144889633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGCT,Gamma-glutamylcyclotransferase,19666,73,1.10 [0.69-1.73],0.6947008572427534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGH,Gamma-glutamyl hydrolase,22236,82,0.76 [0.42-1.37],0.3577714499129744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT1,Glutathione hydrolase 1 proenzyme,22607,79,1.00 [0.66-1.52],0.9952493602310456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT5,Glutathione hydrolase 5 proenzyme,22486,81,0.51 [0.22-1.19],0.1175585293212507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH1,Somatotropin,22602,82,1.01 [0.90-1.12],0.9271786982721586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH2,Growth hormone variant,22124,81,1.02 [0.91-1.14],0.7542599800026792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHR,Growth hormone receptor,19296,70,1.01 [0.45-2.28],0.9720357531128414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRHR,Growth hormone-releasing hormone receptor,22073,79,0.88 [0.59-1.31],0.5285494370858576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRL,Appetite-regulating hormone,22636,82,1.09 [0.85-1.39],0.4991589404715033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GID8,Glucose-induced degradation protein 8 homolog,19678,72,0.99 [0.50-1.96],0.9737173849095396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIGYF2,GRB10-interacting GYF protein 2,19678,72,0.93 [0.69-1.26],0.6319020542060378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP7,GTPase IMAP family member 7,19296,70,0.68 [0.32-1.47],0.3257803184332508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP8,GTPase IMAP family member 8,19016,71,1.07 [0.71-1.61],0.7553898031614934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIP,Gastric inhibitory polypeptide,19209,70,0.99 [0.64-1.52],0.955041306614461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC2,PDZ domain-containing protein GIPC2,19668,71,1.31 [0.61-2.81],0.4817180445930211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC3,PDZ domain-containing protein GIPC3,19608,71,0.82 [0.66-1.02],0.0762139213805172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPR,Gastric inhibitory polypeptide receptor,19160,71,0.91 [0.55-1.50],0.7126352970018299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIT1,ARF GTPase-activating protein GIT1,19160,71,0.83 [0.65-1.05],0.1224158122418934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GJA8,Gap junction alpha-8 protein,19016,71,1.03 [0.72-1.46],0.8859869101634288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GKN1,Gastrokine-1,21646,77,0.96 [0.45-2.01],0.9043567165593808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLA,Alpha-galactosidase A,19253,70,1.09 [0.58-2.04],0.7915121728905169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLB1,Beta-galactosidase,22486,81,1.08 [0.67-1.76],0.7424154684403683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLI2,Zinc finger protein GLI2,19160,71,0.93 [0.46-1.88],0.8314594215319266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLO1,Lactoylglutathione lyase,22232,80,1.28 [0.93-1.77],0.1301984080347977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLOD4,Glyoxalase domain-containing protein 4,22598,82,1.27 [0.74-2.16],0.3838248340065187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLP1R,Glucagon-like peptide 1 receptor,19101,70,1.09 [0.62-1.93],0.7667659637026966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX,Glutaredoxin-1,22485,81,1.26 [0.90-1.74],0.1748802134306595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19296,70,0.79 [0.60-1.03],0.0854440767529143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22073,79,1.17 [0.82-1.67],0.3827189061169962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLYR1,Putative oxidoreductase GLYR1,19602,71,1.05 [0.73-1.51],0.8059646645065012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GM2A,Ganglioside GM2 activator,19228,70,1.17 [0.69-1.98],0.5631633183118023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMFG,Glia maturation factor gamma,19709,73,0.75 [0.55-1.02],0.0649628161163598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR,GMP reductase 1,22885,83,1.21 [0.83-1.77],0.3295946010927607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR2,GMP reductase 2,19296,70,0.94 [0.67-1.32],0.7266996134457644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNAS,Neuroendocrine secretory protein 55,19678,72,1.01 [0.78-1.30],0.9438408266877673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22124,81,0.78 [0.57-1.07],0.1259145182774564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19160,69,0.92 [0.57-1.48],0.723073777332548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNLY,Granulysin,22641,79,1.33 [0.90-1.95],0.1476838271460236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA1,Glucosamine-6-phosphate isomerase 1,19209,70,1.35 [0.79-2.28],0.2698176517315014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA2,Glucosamine-6-phosphate isomerase 2,19296,70,0.66 [0.35-1.27],0.2144732899323942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLGA3,Golgin subfamily A member 3,19678,72,0.87 [0.65-1.18],0.3680065842831048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLM2,Protein GOLM2,22833,80,1.25 [0.52-2.99],0.6133147068627199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22597,82,0.89 [0.74-1.08],0.2393843276185601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GORASP2,Golgi reassembly-stacking protein 2,19608,71,0.69 [0.41-1.14],0.1498512719495218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOT1,"Aspartate aminotransferase, cytoplasmic",19705,73,1.35 [0.81-2.25],0.2454113927279894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BA,Platelet glycoprotein Ib alpha chain,22509,82,0.60 [0.32-1.12],0.1077656334479158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BB,Platelet glycoprotein Ib beta chain,19109,70,0.82 [0.58-1.16],0.2664515008527164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21957,79,1.03 [0.82-1.31],0.7750682375624941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,19296,70,0.55 [0.30-1.00],0.04952560963984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP6,Platelet glycoprotein VI,22606,79,0.82 [0.66-1.03],0.0884542907744377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPA33,Cell surface A33 antigen,22532,81,1.02 [0.88-1.17],0.8248141248442766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC1,Glypican-1,22837,83,1.09 [0.56-2.11],0.807507953973985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC5,Glypican-5,22486,81,1.10 [0.78-1.57],0.586863040993571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPD1,Glycerol-3-phosphate dehydrogenase,19602,71,0.66 [0.41-1.08],0.0974810416277406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPHA2,Glycoprotein hormone alpha-2,19608,71,1.24 [0.85-1.82],0.2604816788079818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPI,Glucose-6-phosphate isomerase,19711,71,0.70 [0.42-1.15],0.1611575377886787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19608,71,1.00 [0.72-1.39],0.9881711672886612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPKOW,G-patch domain and KOW motifs-containing protein,22073,79,1.30 [0.74-2.30],0.3633399812543252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPNMB,Transmembrane glycoprotein NMB,22022,81,0.71 [0.35-1.43],0.3355878913930739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR101,Probable G-protein coupled receptor 101,19101,70,0.98 [0.67-1.42],0.9144702134503504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR158,Probable G-protein coupled receptor 158,19678,72,0.70 [0.34-1.43],0.3243577561392347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,19608,71,0.65 [0.45-0.93],0.0178430084285011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR37,Prosaposin receptor GPR37,22232,80,0.96 [0.71-1.29],0.7662726630994227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPRC5C,G-protein coupled receptor family C group 5 member C,19602,71,0.90 [0.59-1.39],0.6425594358027866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRAP2,GRB2-related adapter protein 2,22636,82,0.87 [0.75-1.01],0.075208818619061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19709,73,0.94 [0.66-1.32],0.7092349298766482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",19678,72,1.57 [1.07-2.29],0.0197089457820018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19101,70,1.39 [1.08-1.79],0.0094045762931498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRK5,G protein-coupled receptor kinase 5,22232,80,0.61 [0.37-1.00],0.0506801054810507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRN,Progranulin,22544,79,0.87 [0.37-2.04],0.7558395596799106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRP,Gastrin-releasing peptide,19209,70,0.82 [0.54-1.26],0.3640380660472189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRPEL1,"GrpE protein homolog 1, mitochondrial",22532,81,0.84 [0.59-1.20],0.337109131765912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRSF1,G-rich sequence factor 1,18910,71,0.83 [0.61-1.13],0.2360431231635673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSAP,Gamma-secretase-activating protein,22124,81,0.89 [0.69-1.16],0.3995956194526833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSN,Gelsolin,19642,71,1.27 [0.37-4.32],0.7011038901717226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",19592,71,0.46 [0.26-0.82],0.0082794629828795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA1,Glutathione S-transferase A1,22601,82,1.05 [0.84-1.32],0.6658825173256947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA3,Glutathione S-transferase A3,22124,81,1.08 [0.84-1.39],0.5419783817333406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTM4,Glutathione S-transferase Mu 4,19109,70,1.07 [0.80-1.43],0.662391093283409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTP1,Glutathione S-transferase P,21936,78,0.90 [0.66-1.21],0.4766474083238582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTT2B,Glutathione S-transferase theta-2B,19668,71,1.02 [0.93-1.12],0.714319829362319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19329,70,0.93 [0.66-1.30],0.6701935053112786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,19160,69,0.71 [0.52-0.96],0.0248266696723092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCA2A,Guanylin,22532,79,0.68 [0.37-1.24],0.2073082507535871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCY2C,Heat-stable enterotoxin receptor,19329,70,1.07 [0.83-1.37],0.6112771813197845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUK1,Guanylate kinase,19109,70,1.39 [0.95-2.04],0.0880564305945914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUSB,Beta-glucuronidase,22743,81,1.16 [0.84-1.59],0.3805703941097069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GYS1,"Glycogen [starch] synthase, muscle",22232,80,0.94 [0.76-1.17],0.6025574349703725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMA,Granzyme A,22885,83,1.11 [0.64-1.91],0.7150370320548964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMB,Granzyme B,22597,82,0.81 [0.58-1.13],0.2121973050603228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMH,Granzyme H,22232,80,1.03 [0.79-1.34],0.8326999687356884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,H2AP,Huntingtin-interacting protein M,19016,71,1.18 [0.82-1.69],0.369868664021919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19109,70,0.73 [0.46-1.18],0.2016666338338227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22765,83,1.35 [1.05-1.72],0.0170482959735652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAO1,Hydroxyacid oxidase 1,22837,83,1.01 [0.87-1.17],0.9290477478325582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HARS1,"Histidine--tRNA ligase, cytoplasmic",22641,79,0.85 [0.66-1.10],0.223366966972628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,22804,83,1.41 [1.03-1.92],0.0306291181755081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR2,Hepatitis A virus cellular receptor 2,22641,79,0.90 [0.50-1.62],0.7193252168236048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBEGF,Proheparin-binding EGF-like growth factor,22765,83,0.82 [0.63-1.07],0.1445189240883711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,22837,83,1.50 [1.13-2.00],0.0055917817746842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBZ,Hemoglobin subunit zeta,19709,73,1.10 [0.89-1.35],0.3832686237972729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCG22,Protein PBMUCL2,19109,70,1.21 [0.90-1.62],0.2103594509650962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCLS1,Hematopoietic lineage cell-specific protein,22885,83,0.89 [0.63-1.26],0.5168204391296314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC8,Histone deacetylase 8,19160,71,1.04 [0.73-1.49],0.8080088742435085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,19101,70,0.59 [0.35-0.99],0.0441253593066366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDDC2,5'-deoxynucleotidase HDDC2,19608,71,1.07 [0.65-1.76],0.7988810414263564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGF,Hepatoma-derived growth factor,22808,83,1.00 [0.82-1.23],0.9727738301285244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGFL2,Hepatoma-derived growth factor-related protein 2,19668,71,0.90 [0.62-1.29],0.5599571510795527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEBP1,Heme-binding protein 1,22232,80,1.15 [0.86-1.55],0.3408625923597185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEG1,Protein HEG homolog 1,19296,70,1.20 [0.49-2.90],0.6890897554792098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPACAM2,HEPACAM family member 2,19668,71,0.79 [0.45-1.38],0.4017819086172044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPH,Hephaestin,19709,73,1.30 [0.53-3.20],0.5614747124204447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEXIM1,Protein HEXIM1,22597,82,0.83 [0.65-1.06],0.128265338266398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGF,Hepatocyte growth factor,22885,83,1.18 [0.67-2.08],0.5747915694829199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGFAC,Hepatocyte growth factor activator,19516,69,0.87 [0.42-1.79],0.6960210136589717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22124,81,1.02 [0.80-1.32],0.8612912143087728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HHEX,Hematopoietically-expressed homeobox protein HHEX,19668,71,0.90 [0.67-1.22],0.5100582694634224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIF1A,Hypoxia-inducible factor 1-alpha,19160,71,1.21 [0.93-1.56],0.1554928313818229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1,Huntingtin-interacting protein 1,19109,70,1.15 [0.63-2.11],0.6436262010283058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1R,Huntingtin-interacting protein 1-related protein,19633,71,1.39 [0.94-2.06],0.0973599979592893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HJV,Hemojuvelin,19678,72,1.04 [0.64-1.69],0.8793495364725773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HK2,Hexokinase-2,22232,80,1.14 [0.57-2.26],0.7166758101252326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19678,72,0.71 [0.36-1.41],0.3294699329186965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22530,81,1.40 [0.83-2.36],0.2020514294018881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22597,82,1.27 [0.64-2.50],0.4929294787112477
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,22837,83,1.70 [1.11-2.61],0.0140736359679994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMCN2,Hemicentin-2,19260,70,0.90 [0.60-1.34],0.6080470305998771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19209,70,0.85 [0.52-1.37],0.4999050455934257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19109,70,1.00 [0.59-1.69],0.9934756579186508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMMR,Hyaluronan mediated motility receptor,18988,71,0.83 [0.50-1.40],0.4916085258891185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX1,Heme oxygenase 1,22386,81,0.89 [0.58-1.38],0.6087906691964536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX2,Heme oxygenase 2,22073,79,0.89 [0.57-1.41],0.6288738062222693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNF1A,Hepatocyte nuclear factor 1-alpha,19160,69,0.90 [0.62-1.30],0.5724799196493325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNMT,Histamine N-methyltransferase,22368,81,0.82 [0.53-1.24],0.3428682758769144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22166,79,0.98 [0.76-1.27],0.8954702755717882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19678,72,0.99 [0.62-1.57],0.9548065455970032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPCAL1,Hippocalcin-like protein 1,22885,83,0.82 [0.64-1.06],0.1315830070185389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPGDS,Hematopoietic prostaglandin D synthase,22124,81,0.76 [0.44-1.31],0.3302272056572605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,19427,72,0.73 [0.58-0.92],0.0069007017735902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRAS,GTPase Hras,19293,70,1.05 [0.85-1.29],0.6651583364510092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19209,70,1.12 [0.62-2.04],0.7102874433694835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRG,Histidine-rich glycoprotein,19620,72,0.57 [0.28-1.15],0.1165595324918085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS1BP3,HCLS1-binding protein 3,19209,70,0.80 [0.61-1.04],0.0926334125826883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22532,81,0.79 [0.47-1.33],0.3790258856329402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22837,83,2.05 [1.40-2.99],0.000232019189143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19160,71,0.70 [0.32-1.53],0.3730254500513329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSBP1,Heat shock factor-binding protein 1,19209,70,0.96 [0.76-1.23],0.7675350277553783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22597,82,1.12 [0.68-1.85],0.6506549631732177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19668,71,1.46 [1.04-2.05],0.0285752255731345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19109,70,0.66 [0.38-1.14],0.1332666294415423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19209,70,0.74 [0.45-1.23],0.2458238421606173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSP90B1,Endoplasmin,21971,79,0.92 [0.67-1.27],0.6192464425323627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA1A,Heat shock 70 kDa protein 1A,22705,82,0.96 [0.73-1.26],0.7499275678185929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA2,Heat shock-related 70 kDa protein 2,19602,71,0.92 [0.45-1.87],0.8171258858333483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB1,Heat shock protein beta-1,22269,81,0.90 [0.68-1.19],0.4531302592622286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB6,Heat shock protein beta-6,22837,83,0.95 [0.55-1.65],0.8654839511881611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22441,82,0.92 [0.41-2.07],0.848167044770969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1A,5-hydroxytryptamine receptor 1A,19101,70,0.94 [0.69-1.27],0.679553316284991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1B,5-hydroxytryptamine receptor 1B,19101,70,0.98 [0.58-1.68],0.9535315998662256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTRA2,"Serine protease HTRA2, mitochondrial",22705,82,0.88 [0.64-1.21],0.4351476620341465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYAL1,Hyaluronidase-1,22471,82,1.23 [0.53-2.86],0.6274613662312563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYOU1,Hypoxia up-regulated protein 1,22905,81,1.08 [0.44-2.70],0.861409818595833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICA1,Islet cell autoantigen 1,22210,82,0.89 [0.69-1.15],0.3642256978703926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM1,Intercellular adhesion molecule 1,22520,82,1.48 [0.75-2.92],0.2625308236549392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM2,Intercellular adhesion molecule 2,22905,81,0.78 [0.42-1.44],0.4277068920836546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM3,Intercellular adhesion molecule 3,22905,81,1.42 [0.65-3.11],0.3770662574735522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM4,Intercellular adhesion molecule 4,22597,82,1.13 [0.78-1.64],0.5298250143962726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM5,Intercellular adhesion molecule 5,22636,82,0.98 [0.63-1.53],0.9380232136984616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICOSLG,ICOS ligand,22532,81,0.98 [0.35-2.76],0.9736541612500964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ID4,DNA-binding protein inhibitor ID-4,19329,70,0.97 [0.58-1.61],0.893129301980058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22073,79,1.24 [0.84-1.81],0.2748959409017072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDO1,"Indoleamine 2,3-dioxygenase 1",19209,70,0.96 [0.67-1.38],0.8232841449540236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDS,Iduronate 2-sulfatase,22885,83,2.13 [0.20-22.27],0.5294091101630898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDUA,Alpha-L-iduronidase,22837,83,1.54 [0.99-2.40],0.0540099960987449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19125,69,1.46 [0.84-2.52],0.1778350098117002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19329,70,1.14 [0.77-1.70],0.5138881870841843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19329,70,1.21 [0.68-2.13],0.5146511197646721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNAR1,Interferon alpha/beta receptor 1,19608,71,0.70 [0.28-1.76],0.4444032694444698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNG,Interferon gamma,22210,82,0.91 [0.77-1.07],0.2660553474725343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR1,Interferon gamma receptor 1,22739,82,0.91 [0.34-2.43],0.8516373849844172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR2,Interferon gamma receptor 2,22486,81,1.33 [0.92-1.90],0.1275400834812281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL1,Interferon lambda-1,22073,79,0.98 [0.62-1.54],0.9273335160891412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL2,Interferon lambda-2,19101,70,1.24 [0.95-1.63],0.11929852111009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNLR1,Interferon lambda receptor 1,22597,82,0.90 [0.52-1.57],0.7144017680691711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNW1,Interferon omega-1,19109,70,0.99 [0.53-1.83],0.972070181694946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFT20,Intraflagellar transport protein 20 homolog,19160,69,0.96 [0.56-1.64],0.8704183225150224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGBP1,Immunoglobulin-binding protein 1,19678,72,1.17 [0.82-1.67],0.3882224696652979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19101,70,0.74 [0.41-1.34],0.3206522765456945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19705,73,0.82 [0.34-1.98],0.6564054025298691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF1R,Insulin-like growth factor 1 receptor,22532,81,0.80 [0.31-2.05],0.6365895468202006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19109,70,1.20 [0.79-1.82],0.3838742205848935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2R,Cation-independent mannose-6-phosphate receptor,22641,79,1.75 [0.74-4.16],0.2059363953647285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP1,Insulin-like growth factor-binding protein 1,22866,81,1.11 [0.94-1.31],0.226306347120213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP2,Insulin-like growth factor-binding protein 2,22866,81,0.88 [0.64-1.20],0.4114828942332652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP3,Insulin-like growth factor-binding protein 3,22698,82,0.81 [0.40-1.65],0.5611437698680447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP4,Insulin-like growth factor-binding protein 4,22344,77,1.56 [0.99-2.47],0.0553580365944244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP6,Insulin-like growth factor-binding protein 6,22516,82,1.15 [0.58-2.31],0.684585185591627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP7,Insulin-like growth factor-binding protein 7,22905,81,0.68 [0.33-1.38],0.283849223485813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22636,82,1.38 [0.78-2.43],0.2641763702953498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFL4,Insulin growth factor-like family member 4,19160,71,0.96 [0.70-1.31],0.7994504226939343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGHMBP2,DNA-binding protein SMUBP-2,19109,70,0.86 [0.56-1.34],0.5086962524472296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLC2,Immunoglobulin lambda constant 2,19699,73,1.37 [0.72-2.60],0.3436275392101298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLON5,IgLON family member 5,19016,71,1.06 [0.86-1.32],0.5713575662027466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF21,Immunoglobulin superfamily member 21,19209,70,0.53 [0.26-1.05],0.0683296928685038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,22532,81,1.67 [1.06-2.65],0.0284182322977315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF8,Immunoglobulin superfamily member 8,22636,82,1.14 [0.59-2.19],0.7036532260997826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF9,Protein turtle homolog A,19709,73,0.95 [0.72-1.26],0.7403200490538651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKBKG,NF-kappa-B essential modulator,22597,82,0.87 [0.71-1.08],0.2177043155551656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKZF2,Zinc finger protein Helios,22124,81,1.01 [0.82-1.24],0.9257513753079244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10,Interleukin-10,22210,82,1.07 [0.86-1.34],0.5199331174554036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RA,Interleukin-10 receptor subunit alpha,22210,82,1.00 [0.72-1.38],0.982673975777407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RB,Interleukin-10 receptor subunit beta,22739,82,1.61 [0.83-3.12],0.1547255198730909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL11,Interleukin-11,22210,82,1.25 [0.99-1.57],0.0611480384694658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12A_IL12B,Interleukin-12,22532,81,0.97 [0.75-1.26],0.8248693086962116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12B,Interleukin-12 subunit beta,22885,83,0.94 [0.66-1.36],0.7560168954810537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB1,Interleukin-12 receptor subunit beta-1,22210,82,1.11 [0.66-1.87],0.7026509813752144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB2,Interleukin-12 receptor subunit beta-2,19160,71,1.24 [0.74-2.07],0.4142663608120729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13,Interleukin-13,22210,82,0.82 [0.51-1.34],0.4357976296122339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA1,Interleukin-13 receptor subunit alpha-1,22347,78,1.51 [0.57-4.00],0.402688900985047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA2,Interleukin-13 receptor subunit alpha-2,19101,70,1.51 [0.69-3.31],0.2975631797836267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15,Interleukin-15,22597,82,1.72 [1.00-2.99],0.0516634581015317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15RA,Interleukin-15 receptor subunit alpha,22210,82,0.91 [0.52-1.60],0.744347068715164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL16,Pro-interleukin-16,22885,83,1.14 [0.74-1.75],0.5565822665417793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17A,Interleukin-17A,22186,82,1.22 [0.82-1.82],0.3201830601034083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17C,Interleukin-17C,22210,82,1.10 [0.84-1.43],0.4954783465854512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17D,Interleukin-17D,22210,82,1.18 [0.69-2.02],0.5485287111566163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17F,Interleukin-17F,22210,82,0.96 [0.74-1.24],0.7285304589697515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RA,Interleukin-17 receptor A,22641,79,1.24 [0.79-1.95],0.3572981437113446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RB,Interleukin-17 receptor B,22302,80,1.02 [0.70-1.48],0.9276826514024692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18,Interleukin-18,22555,82,1.01 [0.66-1.53],0.9741461725428054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18BP,Interleukin-18-binding protein,22698,82,1.01 [0.53-1.95],0.9697600895722152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,22885,83,1.79 [1.01-3.16],0.0462491320052175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18RAP,Interleukin-18 receptor accessory protein,22340,81,1.02 [0.92-1.14],0.7118459682723399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL19,Interleukin-19,22070,80,0.95 [0.70-1.28],0.7183896133480976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1A,Interleukin-1 alpha,22210,82,1.15 [0.85-1.55],0.3784221123170678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1B,Interleukin-1 beta,22107,80,0.92 [0.63-1.32],0.6386545904058945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R1,Interleukin-1 receptor type 1,22607,79,1.46 [0.60-3.56],0.4045773432637415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R2,Interleukin-1 receptor type 2,22601,82,1.01 [0.37-2.80],0.982024415771334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RAP,Interleukin-1 receptor accessory protein,22641,79,0.87 [0.55-1.37],0.5410819214880913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL1,Interleukin-1 receptor-like 1,22837,81,0.84 [0.54-1.29],0.4172623808664287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL2,Interleukin-1 receptor-like 2,22210,82,1.20 [0.73-1.98],0.480167326183062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RN,Interleukin-1 receptor antagonist protein,22596,82,1.03 [0.73-1.46],0.8685860263861527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2,Interleukin-2,22210,82,1.59 [0.84-3.00],0.1563380574092759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20,Interleukin-20,22210,82,0.88 [0.58-1.34],0.5612701043576063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RA,Interleukin-20 receptor subunit alpha,22210,82,1.04 [0.69-1.57],0.8568248086643486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RB,Interleukin-20 receptor subunit beta,19160,71,0.84 [0.48-1.47],0.5476839975286434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,19160,71,1.43 [1.10-1.85],0.00751360703302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22,Interleukin-22,19602,71,1.04 [0.75-1.46],0.7962660673381363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22RA1,Interleukin-22 receptor subunit alpha-1,22210,82,0.98 [0.62-1.56],0.9424335588368448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL24,Interleukin-24,22210,82,0.91 [0.60-1.39],0.664322155103432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL25,Interleukin-25,18946,71,0.97 [0.50-1.87],0.9233521304243048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RA,Interleukin-2 receptor subunit alpha,22463,79,0.83 [0.49-1.39],0.4684391776074721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RB,Interleukin-2 receptor subunit beta,22210,82,0.83 [0.48-1.45],0.5174091868001802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RG,Cytokine receptor common subunit gamma,19602,71,1.16 [0.69-1.94],0.5794604876456768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3,Interleukin-3,19016,71,0.98 [0.68-1.43],0.9265735002899752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31,Interleukin-31,19160,71,1.11 [0.77-1.59],0.5678672420510846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31RA,Interleukin-31 receptor subunit alpha,19084,70,0.94 [0.53-1.66],0.8233223639358287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL32,Interleukin-32,22597,82,0.95 [0.59-1.53],0.848336940368252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL33,Interleukin-33,22210,82,0.86 [0.52-1.41],0.544932496770381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL34,Interleukin-34,22043,79,1.37 [0.78-2.42],0.273395121673491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36A,Interleukin-36 alpha,19160,71,0.91 [0.59-1.40],0.6709919363667469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36G,Interleukin-36 gamma,19078,71,1.11 [0.81-1.51],0.5201907864696422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3RA,Interleukin-3 receptor subunit alpha,22210,82,1.17 [0.64-2.14],0.6099177916200895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4,Interleukin-4,22210,82,1.22 [0.94-1.59],0.1304200845411857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4R,Interleukin-4 receptor subunit alpha,22597,82,1.32 [0.77-2.26],0.3064956426462498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5,Interleukin-5,22210,82,0.90 [0.77-1.05],0.1667455385377501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5RA,Interleukin-5 receptor subunit alpha,22597,82,1.27 [0.89-1.81],0.1833868081404804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6,Interleukin-6,22532,81,0.90 [0.67-1.21],0.4915596351852977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6R,Interleukin-6 receptor subunit alpha,22476,82,1.20 [0.67-2.14],0.5343761009754905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6ST,Interleukin-6 receptor subunit beta,22636,82,0.75 [0.24-2.34],0.6191558201304379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7,Interleukin-7,22597,82,0.75 [0.55-1.02],0.067664159566888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,22641,79,0.69 [0.48-0.99],0.0427549348507341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL9,Interleukin-9,19329,70,1.07 [0.74-1.56],0.7052787877229327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22048,79,1.00 [0.70-1.42],0.999625438573948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMMT,MICOS complex subunit MIC60,19602,71,1.32 [0.85-2.04],0.2203836684211791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPA1,Inositol monophosphatase 1,22486,81,0.76 [0.54-1.06],0.1076693873147042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPACT,Protein IMPACT,19668,71,1.23 [0.83-1.82],0.2999786590565018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPG1,Interphotoreceptor matrix proteoglycan 1,19101,70,1.22 [0.62-2.39],0.5586182069168453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ING1,Inhibitor of growth protein 1,22025,79,0.98 [0.63-1.52],0.9305896579282276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBB,Inhibin beta B chain,19296,70,0.82 [0.52-1.29],0.3925541772737004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBC,Inhibin beta C chain,22641,79,0.86 [0.55-1.36],0.5188051596127452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP1,Inositol polyphosphate 1-phosphatase,22532,81,0.84 [0.58-1.22],0.3645791947211021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19209,70,0.91 [0.60-1.37],0.6471961712822663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19678,72,0.78 [0.44-1.40],0.4096977835343638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22532,81,0.82 [0.67-1.01],0.0584879734746289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL3,Insulin-like 3,19668,71,0.96 [0.66-1.39],0.8104857458091985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,19602,71,1.36 [1.05-1.77],0.0185291401636245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL5,Insulin-like peptide INSL5,19608,71,0.88 [0.68-1.13],0.3083547285516657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSR,Insulin receptor,19160,71,0.95 [0.24-3.73],0.9372175275036982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IPCEF1,Interactor protein for cytohesin exchange factors 1,22451,81,0.90 [0.72-1.12],0.3602651873530077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IQGAP2,Ras GTPase-activating-like protein IQGAP2,22532,81,0.82 [0.57-1.20],0.3070553616753432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22232,80,0.98 [0.78-1.23],0.859387048552517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK1,Interleukin-1 receptor-associated kinase 1,22210,82,0.87 [0.65-1.17],0.346732694526207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK4,Interleukin-1 receptor-associated kinase 4,22597,82,0.90 [0.75-1.08],0.254334889537945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21764,78,0.47 [0.27-0.82],0.0071429101399454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM1,Isthmin-1,22597,82,1.21 [0.73-2.01],0.4590622896806776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,19705,73,1.71 [1.30-2.26],0.0001537658192666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IST1,IST1 homolog,19468,71,0.93 [0.74-1.17],0.5369237251858334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA11,Integrin alpha-11,22597,82,0.74 [0.42-1.31],0.3010103020531426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA2,Integrin alpha-2,19296,70,1.25 [0.63-2.49],0.5290646128592531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA5,Integrin alpha-5,22641,79,0.91 [0.41-2.05],0.8210225784194949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA6,Integrin alpha-6,22597,82,1.12 [0.79-1.59],0.5360015593776934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAL,Integrin alpha-L,19160,71,1.30 [0.76-2.25],0.3381025889146615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAM,Integrin alpha-M,22641,79,1.49 [0.81-2.76],0.2017240451951549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAV,Integrin alpha-V,22837,83,0.61 [0.19-2.02],0.42113218671906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAX,Integrin alpha-X,19329,70,1.05 [0.70-1.58],0.8155857289797845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1,Integrin beta-1,22590,82,0.86 [0.35-2.17],0.7567054322969984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP1,Integrin beta-1-binding protein 1,22124,81,0.99 [0.61-1.59],0.9568965055469336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,22232,80,0.83 [0.69-0.98],0.0292347018269546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB2,Integrin beta-2,22486,80,1.00 [0.50-2.02],0.9897438947657804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB5,Integrin beta-5,22705,82,1.19 [0.72-1.99],0.4994010416151684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB6,Integrin beta-6,22210,82,1.28 [0.66-2.48],0.4713286616636535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB7,Integrin beta-7,22837,83,0.79 [0.51-1.22],0.2894457502962745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGBL1,Integrin beta-like protein 1,19705,73,0.78 [0.40-1.52],0.4636622259884815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19738,73,1.77 [0.61-5.14],0.2911168019051852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22698,82,0.80 [0.48-1.34],0.4019467731849756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19738,73,0.94 [0.40-2.18],0.8818567397333352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19602,71,1.26 [0.82-1.94],0.2878432421118618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITM2A,Integral membrane protein 2A,22597,82,1.08 [0.78-1.50],0.6423250360932973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPA,Inosine triphosphate pyrophosphatase,19109,70,0.95 [0.67-1.34],0.7778286564611986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19209,70,0.95 [0.68-1.33],0.781737358482705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19101,70,1.06 [0.65-1.72],0.8074723069107456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22073,79,1.11 [0.75-1.63],0.6023619312028674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IZUMO1,Izumo sperm-egg fusion protein 1,19016,71,0.75 [0.42-1.33],0.3201904249162481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM2,Junctional adhesion molecule B,22833,80,0.78 [0.35-1.72],0.5305306993066568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM3,Junctional adhesion molecule C,19296,70,0.74 [0.46-1.22],0.2399099380494689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JCHAIN,Immunoglobulin J chain,22210,82,1.22 [0.89-1.68],0.207650313211481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19016,71,0.85 [0.55-1.32],0.479279873473702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JPT2,Jupiter microtubule associated homolog 2,19608,71,0.82 [0.63-1.06],0.1316052355584844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JUN,Transcription factor AP-1,22210,82,0.87 [0.57-1.34],0.5373919480308424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22532,81,0.90 [0.59-1.38],0.6423058101981893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,19608,71,0.79 [0.64-0.99],0.0372927344270757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNC4,Potassium voltage-gated channel subfamily C member 4,19101,70,0.90 [0.58-1.39],0.6391889285742895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNH2,Potassium voltage-gated channel subfamily H member 2,19160,69,1.05 [0.79-1.39],0.7404533217334694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNIP4,Kv channel-interacting protein 4,22073,79,0.95 [0.63-1.45],0.8162022646141808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCTD5,BTB/POZ domain-containing protein KCTD5,19306,71,0.92 [0.54-1.57],0.7561342870573996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDM3A,Lysine-specific demethylase 3A,19160,71,0.90 [0.68-1.20],0.4720654419845755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDR,Vascular endothelial growth factor receptor 2,22705,82,1.01 [0.47-2.21],0.9711991686800028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KEL,Kell blood group glycoprotein,22073,79,1.05 [0.60-1.84],0.8645272524775361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHDC3L,KH domain-containing protein 3,19016,71,0.85 [0.58-1.26],0.424512899803228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHK,Ketohexokinase,19209,70,0.81 [0.56-1.15],0.2391774727242419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA0319,Dyslexia-associated protein KIAA0319,19668,71,1.33 [0.67-2.65],0.4194640535274495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549,UPF0606 protein KIAA1549,19329,70,1.11 [0.82-1.51],0.5034632749545904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,19329,70,2.60 [1.60-4.24],0.0001216004664677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA2013,Uncharacterized protein KIAA2013,19602,71,0.89 [0.57-1.39],0.6122033999938539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF1C,Kinesin-like protein KIF1C,19109,70,0.85 [0.42-1.71],0.6421897903958809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF20B,Kinesin-like protein KIF20B,19101,70,1.01 [0.76-1.35],0.9206922282425976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF22,Kinesin-like protein KIF22,19109,70,0.97 [0.80-1.17],0.7282959156018747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIFBP,KIF-binding protein,22532,81,0.83 [0.66-1.04],0.1051600531657639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19602,71,0.87 [0.67-1.14],0.3088516003688575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22124,81,0.97 [0.75-1.25],0.7979198518957027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19608,71,0.95 [0.83-1.09],0.461928584052286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22124,81,0.86 [0.73-1.02],0.0792712788342004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19016,71,1.00 [0.77-1.30],0.9930172976797498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL1,Kin of IRRE-like protein 1,19101,70,1.17 [0.86-1.58],0.3167206976852323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL2,Kin of IRRE-like protein 2,22073,79,1.32 [0.82-2.13],0.2507404229526023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIT,Mast/stem cell growth factor receptor Kit,22661,82,1.33 [0.69-2.57],0.399232738293079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KITLG,Kit ligand,22636,82,0.61 [0.36-1.02],0.0604919746416773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLB,Beta-klotho,22073,79,0.92 [0.70-1.22],0.574614352779815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLF4,Krueppel-like factor 4,19101,70,0.65 [0.35-1.23],0.1871770361135333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLHL41,Kelch-like protein 41,19678,72,1.21 [0.80-1.85],0.3704179880059809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK1,Kallikrein-1,22396,81,1.05 [0.90-1.22],0.5273215124558892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK10,Kallikrein-10,22633,82,1.09 [0.67-1.77],0.7327689378400684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK11,Kallikrein-11,22482,82,1.04 [0.54-2.01],0.9014805056724025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK12,Kallikrein-12,22124,81,0.99 [0.86-1.13],0.8652030995089868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK13,Kallikrein-13,22135,81,1.27 [0.81-1.99],0.2956589572572773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK14,Kallikrein-14,22837,83,0.86 [0.56-1.31],0.486224247992184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK15,Kallikrein-15,19577,71,1.00 [0.64-1.55],0.996435278501811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK3,Prostate-specific antigen,19705,73,0.90 [0.61-1.34],0.6067974245027947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK4,Kallikrein-4,22837,83,0.78 [0.55-1.10],0.1516328252371156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK6,Kallikrein-6,22677,81,0.75 [0.39-1.43],0.3803937188258312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK7,Kallikrein-7,18775,69,0.98 [0.53-1.82],0.9590721168249592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK8,Kallikrein-8,21872,76,0.98 [0.55-1.75],0.9419872916780334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLKB1,Plasma kallikrein,19338,71,1.11 [0.45-2.75],0.8236712315229351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22885,83,1.13 [0.66-1.91],0.658569505039152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19101,70,0.90 [0.59-1.37],0.6168364346864361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRD1,Natural killer cells antigen CD94,22885,83,1.15 [0.75-1.77],0.5096100752433417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19160,71,1.42 [0.97-2.08],0.0706486105234865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRK1,NKG2-D type II integral membrane protein,19668,71,1.01 [0.61-1.65],0.9767079950303976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT14,"Keratin, type I cytoskeletal 14",21346,75,1.10 [0.54-2.23],0.7957471508112655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT17,"Keratin, type I cytoskeletal 17",19109,70,0.88 [0.46-1.66],0.6855606523456474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT18,"Keratin, type I cytoskeletal 18",22532,81,1.06 [0.83-1.36],0.63730119270965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT19,"Keratin, type I cytoskeletal 19",22564,82,0.89 [0.65-1.21],0.4460282259833221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT5,"Keratin, type II cytoskeletal 5",22073,79,1.42 [0.98-2.07],0.0667236928477874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",19109,70,1.51 [1.03-2.20],0.0351319385512299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT8,"Keratin, type II cytoskeletal 8",19101,70,1.17 [0.87-1.57],0.2921359553803254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYAT1,Kynurenine--oxoglutarate transaminase 1,22597,82,1.05 [0.75-1.48],0.7633245445523047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYNU,Kynureninase,22885,83,0.77 [0.50-1.19],0.2379249303281191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L1CAM,Neural cell adhesion molecule L1,22705,82,1.25 [0.63-2.50],0.5261025379391491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19709,73,0.79 [0.61-1.02],0.0651153313925874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACRT,Extracellular glycoprotein lacritin,19565,71,1.14 [0.77-1.70],0.5108035507463812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACTB2,Endoribonuclease LACTB2,22636,82,0.88 [0.66-1.19],0.4213217657918889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAG3,Lymphocyte activation gene 3 protein,22532,81,1.31 [0.82-2.09],0.2534743277901922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22630,82,0.75 [0.42-1.34],0.3287746591636913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22486,81,1.15 [0.94-1.41],0.1737019393366003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA1,Laminin subunit alpha-1,19109,70,1.04 [0.69-1.55],0.8617993060736586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA4,Laminin subunit alpha-4,22739,82,0.67 [0.37-1.24],0.203653409236564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMB1,Laminin subunit beta-1,19209,70,0.84 [0.39-1.83],0.6671865478555029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP1,Lysosome-associated membrane glycoprotein 1,19152,69,0.51 [0.17-1.53],0.231745929992127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP2,Lysosome-associated membrane glycoprotein 2,21947,78,1.52 [0.50-4.60],0.4619318968839128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP3,Lysosome-associated membrane glycoprotein 3,22845,83,1.09 [0.75-1.60],0.6504531308211197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMTOR5,Ragulator complex protein LAMTOR5,19602,71,1.05 [0.63-1.78],0.8421556703125231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAP3,Cytosol aminopeptidase,22210,82,0.92 [0.61-1.39],0.6951359620898132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LARP1,La-related protein 1,19602,71,1.02 [0.72-1.44],0.9081597082422208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT,Linker for activation of T-cells family member 1,22885,83,0.86 [0.67-1.10],0.2181912136673228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT2,Linker for activation of T-cells family member 2,22532,81,0.88 [0.75-1.03],0.1200546855256677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LATS1,Serine/threonine-protein kinase LATS1,19160,71,0.80 [0.60-1.06],0.1134592063340755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAYN,Layilin,22438,81,0.96 [0.53-1.76],0.8995106809345658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBP,Lipopolysaccharide-binding protein,22698,82,1.19 [0.86-1.66],0.296149261647323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBR,Delta(14)-sterol reductase LBR,22833,80,1.14 [0.88-1.47],0.3324511487359325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCAT,Phosphatidylcholine-sterol acyltransferase,19711,71,0.89 [0.32-2.43],0.8138082628173552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN15,Lipocalin-15,19678,72,0.88 [0.59-1.31],0.5251984048294411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN2,Neutrophil gelatinase-associated lipocalin,21931,80,1.03 [0.60-1.77],0.9068999060055044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCP1,Plastin-2,19705,73,0.78 [0.48-1.29],0.3330473796088617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLR,Low-density lipoprotein receptor,22696,81,1.03 [0.71-1.49],0.8871883888118438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLRAP1,Low density lipoprotein receptor adapter protein 1,19678,72,0.79 [0.63-1.00],0.0523071296741675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LECT2,Leukocyte cell-derived chemotaxin-2,19709,73,0.93 [0.65-1.31],0.6619276736844986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEFTY2,Left-right determination factor 2,22798,83,0.92 [0.62-1.35],0.6673553167457286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEG1,Protein LEG1 homolog,18636,69,0.86 [0.61-1.23],0.4222801658948213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LELP1,Late cornified envelope-like proline-rich protein 1,19101,70,0.73 [0.51-1.07],0.1051976112836527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,19678,72,1.52 [1.04-2.23],0.0317390861990097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEP,Leptin,22636,82,0.98 [0.72-1.34],0.9041036419344678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEPR,Leptin receptor,22636,82,0.97 [0.51-1.85],0.9318241601316424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,19678,72,0.61 [0.37-0.98],0.0425308337117461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS1,Galectin-1,22636,82,0.91 [0.50-1.64],0.7529108479241943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3,Galectin-3,22688,81,0.85 [0.44-1.64],0.6244573327575296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3BP,Galectin-3-binding protein,19738,73,1.11 [0.54-2.31],0.7718989457997372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS4,Galectin-4,22630,82,0.84 [0.57-1.23],0.3712756227583406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS7_LGALS7B,Galectin-7,22600,83,0.97 [0.59-1.59],0.9067210346604824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS8,Galectin-8,22833,80,0.75 [0.53-1.06],0.0976981824402752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS9,Galectin-9,22632,82,0.92 [0.50-1.72],0.7965737680226257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGMN,Legumain,22739,82,0.89 [0.51-1.53],0.6686367541542299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHB,Lutropin subunit beta,22124,81,1.11 [0.90-1.36],0.3479859996647314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22664,82,1.51 [1.13-2.01],0.0055442456622282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIF,Leukemia inhibitory factor,22073,79,1.01 [0.69-1.49],0.9429978980724296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIFR,Leukemia inhibitory factor receptor,22597,82,1.18 [0.53-2.62],0.6829715583105812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22641,79,1.08 [0.61-1.93],0.7933918576451082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19705,73,1.08 [0.89-1.32],0.4147817847246789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19109,70,1.26 [0.88-1.81],0.2007062769404441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22602,82,0.96 [0.51-1.78],0.8905902949290561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19709,73,1.17 [0.86-1.60],0.3112930529707925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22905,81,1.84 [0.90-3.78],0.0970069842456906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22798,81,1.21 [0.68-2.17],0.512114272773081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22210,82,1.52 [0.98-2.35],0.0618794834993767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22905,81,0.98 [0.75-1.29],0.8899087854875437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIPF,Gastric triacylglycerol lipase,19209,70,0.92 [0.62-1.36],0.6743317978167641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB1,Lamin-B1,19565,71,1.26 [0.94-1.70],0.1234981039715332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB2,Lamin-B2,19668,71,0.96 [0.42-2.23],0.9301276802869648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD1,Leiomodin-1,19678,72,0.83 [0.42-1.64],0.5845927610955889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD2,Leiomodin-2,19101,70,0.90 [0.61-1.31],0.5721438717168541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LONP1,"Lon protease homolog, mitochondrial",19209,70,0.79 [0.60-1.04],0.0978722684277712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPA,Apolipoprotein(a),19242,69,0.97 [0.85-1.10],0.597813617388075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPCAT2,Lysophosphatidylcholine acyltransferase 2,22532,81,1.32 [0.96-1.80],0.0859307124153799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPL,Lipoprotein lipase,22636,82,0.76 [0.51-1.12],0.166580410002734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPO,Lactoperoxidase,21935,80,1.17 [0.84-1.65],0.3505711017735881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPP,Lipoma-preferred partner,19109,70,0.73 [0.51-1.05],0.0883598631607758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19109,70,0.91 [0.64-1.29],0.6048449611652322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19160,69,1.38 [1.00-1.91],0.048585954854046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRG1,Leucine-rich alpha-2-glycoprotein,19738,73,1.32 [0.56-3.08],0.5255745467499575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22765,83,1.34 [0.76-2.37],0.3122470295110291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19085,71,0.78 [0.32-1.85],0.5676278458203863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP1,Prolow-density lipoprotein receptor-related protein 1,22532,81,0.78 [0.36-1.68],0.5309181915120176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP11,Low-density lipoprotein receptor-related protein 11,22636,82,1.17 [0.67-2.04],0.5859137454513377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2,Low-density lipoprotein receptor-related protein 2,19160,69,0.99 [0.53-1.84],0.9645428032268368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2BP,LRP2-binding protein,19160,69,1.00 [0.77-1.30],0.986866458746244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22833,80,0.94 [0.65-1.33],0.711459980847267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC25,Leucine-rich repeat-containing protein 25,22532,81,1.24 [0.76-2.02],0.3849468357516509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC37A2,Leucine-rich repeat-containing protein 37A2,19608,71,1.05 [0.61-1.80],0.8570212945643163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC38,Leucine-rich repeat-containing protein 38,19160,69,0.96 [0.60-1.55],0.876926356052584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC59,Leucine-rich repeat-containing protein 59,19709,73,0.75 [0.45-1.26],0.2747837837790182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19602,71,0.83 [0.50-1.36],0.4587825313404716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRN1,Leucine-rich repeat neuronal protein 1,22210,82,1.15 [0.68-1.92],0.6078346723487507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19160,69,1.01 [0.58-1.77],0.968743317645862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19678,72,1.04 [0.45-2.38],0.9264231668163488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM1,U6 snRNA-associated Sm-like protein LSm1,22124,81,1.15 [0.84-1.56],0.3879766233177057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM8,U6 snRNA-associated Sm-like protein LSm8,19329,70,1.00 [0.78-1.29],0.9997272310627968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSP1,Lymphocyte-specific protein 1,22597,82,0.93 [0.57-1.52],0.7676047113661394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA,Lymphotoxin-alpha,22597,82,1.00 [0.62-1.64],0.9861788670767144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA4H,Leukotriene A-4 hydrolase,22837,83,0.99 [0.71-1.38],0.9592170133933342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTB,Lymphotoxin-beta,19602,71,1.22 [0.70-2.11],0.4792413108357701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP2,Latent-transforming growth factor beta-binding protein 2,22905,81,0.74 [0.39-1.41],0.3669915936944551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP3,Latent-transforming growth factor beta-binding protein 3,22124,81,1.18 [0.85-1.64],0.325585581004936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBR,Tumor necrosis factor receptor superfamily member 3,22528,82,1.00 [0.48-2.08],0.9997892893220808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTO1,Protein LTO1 homolog,22210,82,1.32 [0.90-1.93],0.1578031152531016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LUZP2,Leucine zipper protein 2,19602,71,0.90 [0.53-1.54],0.7060181541303617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,22383,81,1.39 [1.08-1.79],0.0096189336085983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY6D,Lymphocyte antigen 6D,22529,82,1.01 [0.59-1.72],0.9813032999992956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY75,Lymphocyte antigen 75,22597,82,1.12 [0.67-1.86],0.6700566173867144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY9,T-lymphocyte surface antigen Ly-9,22418,82,1.54 [0.77-3.06],0.2182072408839622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY96,Lymphocyte antigen 96,22486,81,1.20 [0.69-2.07],0.5237721251360314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYAR,Cell growth-regulating nucleolar protein,22124,81,1.25 [0.96-1.64],0.1022355427500512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYN,Tyrosine-protein kinase Lyn,22532,81,0.83 [0.66-1.05],0.1151987509460839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD1,Ly6/PLAUR domain-containing protein 1,22073,79,0.82 [0.55-1.20],0.3026862811721025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD3,Ly6/PLAUR domain-containing protein 3,22518,82,1.59 [0.92-2.75],0.0977820836894479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD8,Ly6/PLAUR domain-containing protein 8,22124,81,1.27 [0.89-1.81],0.1817854244716237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPLA2,Acyl-protein thioesterase 2,19101,70,1.08 [0.89-1.31],0.4367393823245004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19160,69,0.95 [0.75-1.20],0.6665643218648454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19738,73,1.01 [0.33-3.13],0.988106466373072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYZL2,Lysozyme-like protein 2,19016,71,1.36 [0.80-2.34],0.2588794249127484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LZTFL1,Leucine zipper transcription factor-like protein 1,19296,70,0.87 [0.63-1.21],0.4021961635956312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,M6PR,Cation-dependent mannose-6-phosphate receptor,19209,70,1.03 [0.60-1.78],0.90547203603338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22401,80,1.32 [0.98-1.78],0.0669937120581434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAEA,E3 ubiquitin-protein transferase MAEA,22124,81,1.01 [0.62-1.65],0.9631048557615952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAG,Myelin-associated glycoprotein,19160,69,0.75 [0.46-1.22],0.2448745481614712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGEA3,Melanoma-associated antigen 3,19329,70,0.90 [0.71-1.15],0.4120993688734087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGED1,Melanoma-associated antigen D1,22124,81,0.78 [0.51-1.21],0.2679090519247799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC2,MAM domain-containing protein 2,19709,73,1.13 [0.59-2.18],0.704504763942003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC4,Apical endosomal glycoprotein,19602,71,0.89 [0.58-1.36],0.5876549503729018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19209,70,1.66 [0.67-4.10],0.2691513597150609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN2B2,Epididymis-specific alpha-mannosidase,19709,73,1.17 [0.80-1.71],0.4199695185090268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19016,71,1.01 [0.64-1.59],0.9690103227206652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANF,Mesencephalic astrocyte-derived neurotrophic factor,22739,82,0.87 [0.75-1.01],0.0653477778127371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC1,MANSC domain-containing protein 1,22705,82,0.90 [0.43-1.86],0.7735923314292099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC4,MANSC domain-containing protein 4,19109,70,0.79 [0.54-1.13],0.1976789007742564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19101,70,0.88 [0.42-1.84],0.7416257691090322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19109,70,1.05 [0.76-1.44],0.7602546255896143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2,Microtubule-associated protein 2,19668,71,0.92 [0.54-1.55],0.7468138948991823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19608,71,0.84 [0.58-1.20],0.3305081972772415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22597,82,0.87 [0.72-1.05],0.15452468521782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22124,81,0.97 [0.79-1.19],0.7728686524093377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22438,81,0.87 [0.73-1.04],0.11782523781431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK13,Mitogen-activated protein kinase 13,19016,71,1.40 [0.98-2.01],0.0669039728300033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK9,Mitogen-activated protein kinase 9,22597,82,0.91 [0.58-1.44],0.6850293020444157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPKAPK2,MAP kinase-activated protein kinase 2,19329,70,0.84 [0.61-1.16],0.3018520775807273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPRE3,Microtubule-associated protein RP/EB family member 3,19016,71,1.07 [0.93-1.23],0.3686147752070756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPT,Microtubule-associated protein tau,22073,79,1.30 [0.89-1.92],0.1780133667833126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARCO,Macrophage receptor MARCO,22636,82,1.41 [0.67-2.95],0.3685453353537622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARS1,"Methionine--tRNA ligase, cytoplasmic",19253,70,0.82 [0.63-1.08],0.1575363294979782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MASP1,Mannan-binding lectin serine protease 1,22438,81,1.51 [0.65-3.54],0.3386479127632469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN2,Matrilin-2,22672,82,0.69 [0.35-1.34],0.2701421143087479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN3,Matrilin-3,22451,81,1.18 [0.63-2.22],0.601197942592099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAVS,Mitochondrial antiviral-signaling protein,22124,81,0.90 [0.72-1.12],0.3567227914319807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAX,Protein max,22073,79,0.85 [0.70-1.03],0.0953577817232343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MB,Myoglobin,22905,81,1.16 [0.79-1.70],0.4413808924222355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MBL2,Mannose-binding protein C,19449,71,1.10 [0.89-1.37],0.3784343178478268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCAM,Cell surface glycoprotein MUC18,22698,82,1.09 [0.61-1.94],0.7649813094295742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19678,72,0.69 [0.38-1.26],0.2323524047231517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEMP1,Mast cell-expressed membrane protein 1,19160,71,0.93 [0.72-1.19],0.5569534197550222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCFD2,Multiple coagulation factor deficiency protein 2,22537,80,0.76 [0.48-1.22],0.2576829068721336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCTS1,Malignant T-cell-amplified sequence 1,19608,71,0.34 [0.12-1.03],0.0555508531184913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22486,81,0.86 [0.65-1.13],0.2860484695856621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDH1,"Malate dehydrogenase, cytoplasmic",19590,71,1.15 [0.67-1.97],0.6115674944002245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDK,Midkine,22645,81,0.82 [0.55-1.23],0.3395237732219417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDM1,Nuclear protein MDM1,19160,69,0.71 [0.33-1.52],0.3762709938136545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19209,70,0.79 [0.61-1.02],0.0733701605103991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED18,Mediator of RNA polymerase II transcription subunit 18,22124,81,0.83 [0.64-1.07],0.1533584011714619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED21,Mediator of RNA polymerase II transcription subunit 21,19109,70,0.98 [0.61-1.56],0.928220875690461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF10,Multiple epidermal growth factor-like domains protein 10,22630,82,0.82 [0.49-1.38],0.4557688546790125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF11,Multiple epidermal growth factor-like domains protein 11,19109,70,0.77 [0.35-1.67],0.5068782858305791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF9,Multiple epidermal growth factor-like domains protein 9,22837,81,2.16 [0.86-5.43],0.1011088028241559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MELTF,Melanotransferrin,19709,73,0.90 [0.42-1.97],0.8010624849946623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MENT,Protein MENT,19296,70,0.53 [0.19-1.50],0.2353179683287045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1A,Meprin A subunit alpha,19608,71,0.82 [0.58-1.16],0.2625430915002861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1B,Meprin A subunit beta,22636,82,1.01 [0.86-1.19],0.8823785227028402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEPE,Matrix extracellular phosphoglycoprotein,22630,82,0.75 [0.36-1.53],0.4235378944759682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MERTK,Tyrosine-protein kinase Mer,22885,83,1.36 [0.65-2.86],0.4105977723536368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MESD,LRP chaperone MESD,22641,79,0.85 [0.73-1.01],0.0619925354688182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MET,Hepatocyte growth factor receptor,22691,80,0.61 [0.23-1.62],0.3228725594781038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1,Methionine aminopeptidase 1,22073,79,0.70 [0.34-1.41],0.3148408313899941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22597,82,0.86 [0.67-1.09],0.2007127250788524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP2,Methionine aminopeptidase 2,22798,83,0.93 [0.67-1.29],0.6600404938957166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3,Microfibril-associated glycoprotein 3,22232,80,1.03 [0.70-1.51],0.8733934864845673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3L,Microfibrillar-associated protein 3-like,19160,69,0.65 [0.39-1.06],0.0822722644109276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP4,Microfibril-associated glycoprotein 4,19296,70,1.42 [0.68-2.94],0.3474285357646034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP5,Microfibrillar-associated protein 5,22905,81,1.62 [1.00-2.65],0.0520347275884645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFGE8,Lactadherin,22641,79,1.21 [0.76-1.94],0.4295418982080756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGLL,Monoglyceride lipase,22700,82,0.84 [0.68-1.04],0.1175811607591047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGMT,Methylated-DNA--protein-cysteine methyltransferase,22597,82,0.87 [0.75-1.01],0.073237442573295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIA,Melanoma-derived growth regulatory protein,22705,82,0.85 [0.49-1.47],0.5575246931213278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICALL2,MICAL-like protein 2,19160,69,1.07 [0.77-1.49],0.6686297405135552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22597,82,0.98 [0.87-1.12],0.8006830473680407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIF,Macrophage migration inhibitory factor,22611,79,1.03 [0.78-1.38],0.822944719432876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MILR1,Allergin-1,22210,82,1.05 [0.71-1.56],0.806783691155741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19602,71,0.86 [0.70-1.05],0.1414621987307369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINK1,Misshapen-like kinase 1,19668,71,0.86 [0.68-1.09],0.2206278177837992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MITD1,MIT domain-containing protein 1,22486,81,0.84 [0.69-1.03],0.0884868037663491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MKI67,Proliferation marker protein Ki-67,19160,71,1.26 [0.79-2.01],0.3325501560312924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLLT1,Protein ENL,19016,71,0.98 [0.71-1.37],0.9272557508245626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLN,Promotilin,22597,82,0.95 [0.76-1.18],0.6370070613607319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MME,Neprilysin,22532,81,1.11 [0.88-1.40],0.3837695025534213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP1,Interstitial collagenase,21767,78,0.89 [0.71-1.10],0.266001761178112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP10,Stromelysin-2,22599,82,0.94 [0.67-1.31],0.713360064726942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP12,Macrophage metalloelastase,22657,83,1.18 [0.81-1.72],0.3741746484693191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP13,Collagenase 3,22073,79,0.99 [0.54-1.83],0.9725610182022172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP15,Matrix metalloproteinase-15,19709,73,1.33 [0.99-1.79],0.0597238230504664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP3,Stromelysin-1,22641,79,0.84 [0.54-1.29],0.4205448080073701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP7,Matrilysin,22191,80,1.12 [0.74-1.72],0.585268520122286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP8,Neutrophil collagenase,22793,80,1.20 [0.92-1.55],0.1717668281503109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP9,Matrix metalloproteinase-9,22600,79,1.31 [0.95-1.82],0.1041580758202397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19109,70,0.60 [0.36-1.02],0.0593361140497994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MN1,Transcriptional activator MN1,19160,69,1.20 [0.87-1.66],0.2768499468843798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNAT1,CDK-activating kinase assembly factor MAT1,19329,70,1.28 [0.82-1.98],0.2810041779881235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNDA,Myeloid cell nuclear differentiation antigen,22601,82,1.15 [0.98-1.35],0.0953675930704289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOCS2,Molybdopterin synthase catalytic subunit,19296,70,0.87 [0.61-1.24],0.4542459717242614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOG,Myelin-oligodendrocyte glycoprotein,22837,83,0.68 [0.37-1.25],0.21783221866192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORC3,MORC family CW-type zinc finger protein 3,19668,71,1.01 [0.46-2.24],0.9705435490834442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L1,Mortality factor 4-like protein 1,19329,70,0.94 [0.53-1.67],0.8352071971193112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L2,Mortality factor 4-like protein 2,19016,71,1.14 [0.65-2.01],0.6396362875898609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORN4,MORN repeat-containing protein 4,19016,71,0.91 [0.66-1.26],0.5785653899634442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPHOSPH8,M-phase phosphoprotein 8,22232,80,0.93 [0.71-1.22],0.5954797101817584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPI,Mannose-6-phosphate isomerase,22532,81,0.83 [0.66-1.06],0.1309829686910574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22700,82,0.82 [0.65-1.04],0.0951600017981582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPO,Myeloperoxidase,22641,79,1.41 [0.97-2.04],0.0714718701273375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPRIP,Myosin phosphatase Rho-interacting protein,19559,71,0.90 [0.53-1.52],0.6908632116705519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRC1,Macrophage mannose receptor 1,19711,71,0.94 [0.42-2.09],0.8714899405499317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRI1,Methylthioribose-1-phosphate isomerase,19160,69,1.34 [0.95-1.89],0.0949799037103566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL24,"39S ribosomal protein L24, mitochondrial",19109,70,0.70 [0.35-1.41],0.3141807041296942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL28,"39S ribosomal protein L28, mitochondrial",19678,72,1.00 [0.55-1.81],0.9947164212739062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL46,"39S ribosomal protein L46, mitochondrial",22073,79,0.69 [0.32-1.52],0.359418999614094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL52,"39S ribosomal protein L52, mitochondrial",18988,71,0.91 [0.37-2.28],0.8486761341097334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19678,72,0.66 [0.43-0.99],0.0440110181534308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPS16,"28S ribosomal protein S16, mitochondrial",19160,71,0.99 [0.45-2.18],0.9878252520451284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLN,Mesothelin,22501,81,1.02 [0.71-1.46],0.9181744461824298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLNL,Mesothelin-like protein,19160,69,0.61 [0.31-1.19],0.1457263026917319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSMB,Beta-microseminoprotein,22547,81,0.94 [0.71-1.25],0.6871348540250617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSR1,Macrophage scavenger receptor types I and II,22833,80,0.86 [0.55-1.32],0.487934751120986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSRA,Mitochondrial peptide methionine sulfoxide reductase,22705,82,0.89 [0.68-1.16],0.3899196518060712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MST1,Hepatocyte growth factor-like protein,19398,70,1.27 [0.80-2.01],0.3133387278308751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSTN,Growth/differentiation factor 8,22232,80,1.10 [0.75-1.63],0.6223111590420052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,19160,71,0.77 [0.59-1.00],0.0479880896751077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19668,71,1.12 [0.49-2.60],0.784101820424168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19329,70,0.90 [0.73-1.11],0.345306210606334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",19608,71,0.74 [0.56-0.97],0.0265602495748045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTPN,Myotrophin,22232,80,0.88 [0.47-1.65],0.6934979731771889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTR,Methionine synthase,19109,70,1.14 [0.85-1.55],0.3840266818451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS1,Protein MTSS 1,19608,71,0.87 [0.71-1.07],0.2019863032936669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,19602,71,0.73 [0.57-0.92],0.0073206426863531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTUS1,Microtubule-associated tumor suppressor 1,19329,70,1.01 [0.67-1.52],0.9480416470026212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC13,Mucin-13,22073,79,0.94 [0.62-1.42],0.7784471378357516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC16,Mucin-16,22532,81,1.07 [0.96-1.19],0.2298759702616796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC2,Mucin-2,19705,73,0.96 [0.75-1.22],0.7258610630920754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUCL3,Mucin-like protein 3,19016,71,0.84 [0.47-1.50],0.5564699960767937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MVK,Mevalonate kinase,22210,82,1.04 [0.81-1.34],0.7707643096124562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MXRA8,Matrix remodeling-associated protein 8,19296,70,1.00 [0.47-2.11],0.9926660414692156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC1,"Myosin-binding protein C, slow-type",19709,73,1.13 [0.80-1.59],0.4804022045722321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC2,"Myosin-binding protein C, fast-type",19209,70,0.90 [0.66-1.23],0.519483702733994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19678,72,1.05 [0.77-1.45],0.740663223614022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,19709,73,0.77 [0.61-0.97],0.0236202933722429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH4,Myosin-4,19109,70,1.35 [0.93-1.95],0.1100748834079587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH7B,Myosin-7B,19016,71,1.22 [0.79-1.90],0.3657806400512197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH9,Myosin-9,19705,73,0.85 [0.69-1.03],0.1014883969456326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19109,70,1.19 [0.73-1.94],0.4966222866595514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL3,Myosin light chain 3,19209,70,1.09 [0.78-1.52],0.6265006867783411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,19209,70,1.55 [1.13-2.12],0.0063180532829511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL6B,Myosin light chain 6B,19160,69,1.03 [0.81-1.31],0.8116318468849612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19160,69,1.10 [0.67-1.82],0.7018210619612522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO6,Unconventional myosin-VI,19678,72,1.37 [0.87-2.16],0.173780184313546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO9B,Unconventional myosin-IXb,22210,82,1.10 [0.83-1.46],0.5066597097342345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOC,Myocilin,22641,79,0.82 [0.53-1.27],0.3835310833533341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM1,Myomesin-1,19101,70,0.95 [0.58-1.56],0.8356158390692964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM2,Myomesin-2,19109,70,1.08 [0.66-1.77],0.7475649760480003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM3,Myomesin-3,19296,70,1.02 [0.79-1.32],0.8605910834077695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZB1,Marginal zone B- and B1-cell-specific protein,22711,82,1.29 [0.89-1.86],0.1817601821273523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZT1,Mitotic-spindle organizing protein 1,22124,81,0.99 [0.67-1.45],0.9413059997997594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA10,N-alpha-acetyltransferase 10,19109,70,0.69 [0.44-1.08],0.1014400585570896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA80,N-alpha-acetyltransferase 80,19160,69,0.87 [0.71-1.06],0.1704838758701999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22380,80,1.60 [1.19-2.16],0.0017470461085414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NACC1,Nucleus accumbens-associated protein 1,19602,71,0.78 [0.50-1.21],0.2673141581747034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NADK,NAD kinase,22636,82,1.27 [0.95-1.71],0.106188541980134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGA,Alpha-N-acetylgalactosaminidase,19121,71,1.05 [0.73-1.51],0.7998880907839199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGK,N-acetyl-D-glucosamine kinase,19171,69,1.01 [0.67-1.52],0.9556791403109672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19296,70,1.23 [0.41-3.65],0.7146245483214742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAMPT,Nicotinamide phosphoribosyltransferase,22124,81,1.12 [0.82-1.53],0.4628835812430234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAP1L4,Nucleosome assembly protein 1-like 4,19580,71,1.25 [0.72-2.18],0.420366036368634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAPRT,Nicotinate phosphoribosyltransferase,19668,71,1.28 [0.68-2.38],0.4438524187412266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NARS1,"Asparagine--tRNA ligase, cytoplasmic",19678,72,0.71 [0.45-1.12],0.1396383530587223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22705,82,1.07 [0.50-2.29],0.8525296203807684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBN,Nibrin,22210,82,1.09 [0.78-1.52],0.61729997691133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM1,Neural cell adhesion molecule 1,22698,82,1.19 [0.59-2.42],0.6240142127776811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM2,Neural cell adhesion molecule 2,22641,79,0.82 [0.39-1.73],0.602753767528533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAN,Neurocan core protein,22833,80,0.94 [0.55-1.60],0.8174683069429362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCF2,Neutrophil cytosol factor 2,22569,82,1.16 [0.95-1.42],0.1431843139281216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCK2,Cytoplasmic protein NCK2,22739,82,0.87 [0.72-1.05],0.1418319963546922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCLN,Nicalin,22210,82,0.95 [0.65-1.41],0.8151744740087696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR1,Natural cytotoxicity triggering receptor 1,22563,81,0.79 [0.46-1.38],0.4087996514404933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19608,71,0.64 [0.31-1.32],0.2295104933734346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCS1,Neuronal calcium sensor 1,22837,83,1.43 [0.72-2.84],0.3068888427485624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDRG1,Protein NDRG1,22073,79,1.08 [0.84-1.39],0.5466808795014493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19602,71,1.08 [0.79-1.48],0.6082504162531908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19126,71,1.20 [0.63-2.27],0.5767206483003912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19608,71,0.75 [0.58-0.98],0.0318219459922319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22124,81,0.86 [0.64-1.15],0.3097219252906158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEB,Nebulin,19109,70,1.31 [0.79-2.18],0.2959076836696721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECAP2,Adaptin ear-binding coat-associated protein 2,19109,70,0.85 [0.59-1.22],0.3693476799040665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN1,Nectin-1,19160,71,1.12 [0.56-2.22],0.7460133385913073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN2,Nectin-2,22602,82,1.14 [0.57-2.30],0.7062483667627883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN4,Nectin-4,22705,82,1.43 [0.76-2.69],0.2725163409676595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19160,71,1.09 [0.68-1.75],0.7231793736350921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD9,Enhancer of filamentation 1,19160,71,0.92 [0.46-1.86],0.8168563571249335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEFL,Neurofilament light polypeptide,21994,79,0.85 [0.52-1.41],0.5353680109540132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEK7,Serine/threonine-protein kinase Nek7,19329,70,1.12 [0.87-1.46],0.3834211559496437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL1,Protein kinase C-binding protein NELL1,22705,82,1.14 [0.72-1.82],0.5673918586310842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL2,Protein kinase C-binding protein NELL2,22739,82,1.25 [0.62-2.50],0.5285487042016305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NENF,Neudesin,19602,71,0.98 [0.80-1.21],0.8621715866807662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEO1,Neogenin,19678,72,0.46 [0.16-1.38],0.1654363261647103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEXN,Nexilin,19711,71,0.76 [0.53-1.08],0.1197173965747152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFASC,Neurofascin,22885,83,1.48 [0.73-3.00],0.2821769914628768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFAT5,Nuclear factor of activated T-cells 5,19160,71,1.03 [0.79-1.34],0.8307835000660614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22597,82,0.87 [0.70-1.07],0.1749257697030593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22210,82,0.82 [0.57-1.18],0.2899934032246736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFE2,Transcription factor NF-E2 45 kDa subunit,19209,70,0.90 [0.65-1.23],0.4920856517141013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFIC,Nuclear factor 1 C-type,19678,72,1.37 [1.00-1.88],0.0529733795512721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19109,70,0.82 [0.60-1.13],0.2226450975797047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19329,70,1.15 [0.83-1.59],0.3974644096302503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKBIE,NF-kappa-B inhibitor epsilon,22124,81,0.96 [0.64-1.44],0.8294387057364215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19608,71,0.78 [0.63-0.98],0.0343272790742426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFX1,Transcriptional repressor NF-X1,19109,70,0.76 [0.53-1.10],0.1436030264399648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFYA,Nuclear transcription factor Y subunit alpha,19109,70,0.87 [0.47-1.63],0.6723782976425207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGF,Beta-nerve growth factor,22486,81,0.96 [0.19-4.77],0.9552899002447768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGFR,Tumor necrosis factor receptor superfamily member 16,19709,73,0.87 [0.39-1.92],0.7294707604343484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGRN,Neugrin,19668,71,1.10 [0.41-2.96],0.8486442026755716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NHLRC3,NHL repeat-containing protein 3,18816,69,1.02 [0.48-2.16],0.9547357271903844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID1,Nidogen-1,22621,82,0.97 [0.60-1.58],0.9040608429823532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID2,Nidogen-2,22641,79,0.98 [0.75-1.27],0.8718637204379575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NINJ1,Ninjurin-1,22124,81,0.97 [0.68-1.39],0.8881924004790875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT1,Deaminated glutathione amidase,19209,70,1.05 [0.66-1.68],0.8283683280805354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT2,Omega-amidase NIT2,19640,73,0.87 [0.64-1.17],0.3556122434483788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN1,Neuroligin-1,19160,69,0.97 [0.69-1.37],0.8635191929617899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN2,Neuroligin-2,19101,70,1.10 [0.72-1.68],0.6662216421460829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,19160,71,2.43 [1.06-5.61],0.0369381947767533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME3,Nucleoside diphosphate kinase 3,22672,82,0.93 [0.40-2.16],0.8578911014219323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMI,N-myc-interactor,19531,71,0.81 [0.58-1.13],0.2099057625666336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22486,81,1.21 [0.98-1.50],0.0747988357209638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMRK2,Nicotinamide riboside kinase 2,19016,71,0.77 [0.40-1.46],0.4211238109015263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19678,72,0.94 [0.66-1.33],0.7205117732980395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,22641,79,2.77 [1.48-5.19],0.0013870106913504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOP56,Nucleolar protein 56,19109,70,1.16 [0.99-1.37],0.0735678892877276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS1,"Nitric oxide synthase, brain",22073,79,1.05 [0.70-1.59],0.8079377865058253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS2,"Nitric oxide synthase, inducible",19109,70,1.15 [0.66-2.03],0.6206841569460879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS3,"Nitric oxide synthase, endothelial",22073,79,1.35 [1.00-1.83],0.050194959625569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH1,Neurogenic locus notch homolog protein 1,22905,81,0.97 [0.27-3.50],0.9653101492060894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH2,Neurogenic locus notch homolog protein 2,19705,73,0.64 [0.20-2.06],0.458098769040938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH3,Neurogenic locus notch homolog protein 3,22905,81,0.96 [0.54-1.70],0.8838578395400072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPC2,NPC intracellular cholesterol transporter 2,19368,71,0.64 [0.30-1.38],0.2542319737811411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPDC1,Neural proliferation differentiation and control protein 1,22636,82,0.79 [0.40-1.56],0.499490713395211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS1,Nephrin,19160,71,0.75 [0.37-1.53],0.4327321095623531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS2,Podocin,19160,71,1.08 [0.89-1.32],0.4315526983021658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPL,N-acetylneuraminate lyase,19709,73,1.13 [0.68-1.86],0.6430002126855563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPB,Natriuretic peptides B,22232,80,1.07 [0.91-1.25],0.4075145174673732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPC,C-type natriuretic peptide,22597,82,0.80 [0.49-1.29],0.3577083235099478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPR1,Atrial natriuretic peptide receptor 1,19109,70,1.06 [0.61-1.84],0.8343112811904528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTN,Neuroplastin,22124,81,0.90 [0.69-1.18],0.4645638454209152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX1,Neuronal pentraxin-1,22641,79,1.00 [0.60-1.66],0.9894559044789492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX2,Neuronal pentraxin-2,19705,73,0.53 [0.27-1.07],0.0748086230070861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTXR,Neuronal pentraxin receptor,22636,82,0.82 [0.45-1.48],0.5056030049952596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPY,Pro-neuropeptide Y,22837,83,0.97 [0.72-1.29],0.8123062357686819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRCAM,Neuronal cell adhesion molecule,22636,82,1.79 [0.92-3.48],0.0870387386290081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,19711,71,0.76 [0.59-0.98],0.0316529749614676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRN1,Neuritin,19678,72,0.96 [0.49-1.86],0.9019912860170356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP1,Neuropilin-1,22741,82,0.91 [0.45-1.82],0.7862177601639785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP2,Neuropilin-2,22641,79,1.19 [0.60-2.35],0.6229121986491761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRTN,Neurturin,22210,82,1.20 [0.85-1.69],0.3022851219650468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRXN3,Neurexin-3,19160,69,1.09 [0.59-2.01],0.7846800769699293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NSFL1C,NSFL1 cofactor p47,22833,80,1.22 [0.91-1.63],0.1774177699539275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19709,73,0.89 [0.66-1.19],0.4274002721027687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C1A,Cytosolic 5'-nucleotidase 1A,19668,71,0.83 [0.39-1.79],0.6425021948398397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C3A,Cytosolic 5'-nucleotidase 3A,22566,81,1.00 [0.80-1.24],0.9746053556430214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5E,5'-nucleotidase,22705,82,1.09 [0.79-1.52],0.5984776325623027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF3,Neurotrophin-3,22597,82,1.31 [0.78-2.20],0.3096743640581094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF4,Neurotrophin-4,22124,81,1.06 [0.66-1.71],0.8115019207380049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK2,BDNF/NT-3 growth factors receptor,22636,82,1.05 [0.49-2.26],0.8959407968891129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK3,NT-3 growth factor receptor,22833,80,0.74 [0.30-1.85],0.5233204141329774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22636,82,1.23 [1.01-1.48],0.0348351993748984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUB1,NEDD8 ultimate buster 1,22597,82,0.96 [0.76-1.21],0.7311556727542579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19602,71,1.11 [0.90-1.36],0.3410780196314109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUCB2,Nucleobindin-2,22795,82,0.67 [0.39-1.16],0.1522565426424479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDC,Nuclear migration protein nudC,22885,83,0.85 [0.63-1.15],0.2963614827745808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19209,70,1.65 [0.93-2.92],0.0858389264745144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19109,70,0.72 [0.42-1.24],0.2374616434532221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT16,U8 snoRNA-decapping enzyme,19572,71,0.90 [0.69-1.17],0.42188667475471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22532,81,0.86 [0.60-1.23],0.4066885405728373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT5,ADP-sugar pyrophosphatase,22641,79,1.07 [0.73-1.57],0.7341637869227883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUMB,Protein numb homolog,19160,71,0.77 [0.59-1.01],0.0623675881256272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUP50,Nuclear pore complex protein Nup50,19109,70,0.95 [0.48-1.90],0.8907852182396393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPE4,NXPE family member 4,19109,70,0.94 [0.48-1.84],0.8654391427921564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH1,Neurexophilin-1,22073,79,0.68 [0.38-1.19],0.1750970967290613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH3,Neurexophilin-3,19160,71,1.12 [0.52-2.41],0.7712534952508435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OBP2B,Odorant-binding protein 2b,22415,81,0.90 [0.67-1.22],0.4885022044585744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OCLN,Occludin,19678,72,0.95 [0.56-1.62],0.849018242308417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ODAM,Odontogenic ameloblast-associated protein,22043,79,1.00 [0.69-1.44],0.9910284371341024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OFD1,Oral-facial-digital syndrome 1 protein,19329,70,0.96 [0.68-1.37],0.8350163546753273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGA,Protein O-GlcNAcase,19608,71,0.76 [0.54-1.05],0.0980390252472579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGFR,Opioid growth factor receptor,22532,81,0.94 [0.51-1.73],0.8488559473028412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGN,Mimecan,22641,79,1.19 [0.72-1.94],0.5003799516909206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19329,70,0.94 [0.65-1.38],0.7648567430312421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLFM4,Olfactomedin-4,18572,70,1.13 [0.93-1.36],0.2272186490173363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLR1,Oxidized low-density lipoprotein receptor 1,22418,82,1.11 [0.81-1.53],0.5226951838877977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMD,Osteomodulin,22739,82,0.88 [0.57-1.36],0.5645767127710745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMG,Oligodendrocyte-myelin glycoprotein,22532,81,0.90 [0.66-1.23],0.4968851505076732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMP,Olfactory marker protein,19101,70,1.23 [0.84-1.79],0.2885142067702673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPHN1,Oligophrenin-1,19668,71,0.81 [0.66-1.00],0.053842058216794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPLAH,5-oxoprolinase,19209,70,0.91 [0.65-1.29],0.6037984317643302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPTC,Opticin,22532,81,0.82 [0.52-1.31],0.4152048379282792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,19669,72,0.30 [0.09-0.98],0.0467303928974296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSBPL2,Oxysterol-binding protein-related protein 2,19668,71,1.37 [0.92-2.06],0.1221032329022108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSCAR,Osteoclast-associated immunoglobulin-like receptor,22672,82,1.50 [0.83-2.72],0.183332602123778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSM,Oncostatin-M,22494,82,1.16 [0.88-1.52],0.2937746919846407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSMR,Oncostatin-M-specific receptor subunit beta,22741,82,0.44 [0.17-1.10],0.0781943322560585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSTN,Osteocrin,19160,69,0.98 [0.56-1.72],0.9472789529997144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTOA,Otoancorin,19101,70,1.31 [0.96-1.78],0.088162924647522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD6B,Deubiquitinase OTUD6B,19608,71,0.81 [0.55-1.20],0.294432874519384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,19678,72,0.68 [0.47-0.99],0.0459488287287588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19209,70,0.78 [0.55-1.11],0.164613066418402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXT,Oxytocin-neurophysin 1,22833,80,1.10 [0.95-1.27],0.2093232457932875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,P4HB,Protein disulfide-isomerase,22520,81,0.75 [0.44-1.26],0.2722429997680375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PACS2,Phosphofurin acidic cluster sorting protein 2,19109,70,0.84 [0.57-1.23],0.3740767453837522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI2,Protein-arginine deiminase type-2,22210,82,1.13 [0.84-1.53],0.418950183252043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,22043,79,1.24 [1.01-1.52],0.0357548772432615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAEP,Glycodelin,22486,81,0.99 [0.84-1.17],0.947175095782012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19678,72,1.08 [0.91-1.28],0.3541694217813206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19329,70,1.10 [0.70-1.73],0.6828841209972152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22232,80,0.83 [0.57-1.20],0.3302879022174151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAGR1,PAXIP1-associated glutamate-rich protein 1,19209,70,0.90 [0.53-1.53],0.6933113275751881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18978,71,1.08 [0.71-1.65],0.7214563997010568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAK4,Serine/threonine-protein kinase PAK 4,22073,79,0.99 [0.71-1.38],0.9626361971365076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALLD,Palladin,19160,71,0.85 [0.46-1.58],0.6122595148299059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM,Paralemmin-1,19505,71,0.69 [0.32-1.48],0.3354899775582325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM2,Paralemmin-2,19668,71,0.64 [0.33-1.24],0.1854746470172568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM3,Paralemmin-3,19109,70,1.07 [0.81-1.42],0.6190795414355514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAM,Peptidyl-glycine alpha-amidating monooxygenase,22776,81,1.00 [0.50-2.03],0.9902669361385188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAMR1,Inactive serine protease PAMR1,22641,79,0.54 [0.27-1.11],0.0930290485939007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAPPA,Pappalysin-1,22210,82,1.17 [0.77-1.78],0.4689493737365345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARD3,Partitioning defective 3 homolog,19329,70,0.96 [0.70-1.32],0.8026433812376589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARK7,Parkinson disease protein 7,22641,79,1.19 [0.82-1.71],0.3565197475434986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARP1,Poly [ADP-ribose] polymerase 1,22597,82,0.96 [0.67-1.39],0.8470622714308494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAXX,Protein PAXX,19296,70,0.85 [0.51-1.42],0.5260155903991051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19016,71,3.27 [1.90-5.63],1.918605039276231e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBLD,Phenazine biosynthesis-like domain-containing protein,22073,79,0.97 [0.65-1.45],0.8735426856940921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19608,71,0.66 [0.28-1.53],0.3325282790136203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCARE,Photoreceptor cilium actin regulator,19101,70,1.15 [0.93-1.42],0.1927106988825172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19257,70,0.91 [0.54-1.52],0.7104939201428183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBP2,Poly(rC)-binding protein 2,19678,72,0.85 [0.62-1.16],0.3037811775661885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH1,Protocadherin-1,22815,83,1.88 [0.97-3.67],0.0632468490080414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH12,Protocadherin-12,19678,72,1.72 [0.81-3.67],0.1602682885034118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH17,Protocadherin-17,22636,82,1.25 [0.71-2.18],0.4432463916793649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH7,Protocadherin-7,19608,71,1.34 [0.77-2.32],0.301312513886375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH9,Protocadherin-9,19608,71,0.82 [0.42-1.60],0.5602488728874511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,19602,71,1.72 [1.10-2.70],0.0181215835729404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCNA,Proliferating cell nuclear antigen,19016,71,1.00 [0.70-1.43],0.9948756248302644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK7,Proprotein convertase subtilisin/kexin type 7,19602,71,0.88 [0.52-1.48],0.6202319150462111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK9,Proprotein convertase subtilisin/kexin type 9,22905,81,0.85 [0.51-1.41],0.5380896583345767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCYT2,Ethanolamine-phosphate cytidylyltransferase,19608,71,0.84 [0.63-1.13],0.2496016309789578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDAP1,28 kDa heat- and acid-stable phosphoprotein,19709,73,0.87 [0.69-1.09],0.2159613120360554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1,Programmed cell death protein 1,22805,83,0.89 [0.56-1.42],0.6222092039071432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1LG2,Programmed cell death 1 ligand 2,22532,81,0.73 [0.38-1.39],0.3382062267955543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD5,Programmed cell death protein 5,22833,80,1.14 [0.82-1.58],0.4484874983061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD6,Programmed cell death protein 6,22636,82,0.83 [0.66-1.04],0.1088451940374221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCL2,Phosducin-like protein 2,19016,71,1.04 [0.69-1.55],0.8666313700547299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19016,71,0.94 [0.61-1.45],0.7842288466010663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19109,70,1.06 [0.75-1.50],0.7439182087725517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19296,70,0.80 [0.65-0.98],0.0352895930564937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFA,Platelet-derived growth factor subunit A,22905,81,0.86 [0.66-1.13],0.2853605517147488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFB,Platelet-derived growth factor subunit B,22739,82,0.91 [0.73-1.14],0.406703675107224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFC,Platelet-derived growth factor C,22124,81,0.75 [0.37-1.49],0.4094133600485836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRA,Platelet-derived growth factor receptor alpha,22636,82,1.75 [0.91-3.37],0.094889072243593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRB,Platelet-derived growth factor receptor beta,22905,81,1.69 [0.95-3.04],0.0763833578537402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA2,Protein disulfide-isomerase A2,19016,71,0.90 [0.50-1.63],0.7331464006788576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA3,Protein disulfide-isomerase A3,19296,70,0.47 [0.17-1.28],0.1414429480798478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,19705,73,0.63 [0.42-0.94],0.0219606966132575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA5,Protein disulfide-isomerase A5,19016,71,0.67 [0.43-1.04],0.0756151126684642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM5,PDZ and LIM domain protein 5,19678,72,0.84 [0.70-1.00],0.0533711305363189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM7,PDZ and LIM domain protein 7,22739,82,0.90 [0.77-1.06],0.212583793890127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22124,81,0.73 [0.46-1.15],0.1761467781947367
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDRG1,p53 and DNA damage-regulated protein 1,19160,69,0.82 [0.50-1.33],0.4161044494919296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19016,71,1.03 [0.71-1.49],0.8863567736202522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZD2,PDZ domain-containing protein 2,19109,70,0.98 [0.66-1.45],0.9257818591078812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19160,71,0.70 [0.39-1.28],0.2477775165251974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEAR1,Platelet endothelial aggregation receptor 1,22905,81,0.71 [0.30-1.69],0.4377596538995608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEBP1,Phosphatidylethanolamine-binding protein 1,22641,79,1.22 [0.88-1.69],0.2331602535153453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECAM1,Platelet endothelial cell adhesion molecule,22641,79,0.97 [0.50-1.89],0.928503444003537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19209,70,0.86 [0.38-1.97],0.7202342310445806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PENK,Proenkephalin-A,19296,70,0.66 [0.30-1.45],0.2982709705356219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEPD,Xaa-Pro dipeptidase,19711,71,0.49 [0.21-1.13],0.0928431719230224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,19160,71,0.73 [0.58-0.90],0.0034202123237183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PF4,Platelet factor 4,19596,72,0.83 [0.66-1.04],0.1061970452251043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN2,Prefoldin subunit 2,22073,79,0.87 [0.60-1.25],0.4427202040621304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN4,Prefoldin subunit 4,19016,71,1.21 [0.85-1.72],0.2946260088866263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN6,Prefoldin subunit 6,19160,69,1.21 [0.93-1.59],0.1616991993664397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22492,81,1.03 [0.80-1.32],0.8294389575299101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGA4,Pepsin A-4,19711,71,1.19 [0.86-1.64],0.2947053424473982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19709,73,0.82 [0.54-1.24],0.3397925787107795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,22885,83,1.96 [1.25-3.07],0.0032053762468896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP1,Peptidoglycan recognition protein 1,22798,81,1.23 [0.79-1.93],0.3596600343798566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19478,71,0.50 [0.25-0.99],0.0478955154525659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP4,Peptidoglycan recognition protein 4,19109,70,0.96 [0.65-1.40],0.8170233912446169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGM2,Phosphoglucomutase-2,19160,69,0.95 [0.63-1.44],0.816832867876248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGR,Progesterone receptor,19160,71,1.03 [0.83-1.27],0.8000812332210243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,19678,72,0.80 [0.66-0.98],0.0302640253137818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB1,Pleckstrin homology-like domain family B member 1,19608,71,0.70 [0.45-1.10],0.121446293914971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,19016,71,1.30 [1.11-1.52],0.0012270230003356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22486,81,0.90 [0.46-1.75],0.7594596388650916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19296,70,0.74 [0.43-1.27],0.2693678566487358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI16,Peptidase inhibitor 16,19711,71,1.75 [0.70-4.35],0.2303993299499999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI3,Elafin,22335,79,0.97 [0.66-1.42],0.8619509044984877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19678,72,0.91 [0.68-1.22],0.5233886232606115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIGR,Polymeric immunoglobulin receptor,22353,78,1.27 [0.72-2.25],0.4078097789608544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22597,82,1.08 [0.79-1.48],0.6277530084944325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22641,79,1.25 [0.57-2.71],0.576569329899584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19160,71,0.94 [0.62-1.43],0.7857535818438289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22641,79,0.95 [0.59-1.53],0.8265748260001945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRB,Paired immunoglobulin-like type 2 receptor beta,22636,82,0.95 [0.68-1.34],0.7850008631863986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19296,70,1.28 [0.90-1.82],0.1682046495013712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PITHD1,PITH domain-containing protein 1,18978,71,0.76 [0.53-1.08],0.1262428753486531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD1,Polycystin-1,19709,73,1.07 [0.45-2.54],0.8822090512589711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD2,Polycystin-2,19109,70,0.72 [0.46-1.11],0.1366985034035608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,22666,82,1.43 [1.11-1.86],0.0064678136391575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKN3,Serine/threonine-protein kinase N3,19329,70,0.90 [0.66-1.23],0.518188101522672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G10,Group 10 secretory phospholipase A2,22486,81,0.85 [0.62-1.18],0.3337832218263101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,22705,82,2.23 [1.08-4.61],0.0309331902991372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G1B,Phospholipase A2,22867,81,1.14 [0.72-1.82],0.5744909419309174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G2A,"Phospholipase A2, membrane associated",22560,80,1.04 [0.75-1.46],0.800849201055497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G4A,Cytosolic phospholipase A2,22739,82,0.83 [0.66-1.04],0.0988085619489207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G7,Platelet-activating factor acetylhydrolase,22641,79,0.68 [0.37-1.27],0.2272195863134212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAT,Tissue-type plasminogen activator,22837,81,1.25 [0.84-1.86],0.2648906691519591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,22641,79,1.72 [1.18-2.52],0.0051723419617019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAUR,Urokinase plasminogen activator surface receptor,22488,82,0.52 [0.24-1.13],0.1004524149727029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",19668,71,0.67 [0.47-0.95],0.0251839547833473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19160,71,0.83 [0.47-1.44],0.499437141784153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19668,71,0.83 [0.66-1.05],0.1137120433048459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,19668,71,0.70 [0.49-0.99],0.0455337252358821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLG,Plasminogen,19218,70,0.73 [0.26-2.02],0.5420026950197985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN1,Perilipin-1,22073,79,0.91 [0.50-1.65],0.7493710931931286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN3,Perilipin-3,22636,82,0.97 [0.62-1.54],0.9040015710319628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLPBP,Pyridoxal phosphate homeostasis protein,22636,82,1.05 [0.79-1.40],0.732196013774659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLSCR3,Phospholipid scramblase 3,19638,71,0.83 [0.56-1.23],0.3471255499707143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLTP,Phospholipid transfer protein,22818,81,0.62 [0.36-1.07],0.0836703815828743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC1,Plexin domain-containing protein 1,22124,81,0.88 [0.47-1.65],0.7011245134536062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,19668,71,0.40 [0.16-0.99],0.0480394084954884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNA4,Plexin-A4,22597,82,0.89 [0.71-1.13],0.3550165581102406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,22804,81,2.38 [1.06-5.33],0.0352295963971869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB3,Plexin-B3,22569,81,0.87 [0.56-1.34],0.5252532900685221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22531,82,1.03 [0.92-1.15],0.659766179777906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMCH,Pro-MCH,19109,70,0.72 [0.48-1.09],0.1193841822451311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMM2,Phosphomannomutase 2,19109,70,0.82 [0.55-1.21],0.3111307701430859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMS1,PMS1 protein homolog 1,19160,69,1.06 [0.68-1.65],0.7985943297052028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMVK,Phosphomevalonate kinase,22034,79,0.90 [0.76-1.06],0.2181108337260588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIP,Pancreatic triacylglycerol lipase,19711,71,0.94 [0.65-1.37],0.7499829159388844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,19668,71,1.44 [1.08-1.93],0.0132505154262266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP2,Pancreatic lipase-related protein 2,22630,82,1.05 [0.98-1.13],0.1962865167499939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA1,Paraneoplastic antigen Ma1,19209,70,0.75 [0.48-1.17],0.2031299157763426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA2,Paraneoplastic antigen Ma2,19101,70,0.78 [0.45-1.36],0.3835653093588346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22210,82,0.95 [0.80-1.13],0.5528736565958972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL,Podocalyxin,22532,81,0.57 [0.16-2.05],0.3873191311759357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL2,Podocalyxin-like protein 2,22705,82,1.33 [0.65-2.71],0.4326098957252068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POF1B,Protein POF1B,19160,71,1.36 [0.88-2.10],0.1608107401057792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19160,71,0.59 [0.25-1.38],0.2225920813421592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22532,81,0.91 [0.50-1.67],0.7635484983835109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POMC,Pro-opiomelanocortin,19209,70,1.19 [0.85-1.67],0.3071521537995799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON1,Serum paraoxonase/arylesterase 1,19711,71,0.88 [0.38-2.06],0.7706617907062072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON2,Serum paraoxonase/arylesterase 2,22232,80,0.93 [0.52-1.65],0.7982282612953246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON3,Serum paraoxonase/lactonase 3,22739,82,1.84 [0.81-4.17],0.1441645730558162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POSTN,Periostin,19705,73,1.43 [0.80-2.53],0.2254496676925195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPBP,Platelet basic protein,19592,72,0.82 [0.63-1.06],0.1299110161110472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPCDC,Phosphopantothenoylcysteine decarboxylase,22833,80,1.29 [0.86-1.94],0.2226468297533448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIB,Peptidyl-prolyl cis-trans isomerase B,22643,81,0.83 [0.67-1.01],0.0673494892483124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIE,Peptidyl-prolyl cis-trans isomerase E,19329,70,1.06 [0.76-1.48],0.7162948893009145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19705,73,0.74 [0.49-1.10],0.1368686336694143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPL,Periplakin,19160,71,0.91 [0.45-1.87],0.8058123325074491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1A,Protein phosphatase 1A,22124,81,0.65 [0.32-1.32],0.2352625541265163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1B,Protein phosphatase 1B,19160,71,1.19 [0.89-1.58],0.2427436073468778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,19709,73,0.61 [0.39-0.94],0.0261362301857956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,22532,81,1.44 [1.05-1.97],0.0224595756251241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19602,71,0.71 [0.53-0.95],0.0194410713276113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22705,82,0.88 [0.72-1.09],0.2355238634776852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19329,70,0.64 [0.42-0.98],0.0393081488630766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19678,72,0.95 [0.71-1.27],0.7469501296251253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19678,72,0.76 [0.40-1.47],0.4204222908408376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R2,Protein phosphatase inhibitor 2,22636,82,0.78 [0.61-1.01],0.0586472031179881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R9B,Neurabin-2,22885,83,0.90 [0.73-1.11],0.3207381948178677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19608,71,0.82 [0.67-1.00],0.0531214255263717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,22486,81,0.60 [0.37-0.98],0.0410519501697049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPT1,Palmitoyl-protein thioesterase 1,19160,69,0.71 [0.47-1.09],0.1194665107256011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPY,Pancreatic prohormone,22623,82,1.05 [0.86-1.26],0.6469596870180494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PQBP1,Polyglutamine-binding protein 1,22124,81,1.15 [0.85-1.56],0.3661565196017727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAME,Melanoma antigen preferentially expressed in tumors,19016,71,1.19 [0.50-2.85],0.6948962698267865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAP1,Proline-rich acidic protein 1,19705,73,0.94 [0.55-1.61],0.8170385586961756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRC1,Protein regulator of cytokinesis 1,19602,71,0.49 [0.21-1.13],0.0950657388937142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRCP,Lysosomal Pro-X carboxypeptidase,22773,81,1.34 [0.73-2.45],0.3395107269454053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX1,Peroxiredoxin-1,22020,79,1.02 [0.81-1.28],0.8811239765364767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,19371,70,1.55 [1.13-2.14],0.00660751249032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22210,82,0.95 [0.72-1.25],0.7168845285584082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX5,"Peroxiredoxin-5, mitochondrial",22885,83,0.88 [0.67-1.15],0.3474465441034499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX6,Peroxiredoxin-6,22837,83,1.17 [0.85-1.60],0.3398628926576745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PREB,Prolactin regulatory element-binding protein,22210,82,1.14 [0.61-2.11],0.6862887332728439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRELP,Prolargin,22630,82,0.74 [0.34-1.62],0.4450696893377309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG2,Bone marrow proteoglycan,19705,73,0.89 [0.57-1.37],0.5828532853521595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG3,Proteoglycan 3,19705,73,0.82 [0.52-1.30],0.4056870224062769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22210,82,0.77 [0.52-1.14],0.1954564876835495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19160,69,1.22 [0.64-2.32],0.552164734389684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22636,82,0.90 [0.71-1.13],0.3534295910525428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19632,71,0.95 [0.72-1.24],0.687191106472258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKCQ,Protein kinase C theta type,22210,82,0.87 [0.54-1.41],0.5834642343708332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKD2,Serine/threonine-protein kinase D2,19109,70,1.06 [0.68-1.65],0.7931810325054076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKG1,cGMP-dependent protein kinase 1,19296,70,0.87 [0.72-1.04],0.1226990826438838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22124,81,0.93 [0.68-1.25],0.6119277550269182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRL,Prolactin,22833,80,1.01 [0.78-1.32],0.928325097792409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRND,Prion-like protein doppel,19668,71,1.13 [0.74-1.73],0.5616440274050397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROC,Vitamin K-dependent protein C,22661,82,1.11 [0.50-2.46],0.8065746303476466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROCR,Endothelial protein C receptor,19109,70,1.09 [0.63-1.90],0.7513254879239519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROK1,Prokineticin-1,22597,82,1.01 [0.75-1.36],0.9371955077340696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROS1,Vitamin K-dependent protein S,19738,73,0.53 [0.21-1.34],0.1789468488979896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,19158,70,1.45 [1.07-1.96],0.0154779621591546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR5,Proline-rich protein 5,19160,71,0.94 [0.57-1.56],0.8157308852379019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRRT3,Proline-rich transmembrane protein 3,19209,70,0.73 [0.39-1.37],0.327903358512472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS2,Trypsin-2,22698,82,1.04 [0.70-1.53],0.8506425108335833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS22,Brain-specific serine protease 4,19160,71,1.49 [0.95-2.35],0.0820225062869714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS27,Serine protease 27,22569,82,1.12 [0.69-1.82],0.6441316950280889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS53,Serine protease 53,19668,71,0.97 [0.52-1.83],0.932112989932047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS8,Prostasin,22555,82,1.23 [0.76-1.99],0.3907097038096924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22073,79,0.88 [0.74-1.04],0.1302002986658306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTG,Protogenin,22837,83,0.79 [0.36-1.71],0.546432915135142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTN3,Myeloblastin,22047,79,0.87 [0.56-1.35],0.5418092135633397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRUNE2,Protein prune homolog 2,19329,70,0.93 [0.42-2.08],0.8583745369908182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAP,Prosaposin,19513,71,0.65 [0.28-1.54],0.3288734624310121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAPL1,Proactivator polypeptide-like 1,19608,71,1.13 [0.72-1.77],0.5923921887637741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSCA,Prostate stem cell antigen,19608,71,0.95 [0.87-1.03],0.2067292124896772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22486,81,0.91 [0.78-1.06],0.2182631785212704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSIP1,PC4 and SFRS1-interacting protein,22597,82,0.89 [0.64-1.24],0.4869743588937791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMA1,Proteasome subunit alpha type-1,22124,81,0.72 [0.45-1.16],0.1801859615064336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMC3,26S proteasome regulatory subunit 6A,19016,71,0.75 [0.35-1.62],0.4629005634673667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD1,26S proteasome non-ATPase regulatory subunit 1,19678,72,1.20 [0.78-1.84],0.4024168975791977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19160,69,1.20 [0.86-1.66],0.2753560014998185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,22532,81,1.53 [1.14-2.06],0.0044830574628014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME1,Proteasome activator complex subunit 1,22456,81,1.46 [0.88-2.41],0.1397095535781584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME2,Proteasome activator complex subunit 2,22374,81,1.50 [0.90-2.50],0.1236943385517093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,22597,82,1.52 [1.08-2.16],0.0178905932145325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,19160,71,1.43 [1.02-1.99],0.0375050918539067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSPN,Persephin,22597,82,1.06 [0.87-1.29],0.5479090806999684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSRC1,Proline/serine-rich coiled-coil protein 1,22124,81,1.04 [0.75-1.46],0.803146911471661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18605,66,0.80 [0.65-0.99],0.0368911913960001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22073,79,0.77 [0.39-1.49],0.4299345837992426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGDS,Prostaglandin-H2 D-isomerase,22439,82,0.97 [0.48-1.95],0.9298127715139528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGES2,Prostaglandin E synthase 2,19008,69,0.68 [0.43-1.06],0.089568276095189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGR1,Prostaglandin reductase 1,19709,73,1.02 [0.77-1.35],0.8876394495987864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH,Parathyroid hormone,19160,69,1.00 [0.74-1.35],0.9835578858338044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22597,82,1.22 [0.81-1.84],0.3412972305380592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTK7,Inactive tyrosine-protein kinase 7,22073,79,0.74 [0.43-1.25],0.2591544393151611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTN,Pleiotrophin,22232,80,1.09 [0.73-1.63],0.6586981596833227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTP4A3,Protein tyrosine phosphatase type IVA 3,19160,71,1.05 [0.70-1.58],0.8134644280467913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22486,81,0.92 [0.71-1.19],0.5462569562517228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22700,82,0.85 [0.69-1.05],0.1258241351029813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19122,71,0.70 [0.35-1.39],0.3069722789018853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19709,73,0.57 [0.26-1.27],0.1698761543563754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRC,Receptor-type tyrosine-protein phosphatase C,19705,73,0.54 [0.19-1.48],0.2296002565933432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRF,Receptor-type tyrosine-protein phosphatase F,22905,81,1.28 [0.64-2.53],0.4842910771998256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRH,Receptor-type tyrosine-protein phosphatase H,19608,71,0.98 [0.61-1.59],0.9442635786658335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19608,71,0.62 [0.20-1.94],0.4077851002105975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRM,Receptor-type tyrosine-protein phosphatase mu,22560,82,1.22 [0.54-2.74],0.6299229989246669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22407,81,0.59 [0.32-1.11],0.1023771596358743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRR,Receptor-type tyrosine-protein phosphatase R,19668,71,0.68 [0.36-1.31],0.2540670897760994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRS,Receptor-type tyrosine-protein phosphatase S,22905,81,0.47 [0.21-1.05],0.067156358454991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19709,73,0.96 [0.49-1.90],0.910960500870754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19296,70,0.98 [0.67-1.42],0.896896603401769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21983,79,1.29 [0.92-1.81],0.1342617110778488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTTG1,Securin,19329,70,0.92 [0.52-1.62],0.7670694935915096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTX3,Pentraxin-related protein PTX3,22597,82,0.77 [0.54-1.10],0.154599365709568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVALB,Parvalbumin alpha,22725,83,0.90 [0.76-1.06],0.2030379349649238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVR,Poliovirus receptor,22833,80,1.12 [0.65-1.91],0.692516341807319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXDNL,Peroxidasin-like protein,19602,71,0.96 [0.63-1.46],0.8447471523004055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXN,Paxillin,22073,79,1.07 [0.74-1.54],0.7127146753940318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYDC1,Pyrin domain-containing protein 1,19209,70,1.20 [0.74-1.94],0.4647035048840632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYY,Peptide YY,19109,70,0.80 [0.62-1.03],0.0863466538387347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PZP,Pregnancy zone protein,19738,73,1.19 [0.86-1.66],0.2985617239230269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QDPR,Dihydropteridine reductase,22536,81,1.03 [0.66-1.61],0.898628119333976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,22676,81,2.13 [1.07-4.24],0.0318895036307762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QSOX1,Sulfhydryl oxidase 1,19333,72,0.92 [0.51-1.66],0.7892249146139352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB10,Ras-related protein Rab-10,19709,73,0.71 [0.46-1.10],0.1271096997823406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,19709,73,0.78 [0.63-0.96],0.0164158510463048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB27B,Ras-related protein Rab-27B,19709,73,0.79 [0.61-1.02],0.0666736229382653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB2B,Ras-related protein Rab-2B,19602,71,0.77 [0.53-1.13],0.1848682466724058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB33A,Ras-related protein Rab-33A,19109,70,0.81 [0.57-1.16],0.2573137113375313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB37,Ras-related protein Rab-37,22210,82,0.92 [0.71-1.18],0.5095339926748459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB39B,Ras-related protein Rab-39B,19109,70,1.12 [0.90-1.39],0.2947855872110857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19101,70,0.87 [0.56-1.37],0.554713480775605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB44,Ras-related protein Rab-44,19602,71,1.36 [0.99-1.88],0.0566221199240898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6A,Ras-related protein Rab-6A,22597,82,1.28 [0.88-1.86],0.1931026361314981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6B,Ras-related protein Rab-6B,22073,79,1.18 [0.82-1.70],0.3655855516943669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEP1,Rab GTPase-binding effector protein 1,19296,70,0.86 [0.64-1.16],0.3159080681842784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEPK,Rab9 effector protein with kelch motifs,22124,81,0.92 [0.64-1.30],0.6256514226861323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABGAP1L,Rab GTPase-activating protein 1-like,22210,82,1.19 [0.87-1.62],0.273151948659301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAC3,Ras-related C3 botulinum toxin substrate 3,19160,69,0.97 [0.69-1.36],0.846010968742215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD23B,UV excision repair protein RAD23 homolog B,22124,81,0.94 [0.61-1.43],0.7606224689075797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD51,DNA repair protein RAD51 homolog 1,19329,70,0.96 [0.63-1.47],0.8594364512439971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALB,Ras-related protein Ral-B,19160,71,1.66 [0.89-3.13],0.1138938418467301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALY,RNA-binding protein Raly,19602,71,1.19 [0.81-1.74],0.3832085559619098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP1,Ran-specific GTPase-activating protein,19209,70,1.33 [0.88-2.01],0.1691987501305945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP2,E3 SUMO-protein ligase RanBP2,19101,70,1.41 [0.76-2.61],0.2823399755421656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANGAP1,Ran GTPase-activating protein 1,22124,81,0.94 [0.62-1.43],0.7641597929641312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAP1A,Ras-related protein Rap-1A,19160,71,0.72 [0.47-1.11],0.1390772039868169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAPGEF2,Rap guanine nucleotide exchange factor 2,19329,70,0.74 [0.46-1.18],0.2060876915239527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES1,Retinoic acid receptor responder protein 1,22124,81,0.75 [0.39-1.46],0.4050115444762127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES2,Retinoic acid receptor responder protein 2,22741,82,1.02 [0.67-1.56],0.9226100386031711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASA1,Ras GTPase-activating protein 1,22073,79,0.99 [0.54-1.80],0.9696103828116264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19016,71,1.04 [0.62-1.74],0.8891700785219296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASSF2,Ras association domain-containing protein 2,22124,81,1.10 [0.81-1.50],0.5324432712070604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBFOX3,RNA binding protein fox-1 homolog 3,19678,72,0.81 [0.42-1.57],0.5302863661119572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,22095,79,1.67 [1.16-2.40],0.0054151079698411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM17,Splicing factor 45,19678,72,0.90 [0.67-1.21],0.483609681946525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM19,Probable RNA-binding protein 19,19109,70,0.95 [0.58-1.56],0.8495994630541579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM25,RNA-binding protein 25,19016,71,1.02 [0.62-1.66],0.9470402037799908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP1,Retinol-binding protein 1,19160,69,1.07 [0.79-1.44],0.6554261004137453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP2,Retinol-binding protein 2,22532,81,0.84 [0.64-1.11],0.2160351305779043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP5,Retinol-binding protein 5,22532,81,1.06 [0.74-1.50],0.7537201677111189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP7,Retinoid-binding protein 7,19608,71,1.17 [0.84-1.64],0.3485850570630757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS,RNA-binding protein with multiple splicing,19160,71,1.19 [0.91-1.56],0.202227896893717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS2,RNA-binding protein with multiple splicing 2,19209,70,0.89 [0.71-1.12],0.3319693352402003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCC1,Regulator of chromosome condensation,19602,71,1.09 [0.74-1.62],0.6659712305682431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCOR1,REST corepressor 1,22232,80,0.90 [0.55-1.47],0.6783492587642965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19209,70,0.98 [0.31-3.08],0.9670956250844026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REEP4,Receptor expression-enhancing protein 4,19678,72,0.86 [0.58-1.26],0.4359557759840438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1A,Lithostathine-1-alpha,22478,82,0.99 [0.65-1.48],0.9442702878993664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1B,Lithostathine-1-beta,22905,81,0.95 [0.67-1.36],0.78251071958036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3A,Regenerating islet-derived protein 3-alpha,22905,81,0.98 [0.71-1.36],0.906697098991906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3G,Regenerating islet-derived protein 3-gamma,19602,71,1.21 [0.71-2.08],0.4859738338873377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,22672,82,0.54 [0.35-0.83],0.0052076760936536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELB,Transcription factor RelB,19160,71,1.26 [0.89-1.79],0.190377435354169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELT,Tumor necrosis factor receptor superfamily member 19L,22641,79,1.03 [0.49-2.18],0.9386462335135486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REN,Renin,22636,82,0.86 [0.65-1.15],0.3203636940540114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REPS1,RalBP1-associated Eps domain-containing protein 1,19160,71,0.89 [0.48-1.64],0.7029461824969288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REST,RE1-silencing transcription factor,19016,71,1.00 [0.53-1.90],0.9908109194912472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22532,81,0.95 [0.59-1.54],0.8432238382314449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RETN,Resistin,22568,81,1.25 [0.78-2.02],0.3571556040191563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REXO2,"Oligoribonuclease, mitochondrial",19109,70,0.81 [0.48-1.38],0.4457177697040545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RFC4,Replication factor C subunit 4,19602,71,0.53 [0.17-1.70],0.2896789335192476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,19678,72,0.73 [0.54-0.98],0.0387082623582492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19329,70,0.85 [0.57-1.28],0.4452169026912674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMA,Repulsive guidance molecule A,22833,80,0.54 [0.28-1.03],0.062429481534452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMB,RGM domain family member B,22833,80,1.07 [0.49-2.33],0.8631194959752029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS10,Regulator of G-protein signaling 10,19678,72,0.77 [0.52-1.15],0.1993690610386345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS8,Regulator of G-protein signaling 8,22210,82,1.05 [0.79-1.40],0.7144101284681759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RHOC,Rho-related GTP-binding protein RhoC,22329,80,0.85 [0.72-1.00],0.0520647411018682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RICTOR,Rapamycin-insensitive companion of mTOR,19160,71,1.30 [0.93-1.82],0.1217679558035512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19296,70,1.31 [0.85-2.03],0.2222478886171111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILP,Rab-interacting lysosomal protein,22765,83,1.22 [0.89-1.67],0.2117336917341629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILPL2,RILP-like protein 2,19709,73,0.82 [0.65-1.02],0.0741519512849606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19109,70,1.15 [0.87-1.51],0.3250435797373993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN1,Prorelaxin H1,19678,72,1.09 [0.85-1.42],0.4928697933900753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN2,Prorelaxin H2,19260,70,1.05 [0.89-1.25],0.562730148756183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE1,Ribonuclease pancreatic,19711,71,1.30 [0.54-3.10],0.5560104157759076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE10,Inactive ribonuclease-like protein 10,19209,70,1.21 [0.79-1.85],0.3829516406523583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE3,Eosinophil cationic protein,22534,82,1.15 [0.99-1.34],0.0770691446866474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE4,Ribonuclease 4,19044,70,0.64 [0.33-1.24],0.1886066896287274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE6,Ribonuclease K6,19556,71,1.17 [0.58-2.34],0.6624700429436483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASEH2A,Ribonuclease H2 subunit A,19678,72,1.11 [0.73-1.68],0.6318575320379483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASET2,Ribonuclease T2,22805,81,1.13 [0.54-2.36],0.7507558595268342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF149,E3 ubiquitin-protein ligase RNF149,19209,70,0.98 [0.46-2.10],0.9624708490822916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF168,E3 ubiquitin-protein ligase RNF168,19160,71,0.68 [0.36-1.30],0.2431530878011965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,19160,71,0.44 [0.20-0.99],0.0478792669268685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF4,E3 ubiquitin-protein ligase RNF4,19329,70,0.95 [0.66-1.36],0.7678186596149151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF41,E3 ubiquitin-protein ligase NRDP1,22124,81,1.08 [0.81-1.43],0.6123364984021893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF43,E3 ubiquitin-protein ligase RNF43,19329,70,1.03 [0.70-1.51],0.8755698408190239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,19209,70,0.71 [0.53-0.95],0.0226316642657796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO1,Roundabout homolog 1,22672,82,1.01 [0.44-2.28],0.9872340955221208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO2,Roundabout homolog 2,22833,80,1.19 [0.51-2.78],0.6890317109340582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO4,Roundabout homolog 4,19209,70,2.36 [0.65-8.56],0.1901622259305554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22636,82,1.08 [0.57-2.02],0.8183652062576121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RP2,Protein XRP2,22532,81,0.81 [0.50-1.32],0.395629717265776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPA2,Replication protein A 32 kDa subunit,19160,71,0.98 [0.47-2.06],0.9672399466923276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPE,Ribulose-phosphate 3-epimerase,19329,70,1.08 [0.79-1.47],0.6211711891572922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPGR,X-linked retinitis pigmentosa GTPase regulator,19160,69,1.02 [0.59-1.77],0.9403677291560156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPL14,60S ribosomal protein L14,19209,70,1.25 [0.77-2.04],0.3623444483560607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPS10,40S ribosomal protein S10,19109,70,1.35 [0.89-2.06],0.1634890123647489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRAS,Ras-related protein R-Ras,19160,69,0.86 [0.71-1.03],0.1062029437326316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22124,81,1.06 [0.74-1.51],0.7616142168318518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22124,81,0.82 [0.61-1.11],0.2002488201908788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRP15,RRP15-like protein,19101,70,1.20 [0.96-1.49],0.1051229632511938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO1,R-spondin-1,22486,81,1.07 [0.61-1.89],0.8147903705989928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO3,R-spondin-3,22837,83,0.72 [0.35-1.47],0.3683907461103055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTBDN,Retbindin,22532,81,0.81 [0.40-1.63],0.5549337022590786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTKN2,Rhotekin-2,19109,70,0.83 [0.50-1.37],0.4654067091266975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19678,72,0.80 [0.62-1.03],0.0853493595548033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4R,Reticulon-4 receptor,22837,83,1.52 [0.97-2.39],0.0695355205199165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RUVBL1,RuvB-like 1,22124,81,0.91 [0.75-1.12],0.3684361806414283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RWDD1,RWD domain-containing protein 1,22833,80,0.89 [0.66-1.21],0.470881697146682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RYR1,Ryanodine receptor 1,19109,70,1.00 [0.51-1.96],0.9940047089097208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A11,Protein S100-A11,22456,82,1.16 [0.80-1.67],0.4353514983537798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A12,Protein S100-A12,22330,81,1.01 [0.79-1.31],0.9092645718499808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A13,Protein S100-A13,19160,71,1.21 [0.65-2.24],0.5522292107707201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A14,Protein S100-A14,19678,72,0.90 [0.59-1.38],0.6383993763496154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A16,Protein S100-A16,22043,79,0.96 [0.70-1.33],0.8272290239180276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A3,Protein S100-A3,19602,71,0.93 [0.55-1.59],0.7937205401923064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A4,Protein S100-A4,22705,82,1.04 [0.74-1.45],0.8256187385121976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100G,Protein S100-G,19678,72,1.24 [0.76-2.01],0.3884792586206375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100P,Protein S100-P,22232,80,1.02 [0.71-1.46],0.9302323504733644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAA4,Serum amyloid A-4 protein,19738,73,0.92 [0.41-2.06],0.8402258282014547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAFB2,Scaffold attachment factor B2,19678,72,1.32 [0.67-2.59],0.4163961845772945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAG,S-arrestin,19101,70,1.19 [0.82-1.73],0.3658289318961901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAMD9L,Sterile alpha motif domain-containing protein 9-like,22597,82,0.84 [0.64-1.11],0.2138545409140288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAP18,Histone deacetylase complex subunit SAP18,19329,70,1.15 [0.89-1.50],0.2786484693706427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,19634,73,0.81 [0.66-0.99],0.0385488809732362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19109,70,0.84 [0.42-1.68],0.6148774412054143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT1,Diamine acetyltransferase 1,19109,70,1.27 [0.89-1.82],0.1922146426514903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT2,Thialysine N-epsilon-acetyltransferase,19329,70,0.90 [0.63-1.30],0.5776929069233909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SATB1,DNA-binding protein SATB1,19678,72,1.20 [0.63-2.29],0.5872664595575388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SBSN,Suprabasin,19666,72,0.65 [0.33-1.30],0.2252500483625004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCAMP3,Secretory carrier-associated membrane protein 3,22532,81,0.94 [0.74-1.19],0.597937079715987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARA5,Scavenger receptor class A member 5,22833,80,1.05 [0.53-2.08],0.8941085746179138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB1,Scavenger receptor class B member 1,22073,79,0.78 [0.51-1.20],0.25679835995682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB2,Lysosome membrane protein 2,22061,78,0.73 [0.36-1.48],0.3774114440647053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF1,Scavenger receptor class F member 1,22905,81,0.87 [0.54-1.39],0.5500266945655441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF2,Scavenger receptor class F member 2,22833,80,1.08 [0.54-2.17],0.8235718378065244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,22723,82,0.49 [0.26-0.91],0.0252314820681588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG3,Secretogranin-3,22672,82,0.74 [0.42-1.33],0.3147919986388844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB1A1,Uteroglobin,22666,82,1.00 [0.70-1.41],0.9834030814374924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB2A2,Mammaglobin-A,19109,70,1.19 [0.62-2.28],0.6102508268126043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A1,Secretoglobin family 3A member 1,19296,70,0.90 [0.36-2.28],0.82504948551915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A2,Secretoglobin family 3A member 2,22700,82,0.87 [0.68-1.12],0.2728228111790169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGN,Secretagogin,22210,82,1.07 [0.69-1.67],0.7566709173083345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCIN,Adseverin,19101,70,0.82 [0.58-1.16],0.2684942159379924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCLY,Selenocysteine lyase,22765,83,0.97 [0.64-1.47],0.8996775573566129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2A,Sodium channel protein type 2 subunit alpha,19101,70,0.92 [0.56-1.52],0.7584613646078514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2B,Sodium channel subunit beta-2,19160,69,1.38 [0.70-2.70],0.3527696297625211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3A,Sodium channel protein type 3 subunit alpha,19160,69,0.79 [0.40-1.56],0.4961830205043771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3B,Sodium channel subunit beta-3,19101,70,0.85 [0.50-1.45],0.5585477916378779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN4B,Sodium channel subunit beta-4,19209,70,1.01 [0.58-1.76],0.9753172987254444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCP2,Non-specific lipid-transfer protein,22124,81,0.96 [0.74-1.26],0.7797974776361492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCPEP1,Retinoid-inducible serine carboxypeptidase,19133,69,0.81 [0.50-1.32],0.4053432426186691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRG1,Scrapie-responsive protein 1,19709,73,0.63 [0.27-1.49],0.2938418821184801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRIB,Protein scribble homolog,19209,70,0.92 [0.71-1.19],0.5295700579102373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRN1,Secernin-1,22597,82,0.87 [0.61-1.24],0.4418196470999173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCT,Secretin,19160,69,0.86 [0.51-1.43],0.556507564004044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC1,Syndecan-1,22636,82,1.38 [0.87-2.19],0.1725129270742728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC4,Syndecan-4,22636,82,0.86 [0.56-1.33],0.499899445620106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDCCAG8,Serologically defined colon cancer antigen 8,19602,71,0.92 [0.75-1.12],0.4121478172598071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDHB,Succinate dehydrogenase,19608,71,0.75 [0.51-1.09],0.1282001952594846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDK2,Protein sidekick-2,19296,70,1.46 [0.86-2.47],0.1616370164992537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEC31A,Protein transport protein Sec31A,19209,70,0.77 [0.57-1.03],0.0736583976810016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEL1L,Protein sel-1 homolog 1,19209,70,1.09 [0.55-2.14],0.8120311389970631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELE,E-selectin,22905,81,1.04 [0.70-1.54],0.8515430045491427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELENOP,Selenoprotein P,19738,73,2.22 [0.98-5.01],0.0544171067187487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELL,L-selectin,19738,73,0.88 [0.33-2.35],0.7960607064254588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELP,P-selectin,22698,82,0.76 [0.54-1.08],0.1224503986146794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELPLG,P-selectin glycoprotein ligand 1,22597,82,1.15 [0.54-2.45],0.7252640763907776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3F,Semaphorin-3F,22636,82,0.71 [0.33-1.53],0.3787496954308708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3G,Semaphorin-3G,19296,70,1.62 [1.00-2.64],0.0522647217529115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4C,Semaphorin-4C,22532,81,0.93 [0.45-1.93],0.8372849339247088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4D,Semaphorin-4D,22833,80,0.69 [0.36-1.34],0.2741921331563158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA6C,Semaphorin-6C,19160,71,1.00 [0.43-2.34],0.996887913043352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,22837,81,2.56 [1.51-4.34],0.0004936724457165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN3,Neuronal-specific septin-3,19678,72,0.89 [0.64-1.23],0.4743658875721949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN7,Septin-7,19329,70,1.18 [0.83-1.68],0.3634586452973253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN8,Septin-8,19627,71,1.43 [0.74-2.76],0.2837690053533671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN9,Septin-9,22532,81,0.51 [0.24-1.11],0.0886598501989375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA1,Alpha-1-antitrypsin,19351,73,1.09 [0.06-19.35],0.951523098417666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA11,Serpin A11,22905,81,0.75 [0.46-1.21],0.2325154006588298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA12,Serpin A12,21992,81,1.00 [0.83-1.21],0.9714425587941692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA3,Alpha-1-antichymotrypsin,19658,73,0.61 [0.23-1.64],0.3263376185986123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA4,Kallistatin,19358,70,1.95 [0.76-5.03],0.1678821082416794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA5,Plasma serine protease inhibitor,19432,71,0.96 [0.48-1.92],0.9074623249866236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA6,Corticosteroid-binding globulin,19738,73,1.14 [0.32-4.08],0.8421719895443431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA7,Thyroxine-binding globulin,19738,73,1.00 [0.30-3.31],0.995473209625206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA9,Serpin A9,22400,80,0.99 [0.74-1.31],0.9339604184648512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB1,Leukocyte elastase inhibitor,22570,79,0.95 [0.76-1.18],0.6406425481381466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB5,Serpin B5,22232,80,0.87 [0.60-1.28],0.4858421666566869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB6,Serpin B6,22762,80,0.73 [0.52-1.02],0.0671030286248606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB8,Serpin B8,22885,83,1.23 [0.94-1.61],0.1267975297830726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB9,Serpin B9,22486,81,0.66 [0.37-1.16],0.1487929352571071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINC1,Antithrombin-III,19693,72,0.58 [0.22-1.52],0.2636188229512498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPIND1,Heparin cofactor 2,19693,72,0.68 [0.30-1.56],0.3592261831145737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE1,Plasminogen activator inhibitor 1,22905,81,0.78 [0.59-1.03],0.0825227891543911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE2,Glia-derived nexin,19709,73,0.79 [0.56-1.13],0.1976327866220124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF1,Pigment epithelium-derived factor,19435,72,0.88 [0.37-2.11],0.7786103650649933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF2,Alpha-2-antiplasmin,19359,72,1.64 [0.32-8.56],0.554552573660795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPING1,Plasma protease C1 inhibitor,19693,72,0.48 [0.14-1.60],0.2293555448217538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINH1,Serpin H1,19329,70,0.84 [0.71-1.01],0.0647916115368442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI1,Neuroserpin,19253,70,1.42 [0.73-2.76],0.3073085352319573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI2,Serpin I2,19608,71,1.09 [0.73-1.63],0.6645807324386448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22073,79,0.96 [0.70-1.32],0.799267288386203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SETMAR,Histone-lysine N-methyltransferase SETMAR,22424,81,0.92 [0.47-1.83],0.8226650511680675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6,Seizure protein 6 homolog,19160,69,0.67 [0.30-1.49],0.3287616193720479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L,Seizure 6-like protein,22705,82,0.89 [0.43-1.85],0.7622683617632949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L2,Seizure 6-like protein 2,22532,81,0.85 [0.36-2.00],0.7128205627489415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SF3B4,Splicing factor 3B subunit 4,22532,81,1.16 [0.90-1.50],0.2490540208881223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP1,Secreted frizzled-related protein 1,22420,81,1.32 [0.85-2.05],0.2156580587388313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP4,Secreted frizzled-related protein 4,19296,70,1.39 [0.80-2.43],0.2469543018288913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA1,Pulmonary surfactant-associated protein A1,22124,81,0.95 [0.67-1.36],0.781153283215622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,22124,81,1.79 [1.32-2.43],0.0001641536101027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPD,Pulmonary surfactant-associated protein D,22636,82,0.98 [0.73-1.32],0.9046078302206696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SGSH,N-sulphoglucosamine sulphohydrolase,19356,72,1.03 [0.69-1.54],0.8984501049980969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2B3,SH2B adapter protein 3,22124,81,0.85 [0.70-1.04],0.1211083422388201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2D1A,SH2 domain-containing protein 1A,22597,82,0.87 [0.60-1.27],0.4828479470142062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19101,70,0.81 [0.51-1.26],0.3437768637181262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BP1,SH3 domain-binding protein 1,19608,71,0.79 [0.47-1.33],0.3797905285495675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GL3,Endophilin-A3,19224,70,1.06 [0.81-1.40],0.6507267710457771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,19668,71,1.44 [1.04-1.98],0.026212253201265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHBG,Sex hormone-binding globulin,19711,71,1.44 [0.93-2.22],0.1008835661594906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHC1,SHC-transforming protein 1,19016,71,1.04 [0.86-1.26],0.6984403631188332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHD,SH2 domain-containing adapter protein D,19070,70,1.11 [0.89-1.38],0.3564947151149082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHH,Sonic hedgehog protein,19160,71,0.65 [0.36-1.16],0.1448520184645633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHISA5,Protein shisa-5,19705,73,0.70 [0.27-1.83],0.4640654536447398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22700,82,0.96 [0.77-1.20],0.7162481295717058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHPK,Sedoheptulokinase,19329,70,1.43 [0.94-2.17],0.0924540781467868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIAE,Sialate O-acetylesterase,22669,82,1.03 [0.67-1.56],0.9045396639603384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC1,Sialoadhesin,22739,82,1.05 [0.66-1.65],0.8438822338481021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22597,82,0.77 [0.42-1.42],0.4003241250230299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22073,79,0.97 [0.75-1.26],0.8387593336261278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC5,Sialic acid-binding Ig-like lectin 5,22641,79,1.16 [0.94-1.42],0.160467162246142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22837,83,1.01 [0.56-1.83],0.9629602771480932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22636,82,0.69 [0.34-1.38],0.2880411311845474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19209,70,0.57 [0.34-0.96],0.0338140696177962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC9,Sialic acid-binding Ig-like lectin 9,22804,83,0.52 [0.27-1.00],0.0504472518887548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIL1,Nucleotide exchange factor SIL1,19209,70,1.25 [0.69-2.26],0.4706273839736834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22686,81,1.13 [0.79-1.61],0.5122003183356871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPB1,Signal-regulatory protein beta-1,22596,82,1.04 [0.67-1.60],0.8766823245880752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19160,71,0.90 [0.67-1.22],0.4925943157778041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT2,NAD-dependent protein deacetylase sirtuin-2,22532,81,0.97 [0.78-1.21],0.8037904760070701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22073,79,0.66 [0.43-1.03],0.0661837237144975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIT1,Signaling threshold-regulating transmembrane adapter 1,22210,82,0.87 [0.61-1.24],0.4371744986599363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP1,Src kinase-associated phosphoprotein 1,22438,81,1.05 [0.80-1.36],0.7344819758081165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP2,Src kinase-associated phosphoprotein 2,22739,82,0.92 [0.76-1.11],0.3880503047596227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKIV2L,Helicase SKI2W,19109,70,1.32 [0.84-2.05],0.228705825691947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLA2,Src-like-adapter 2,19678,72,0.81 [0.65-1.00],0.051168112783245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF1,Signaling lymphocytic activation molecule,22210,82,0.92 [0.66-1.28],0.6288851157011879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF6,SLAM family member 6,22124,81,0.95 [0.56-1.63],0.8656448021753906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF7,SLAM family member 7,22597,82,1.27 [0.91-1.77],0.1597480347234479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF8,SLAM family member 8,22124,81,1.35 [0.93-1.97],0.1157723172567826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC12A2,Solute carrier family 12 member 2,19109,70,0.90 [0.38-2.13],0.8184414384143093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC13A1,Solute carrier family 13 member 1,19602,71,0.95 [0.63-1.41],0.7870176851904455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC16A1,Monocarboxylate transporter 1,22073,79,0.97 [0.69-1.38],0.8822631613976106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC1A4,Neutral amino acid transporter A,19160,69,1.02 [0.66-1.57],0.9213275936101236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC27A4,Long-chain fatty acid transport protein 4,22073,79,0.84 [0.60-1.19],0.3345648287534911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC28A1,Sodium/nucleoside cotransporter 1,19016,71,0.77 [0.49-1.21],0.2621979308374362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC34A3,Sodium-dependent phosphate transport protein 2C,19016,71,1.14 [0.75-1.72],0.5328574862721378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A14,Zinc transporter ZIP14,22073,79,1.37 [0.82-2.30],0.2303448871397383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A5,Zinc transporter ZIP5,22597,82,1.17 [0.84-1.62],0.3468888387024056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC44A4,Choline transporter-like protein 4,19160,69,0.82 [0.55-1.22],0.3239651651730267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC4A1,Band 3 anion transport protein,19705,73,1.48 [0.94-2.31],0.0893349209695203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC51B,Organic solute transporter subunit beta,19109,70,0.96 [0.71-1.29],0.7688254731607257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19296,70,0.76 [0.57-1.01],0.0568243893850146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19608,71,0.81 [0.48-1.39],0.4451284087747584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19016,71,1.14 [0.79-1.63],0.4851258523563502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIT2,Slit homolog 2 protein,22073,79,1.02 [0.69-1.50],0.9164244813831391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK1,SLIT and NTRK-like protein 1,19160,71,0.81 [0.39-1.68],0.5740455993602736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK2,SLIT and NTRK-like protein 2,22837,83,0.97 [0.58-1.63],0.9195763804395626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK6,SLIT and NTRK-like protein 6,22232,80,1.04 [0.58-1.86],0.8959615108305888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLK,STE20-like serine/threonine-protein kinase,19329,70,1.16 [0.92-1.45],0.2088819260442657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLMAP,Sarcolemmal membrane-associated protein,19608,71,0.87 [0.66-1.16],0.356717352525661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLURP1,Secreted Ly-6/uPAR-related protein 1,19549,71,0.75 [0.38-1.48],0.4034304841274845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD1,Mothers against decapentaplegic homolog 1,22124,81,0.98 [0.76-1.25],0.8504272897546746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD2,Mothers against decapentaplegic homolog 2,19602,71,0.90 [0.64-1.26],0.5342402907288757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,19602,71,0.56 [0.35-0.92],0.0208688241560189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD5,Mothers against decapentaplegic homolog 5,22532,81,0.51 [0.20-1.27],0.1495531823943537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMARCA2,Probable global transcription activator SNF2L2,22073,79,0.91 [0.68-1.22],0.5339748345361733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMC3,Structural maintenance of chromosomes protein 3,19016,71,1.10 [0.75-1.60],0.6342861146655001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMNDC1,Survival of motor neuron-related-splicing factor 30,19608,71,1.11 [0.81-1.53],0.5090750089289824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC1,SPARC-related modular calcium-binding protein 1,22837,83,0.82 [0.45-1.48],0.5094074205309123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC2,SPARC-related modular calcium-binding protein 2,22739,82,1.17 [0.69-1.98],0.5523338199877073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,22720,80,1.53 [1.03-2.27],0.0340885953341677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD3,Sphingomyelin phosphodiesterase 3,19160,71,1.02 [0.69-1.48],0.93604537219361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22705,82,1.19 [0.87-1.63],0.2637115409965315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19602,71,1.05 [0.80-1.37],0.7371341316245714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMS,Spermine synthase,19101,70,0.64 [0.40-1.01],0.0529752338306729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMTN,Smoothelin,19636,71,0.90 [0.70-1.16],0.4159308707073725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,22636,82,0.80 [0.65-0.99],0.0404106685581434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP25,Synaptosomal-associated protein 25,19101,70,0.78 [0.48-1.29],0.3397170064791056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP29,Synaptosomal-associated protein 29,22705,82,0.90 [0.72-1.11],0.3105078234780958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAPIN,SNARE-associated protein Snapin,19678,72,0.81 [0.54-1.22],0.3188676958134911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCA,Alpha-synuclein,19296,70,1.07 [0.87-1.31],0.531019116136289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,22486,81,0.74 [0.55-0.98],0.0337954345589474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19209,70,1.19 [0.63-2.26],0.5973291860034491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNRPB2,U2 small nuclear ribonucleoprotein B'',19668,71,1.22 [0.85-1.76],0.2819549467855637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNU13,NHP2-like protein 1,19109,70,1.09 [0.78-1.52],0.6121597203109492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX15,Sorting nexin-15,19296,70,1.11 [0.73-1.68],0.6313077525097219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX18,Sorting nexin-18,19608,71,0.72 [0.40-1.28],0.2614826761366428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX2,Sorting nexin-2,19602,71,0.96 [0.72-1.29],0.7938205034522041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX5,Sorting nexin-5,19209,70,0.95 [0.44-2.07],0.9039976606588812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX9,Sorting nexin-9,22636,82,0.95 [0.71-1.27],0.7383855593033295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD1,Superoxide dismutase [Cu-Zn],22155,82,1.21 [0.82-1.77],0.3447680283225084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD2,"Superoxide dismutase [Mn], mitochondrial",22641,79,0.82 [0.47-1.42],0.4763179590641048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD3,Extracellular superoxide dismutase,19711,71,1.10 [0.78-1.55],0.6013248304112211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORBS1,Sorbin and SH3 domain-containing protein 1,19678,72,1.25 [0.80-1.96],0.3258188812389231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORCS2,VPS10 domain-containing receptor SorCS2,22124,81,1.25 [0.71-2.20],0.435888238412191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORD,Sorbitol dehydrogenase,22728,83,1.16 [0.87-1.56],0.3106705589016977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORT1,Sortilin,22602,82,0.60 [0.35-1.05],0.0726665764506183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOST,Sclerostin,22602,82,1.13 [0.68-1.88],0.6244550445631306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19160,69,1.15 [0.77-1.70],0.4982895256366678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX2,Transcription factor SOX-2,19651,72,1.02 [0.39-2.67],0.9665125566682968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX9,Transcription factor SOX-9,19160,69,0.86 [0.37-2.05],0.7408863360475015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19678,72,1.62 [0.93-2.84],0.0902438243119099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPAG1,Sperm-associated antigen 1,19678,72,1.03 [0.70-1.51],0.8819297582612186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARC,SPARC,22705,82,0.79 [0.61-1.02],0.0760457231026163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARCL1,SPARC-like protein 1,22624,81,1.10 [0.54-2.22],0.8009188872479069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPART,Spartin,19296,70,0.93 [0.69-1.25],0.6283156138111952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPESP1,Sperm equatorial segment protein 1,19709,73,1.51 [0.71-3.22],0.2828802313381243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK1,Serine protease inhibitor Kazal-type 1,22641,79,1.37 [0.88-2.13],0.1593344785238884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK2,Serine protease inhibitor Kazal-type 2,19296,70,1.01 [0.54-1.89],0.9660397232535616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK4,Serine protease inhibitor Kazal-type 4,22597,82,0.87 [0.64-1.19],0.3821666595185136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK5,Serine protease inhibitor Kazal-type 5,22641,79,1.36 [0.74-2.50],0.325076701929226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK6,Serine protease inhibitor Kazal-type 6,22837,83,1.02 [0.71-1.46],0.9226190455721986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK8,Serine protease inhibitor Kazal-type 8,19109,70,0.88 [0.46-1.68],0.6978156248874772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,22577,79,2.04 [1.05-3.95],0.0352928064811711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT2,Kunitz-type protease inhibitor 2,22739,82,0.72 [0.46-1.12],0.1429769892230775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT3,Kunitz-type protease inhibitor 3,19608,71,0.97 [0.82-1.16],0.7554739417207723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPOCK1,Testican-1,22486,81,1.09 [0.50-2.39],0.8320434099214893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON1,Spondin-1,22672,82,0.59 [0.32-1.10],0.0961613175905831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON2,Spondin-2,22536,82,1.40 [0.80-2.47],0.2400433604781444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,22866,81,0.66 [0.45-0.99],0.0451084333520512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19160,71,0.92 [0.53-1.58],0.7639323035212118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRING1,SREBP regulating gene protein,19016,71,0.94 [0.63-1.41],0.7687733633990255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR1B,Cornifin-B,19329,70,1.19 [0.96-1.49],0.1153464578305889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR3,Small proline-rich protein 3,19668,71,0.85 [0.62-1.18],0.3364556549325019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,22210,82,0.78 [0.62-0.98],0.0293708408924641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19101,70,1.70 [1.00-2.88],0.0498321199828143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTLC1,Serine palmitoyltransferase 1,19668,71,0.98 [0.53-1.82],0.9470270725212702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRC,Proto-oncogene tyrosine-protein kinase Src,22664,81,0.91 [0.78-1.07],0.2533118621879889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRP14,Signal recognition particle 14 kDa protein,22532,81,1.09 [0.80-1.50],0.5811826383312084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPK2,SRSF protein kinase 2,22597,82,0.86 [0.66-1.10],0.2274267786141054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPX,Sushi repeat-containing protein SRPX,19709,73,0.91 [0.46-1.81],0.7911448443734328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSB,Lupus La protein,22073,79,1.00 [0.71-1.41],0.986423370210868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19160,71,0.86 [0.44-1.70],0.6743252266500561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22602,82,1.01 [0.84-1.22],0.8922711350271095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22698,82,0.96 [0.60-1.54],0.8727758247587718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSH3,Protein phosphatase Slingshot homolog 3,19016,71,1.55 [0.80-2.97],0.1921316526562214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSNA1,Sjoegren syndrome nuclear autoantigen 1,19608,71,1.01 [0.65-1.56],0.9675057075119542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST13,Hsc70-interacting protein,19296,70,1.30 [0.87-1.93],0.1986295590682223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22532,81,1.12 [0.71-1.76],0.6395307152049261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22905,81,1.54 [0.80-2.98],0.1999574782591469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19160,71,0.81 [0.46-1.43],0.4700308536241285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAB2,Stabilin-2,19705,73,0.65 [0.30-1.39],0.2667504758693648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAM,Signal transducing adapter molecule 1,19602,71,0.77 [0.41-1.48],0.4406375520946536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAMBP,STAM-binding protein,22438,81,1.01 [0.75-1.37],0.947115649539724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT2,Signal transducer and activator of transcription 2,19160,71,0.75 [0.55-1.03],0.0775333306614625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT5B,Signal transducer and activator of transcription 5B,22532,81,0.92 [0.80-1.06],0.2525203022050591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19016,71,0.96 [0.68-1.36],0.835335123987949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC1,Stanniocalcin-1,22833,80,1.33 [0.84-2.13],0.2266703649778525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC2,Stanniocalcin-2,22608,79,1.32 [0.59-2.91],0.498289799216097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STEAP4,Metalloreductase STEAP4,19101,70,1.00 [0.74-1.35],0.9789323096748658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STIP1,Stress-induced-phosphoprotein 1,22611,79,1.08 [0.80-1.45],0.6165807299072903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK11,Serine/threonine-protein kinase STK11,22232,80,0.98 [0.75-1.29],0.9108709808700662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK24,Serine/threonine-protein kinase 24,22073,79,0.80 [0.57-1.12],0.1884130050707609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK4,Serine/threonine-protein kinase 4,22636,82,0.84 [0.67-1.06],0.1349989598128416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STOML2,"Stomatin-like protein 2, mitochondrial",19016,71,1.02 [0.81-1.30],0.8428570207844577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX16,Syntaxin-16,22124,81,1.02 [0.73-1.44],0.892517069252158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX1B,Syntaxin-1B,19160,69,0.91 [0.50-1.65],0.7537068154803304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX3,Syntaxin-3,19668,71,1.07 [0.63-1.84],0.7926876519864091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX4,Syntaxin-4,22532,81,1.01 [0.73-1.40],0.96037917231932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX5,Syntaxin-5,19160,71,0.79 [0.41-1.49],0.4623990032571808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX6,Syntaxin-6,22124,81,0.90 [0.66-1.23],0.5007528937066037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX7,Syntaxin-7,19160,71,1.39 [0.89-2.17],0.150913140812852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX8,Syntaxin-8,22597,82,0.96 [0.64-1.43],0.8250076088346032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP1,Syntaxin-binding protein 1,19678,72,0.80 [0.60-1.07],0.1352408771953067
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP3,Syntaxin-binding protein 3,22124,81,0.72 [0.43-1.20],0.202029083891158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGP1,SURP and G-patch domain-containing protein 1,19608,71,0.83 [0.46-1.50],0.5312620779276873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGT1,Protein SGT1 homolog,22124,81,1.05 [0.82-1.34],0.7158981900029301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT1A1,Sulfotransferase 1A1,22833,80,0.89 [0.77-1.03],0.1114305962892562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT2A1,Bile salt sulfotransferase,22597,82,1.03 [0.72-1.48],0.8552019519574025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF1,Formylglycine-generating enzyme,19160,71,1.06 [0.79-1.43],0.6864033654960537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22833,80,0.72 [0.51-1.03],0.0720932474336497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUOX,"Sulfite oxidase, mitochondrial",19678,72,0.94 [0.65-1.36],0.7513785584056499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD1,Sushi domain-containing protein 1,22232,80,0.93 [0.62-1.39],0.7155920517596697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD2,Sushi domain-containing protein 2,22641,79,1.08 [0.55-2.14],0.819082229049753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD4,Sushi domain-containing protein 4,19602,71,1.22 [0.77-1.94],0.3998519911765172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD5,Sushi domain-containing protein 5,19180,70,1.10 [0.55-2.17],0.7908529975558345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SV2A,Synaptic vesicle glycoprotein 2A,19160,69,0.76 [0.50-1.16],0.2046610321865824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SWAP70,Switch-associated protein 70,19608,71,0.81 [0.41-1.58],0.5321044072208123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYAP1,Synapse-associated protein 1,19296,70,0.73 [0.47-1.13],0.1536571259554692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19101,70,0.87 [0.56-1.34],0.5186117757760198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYT1,Synaptotagmin-1,19668,71,1.27 [0.80-2.02],0.3103780065719985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYTL4,Synaptotagmin-like protein 4,19709,73,0.77 [0.55-1.07],0.1223462990355333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19329,70,0.86 [0.69-1.07],0.1787305325069372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,22532,81,0.84 [0.71-0.99],0.0401775636953215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACSTD2,Tumor-associated calcium signal transducer 2,20102,72,1.05 [0.51-2.17],0.8945463979070395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,19602,71,0.44 [0.24-0.80],0.0072858631102502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAFA5,Chemokine-like protein TAFA-5,22532,81,0.77 [0.43-1.38],0.3816431376725571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAGLN3,Transgelin-3,19016,71,1.13 [0.81-1.58],0.4636338052973686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TALDO1,Transaldolase,19622,73,0.90 [0.55-1.49],0.6863838355629613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TANK,TRAF family member-associated NF-kappa-B activator,22210,82,0.88 [0.66-1.17],0.3710159199699425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAP1,Antigen peptide transporter 1,19329,70,1.09 [0.78-1.53],0.6155629935788953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARBP2,RISC-loading complex subunit TARBP2,22073,79,0.87 [0.67-1.12],0.2836236929554603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19160,69,1.12 [0.87-1.45],0.3769889242742186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19602,71,0.96 [0.52-1.76],0.8891063676844282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAX1BP1,Tax1-binding protein 1,19668,71,0.89 [0.62-1.29],0.54714155835924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,22073,79,1.52 [1.11-2.08],0.009471995431426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D23,TBC1 domain family member 23,22532,81,0.86 [0.69-1.08],0.2023509387387603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D5,TBC1 domain family member 5,22597,82,1.07 [0.84-1.36],0.5766091109107072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCA,Tubulin-specific chaperone A,19296,70,0.99 [0.76-1.29],0.9601261549024332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCB,Tubulin-folding cofactor B,22486,81,0.88 [0.73-1.06],0.1773424128128075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCC,Tubulin-specific chaperone C,22486,81,0.90 [0.71-1.14],0.3880906638997169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22124,81,0.90 [0.71-1.13],0.3583445654724639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBR1,T-box brain protein 1,19160,69,0.97 [0.59-1.58],0.9010613790801736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1A,T-cell leukemia/lymphoma protein 1A,22447,81,0.94 [0.76-1.16],0.5499755330808354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1B,T-cell leukemia/lymphoma protein 1B,22232,80,0.95 [0.73-1.23],0.6844105075098731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN1,Transcobalamin-1,19301,71,1.52 [0.82-2.83],0.1859383413997302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN2,Transcobalamin-2,22866,81,1.37 [0.76-2.48],0.2943461781627663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCOF1,Treacle protein,19709,73,0.67 [0.30-1.47],0.3161827135734587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCP11,T-complex protein 11 homolog,19329,70,0.80 [0.48-1.31],0.3741601838353037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCTN3,Tectonic-3,19709,73,0.54 [0.25-1.15],0.1121646086874312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDGF1,Teratocarcinoma-derived growth factor 1,22073,79,0.93 [0.81-1.07],0.3156507781612345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDO2,"Tryptophan 2,3-dioxygenase",19160,69,0.86 [0.45-1.63],0.6425071040044521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDP1,Tyrosyl-DNA phosphodiesterase 1,19602,71,1.00 [0.73-1.37],0.992534548874931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDRKH,Tudor and KH domain-containing protein,22073,79,0.86 [0.67-1.10],0.2291655717405165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEF,Thyrotroph embryonic factor,19109,70,0.95 [0.55-1.65],0.8657304932448221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEK,Angiopoietin-1 receptor,22705,82,1.59 [0.65-3.92],0.3114887007288812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TERF1,Telomeric repeat-binding factor 1,19160,71,1.61 [0.85-3.04],0.1438123421568478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TET2,Methylcytosine dioxygenase TET2,19293,70,1.05 [0.86-1.30],0.6210469926741838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX101,Testis-expressed protein 101,19160,69,1.27 [0.72-2.25],0.414670893910522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX33,Testis-expressed protein 33,19329,70,1.34 [0.92-1.94],0.1309037040554644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TF,Serotransferrin,19738,73,0.55 [0.20-1.54],0.2568094460544628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFAP2A,Transcription factor AP-2-alpha,19101,70,1.21 [0.88-1.67],0.2399863797790278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF1,Trefoil factor 1,22530,78,0.98 [0.75-1.28],0.8951461363614311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF2,Trefoil factor 2,22700,82,0.98 [0.69-1.40],0.9007488271921134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,22593,81,1.50 [1.14-1.96],0.0034578502176218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI,Tissue factor pathway inhibitor,22553,82,0.57 [0.29-1.10],0.0915063807934424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,22633,82,1.44 [1.03-2.00],0.0326407915009764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFRC,Transferrin receptor protein 1,22710,82,0.87 [0.52-1.45],0.581319210451976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TG,Thyroglobulin,19602,71,1.08 [0.90-1.30],0.3808827021651456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFA,Protransforming growth factor alpha,22597,82,0.75 [0.48-1.16],0.197184138028181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB1,Transforming growth factor beta-1 proprotein,22845,83,0.72 [0.43-1.22],0.2261253659730891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB2,Transforming growth factor beta-2 proprotein,19602,71,0.99 [0.65-1.51],0.952748914184283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,22476,82,2.21 [1.10-4.46],0.0260300239246604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR1,TGF-beta receptor type-1,19160,71,1.81 [0.94-3.49],0.0757819410576026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR2,TGF-beta receptor type-2,22705,82,1.16 [0.62-2.18],0.6482763024616756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR3,Transforming growth factor beta receptor type 3,22905,81,0.66 [0.38-1.13],0.1304991705491035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,22606,82,1.53 [1.19-1.95],0.0007366053774618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGOLN2,Trans-Golgi network integral membrane protein 2,19711,71,0.63 [0.26-1.51],0.2990810522699551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18978,71,0.95 [0.73-1.24],0.7137530567825546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBD,Thrombomodulin,22636,82,1.13 [0.55-2.30],0.7436607504874491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS2,Thrombospondin-2,22641,79,1.30 [0.76-2.23],0.3443758002610172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS4,Thrombospondin-4,22621,82,1.39 [0.90-2.15],0.1358877923316024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THOP1,Thimet oligopeptidase,22532,81,1.76 [0.98-3.17],0.0581207484767151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THPO,Thrombopoietin,22232,80,0.62 [0.36-1.05],0.0749238838581548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THRAP3,Thyroid hormone receptor-associated protein 3,19109,70,0.94 [0.76-1.17],0.5979953612397488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THSD1,Thrombospondin type-1 domain-containing protein 1,19015,70,0.61 [0.29-1.25],0.1733979727756765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THTPA,Thiamine-triphosphatase,19575,71,0.87 [0.68-1.13],0.3042549862029305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THY1,Thy-1 membrane glycoprotein,22833,80,1.12 [0.54-2.30],0.7629119237251555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIA1,Nucleolysin TIA-1 isoform p40,21991,80,0.86 [0.72-1.02],0.0824381239695704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIE1,Tyrosine-protein kinase receptor Tie-1,22905,81,0.82 [0.54-1.25],0.3584742268720591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22025,79,0.89 [0.58-1.37],0.5861087715870295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19329,70,0.80 [0.41-1.57],0.5094293946420472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22698,82,0.94 [0.60-1.47],0.7781761517944578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19709,73,0.51 [0.27-0.95],0.0344397083334969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19668,71,0.85 [0.65-1.11],0.2438781508645908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP1,Metalloproteinase inhibitor 1,22362,81,0.65 [0.31-1.35],0.24502535765527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP2,Metalloproteinase inhibitor 2,19709,73,1.36 [0.74-2.49],0.3216612589392297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP3,Metalloproteinase inhibitor 3,22739,82,0.96 [0.83-1.11],0.5625642848392165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP4,Metalloproteinase inhibitor 4,22641,79,0.85 [0.51-1.40],0.5193110266496599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,22561,82,2.44 [1.05-5.66],0.0380089134212112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJAP1,Tight junction-associated protein 1,22705,82,0.88 [0.70-1.12],0.3139722976384519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJP3,Tight junction protein ZO-3,19101,70,1.05 [0.63-1.74],0.8492506391421181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TK1,"Thymidine kinase, cytosolic",19329,70,0.82 [0.46-1.45],0.495491848663219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR1,Toll-like receptor 1,19160,71,1.28 [0.56-2.96],0.5587452810377513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR2,Toll-like receptor 2,19329,70,0.80 [0.30-2.17],0.6643400718863683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR3,Toll-like receptor 3,22885,83,1.17 [0.84-1.62],0.3454676917761903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR4,Toll-like receptor 4,19160,71,1.28 [0.59-2.77],0.5361573194334123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19160,69,0.82 [0.52-1.30],0.4015246477670903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED1,Transmembrane emp24 domain-containing protein 1,19329,70,0.80 [0.50-1.27],0.3492179874318801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED10,Transmembrane emp24 domain-containing protein 10,19109,70,0.94 [0.58-1.52],0.7997916444496771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED4,Transmembrane emp24 domain-containing protein 4,19109,70,0.81 [0.50-1.31],0.3926133121958984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED8,Protein TMED8,19608,71,0.86 [0.69-1.06],0.1610258504596939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM106A,Transmembrane protein 106A,19602,71,0.72 [0.51-1.02],0.0665794455334903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM132A,Transmembrane protein 132A,19209,70,1.33 [0.95-1.85],0.0966490379492022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM25,Transmembrane protein 25,19678,72,1.06 [0.65-1.73],0.8202692949379313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMOD4,Tropomodulin-4,19016,71,1.08 [0.63-1.85],0.7736449066431977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11B,Transmembrane protease serine 11B,19101,70,1.13 [0.88-1.46],0.346633493993658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11D,Transmembrane protease serine 11D,19627,71,1.47 [0.86-2.51],0.155065480313121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS15,Enteropeptidase,22532,81,1.00 [0.80-1.23],0.9650609858858076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS5,Transmembrane protease serine 5,22378,81,1.00 [0.59-1.68],0.9924052294131712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMSB10,Thymosin beta-10,22641,79,0.84 [0.64-1.09],0.1913019623184938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNC,Tenascin,22698,82,0.98 [0.65-1.48],0.9251840474363286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNF,Tumor necrosis factor,22191,80,1.01 [0.61-1.67],0.9604742800543687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19608,71,0.74 [0.44-1.25],0.2582451142030546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22210,82,0.53 [0.30-0.93],0.0259547423975406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19296,70,0.74 [0.51-1.09],0.1337689856064402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22486,81,1.09 [0.59-2.02],0.7741585865229857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22486,81,0.99 [0.59-1.66],0.9838140118111016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22668,81,1.03 [0.69-1.52],0.8962566565550035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22885,83,0.92 [0.54-1.56],0.7469635156118342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22630,82,1.52 [0.79-2.93],0.2128721436059302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22705,82,0.91 [0.51-1.65],0.7678672733026156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22672,82,2.86 [1.78-4.61],1.5718498564249358e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22210,82,1.18 [0.72-1.94],0.50040232362986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22672,82,0.52 [0.26-1.06],0.070756378322373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19296,70,1.43 [0.80-2.55],0.2222805438097225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22837,83,0.84 [0.43-1.63],0.6042607047308441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22641,79,0.74 [0.35-1.56],0.4336780482171501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22641,79,1.14 [0.68-1.92],0.6255740644218925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22833,80,0.63 [0.30-1.32],0.2217744032733095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22845,83,0.97 [0.57-1.66],0.9141622041957204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22486,81,1.07 [0.75-1.53],0.7036981994021811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22833,80,0.82 [0.52-1.30],0.4011806593428256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22486,81,1.02 [0.60-1.70],0.9535139866048262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22885,83,0.98 [0.46-2.08],0.9651943934264394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22597,82,0.88 [0.64-1.22],0.4561795478853812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22885,83,0.67 [0.34-1.31],0.2448767034652064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22739,82,0.39 [0.19-0.83],0.01427103824874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22866,81,0.59 [0.27-1.30],0.1907662051402837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22486,81,0.90 [0.64-1.28],0.5684223196583347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF8,Tumor necrosis factor ligand superfamily member 8,19705,73,0.73 [0.39-1.39],0.3389403537949449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNIP1,TNFAIP3-interacting protein 1,19668,71,0.95 [0.73-1.22],0.6660889291207428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNN,Tenascin-N,19705,73,0.70 [0.42-1.17],0.1756348658600084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNNI3,"Troponin I, cardiac muscle",22232,80,0.97 [0.77-1.23],0.8280922807763016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNPO1,Transportin-1,19329,70,0.55 [0.28-1.09],0.086171507667561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNR,Tenascin-R,22486,81,1.29 [0.81-2.05],0.2757553304530526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNXB,Tenascin-X,22641,79,0.75 [0.34-1.65],0.4707270108083291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19709,73,0.72 [0.52-0.98],0.0379681710808428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1,DNA topoisomerase 1,19608,71,0.96 [0.78-1.20],0.734329033133922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1MT,"DNA topoisomerase I, mitochondrial",19016,71,0.75 [0.44-1.28],0.2976856492404639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP2B,DNA topoisomerase 2-beta,19160,71,0.92 [0.68-1.23],0.5732316067752963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOR1AIP1,Torsin-1A-interacting protein 1,19209,70,0.86 [0.54-1.37],0.5271013922941052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53,Cellular tumor antigen p53,22124,81,0.83 [0.52-1.33],0.431987400579769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53BP1,TP53-binding protein 1,19160,71,1.06 [0.82-1.36],0.6684089127427914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53I3,Quinone oxidoreductase PIG3,18873,69,0.83 [0.53-1.30],0.4268744344246336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22232,80,0.82 [0.41-1.63],0.5717199040978105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP73,Tumor protein p73,19160,69,1.17 [0.60-2.28],0.6389153434874548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPBGL,Trophoblast glycoprotein-like,19160,69,0.54 [0.28-1.07],0.0795414955810433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPD52L2,Tumor protein D54,19296,70,0.87 [0.70-1.06],0.1693835434783618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPK1,Thiamin pyrophosphokinase 1,19709,73,0.62 [0.27-1.42],0.257078045471463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPM3,Tropomyosin alpha-3 chain,19109,70,1.14 [0.69-1.88],0.6058803426496311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPMT,Thiopurine S-methyltransferase,22124,81,1.13 [0.88-1.45],0.3533723822639065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPP1,Tripeptidyl-peptidase 1,22487,82,1.16 [0.76-1.76],0.483885367684092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP2,Tubulin polymerization-promoting protein family member 2,19329,70,1.18 [0.92-1.49],0.1870429809464685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP3,Tubulin polymerization-promoting protein family member 3,22073,79,0.76 [0.43-1.34],0.3429474489346967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPR,Nucleoprotein TPR,19109,70,1.12 [0.76-1.66],0.5591147287804754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPRKB,EKC/KEOPS complex subunit TPRKB,19016,71,1.08 [0.78-1.50],0.6343265626877062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSAB1,Tryptase alpha/beta-1,22848,83,1.34 [0.92-1.94],0.1241824308767493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSD1,Tryptase delta,19678,72,1.06 [0.60-1.87],0.8460157989942103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSG1,Tryptase gamma,19160,71,1.15 [0.51-2.60],0.729348782036707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPT1,Translationally-controlled tumor protein,22210,82,0.76 [0.52-1.10],0.1449447337394695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF2,TNF receptor-associated factor 2,22597,82,1.28 [0.98-1.66],0.0686367770420614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19160,71,1.36 [0.84-2.20],0.2179333486667974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19109,70,1.07 [0.68-1.68],0.7836210205272819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19329,70,0.86 [0.64-1.15],0.2973467482840223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREH,Trehalase,19705,73,1.20 [0.88-1.63],0.2420160837547814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREM2,Triggering receptor expressed on myeloid cells 2,22630,82,0.79 [0.53-1.16],0.22542231194486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML1,Trem-like transcript 1 protein,19711,71,0.75 [0.48-1.16],0.1925188788003723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML2,Trem-like transcript 2 protein,22641,79,0.83 [0.45-1.55],0.5656984214721112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIAP1,TP53-regulated inhibitor of apoptosis 1,22837,83,0.85 [0.62-1.17],0.3170716269815762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM21,E3 ubiquitin-protein ligase TRIM21,22597,82,0.90 [0.71-1.14],0.3993188065977759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM24,Transcription intermediary factor 1-alpha,19286,70,0.71 [0.48-1.05],0.0838112355424239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19608,71,0.89 [0.73-1.10],0.2868130522839885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM26,Tripartite motif-containing protein 26,19016,71,0.80 [0.51-1.25],0.3321055170596977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,19160,69,0.67 [0.48-0.95],0.0224038801483475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM5,Tripartite motif-containing protein 5,22597,82,0.85 [0.68-1.07],0.1701345085399793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM58,E3 ubiquitin-protein ligase TRIM58,19602,71,0.90 [0.69-1.17],0.4257762203763501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRPV3,Transient receptor potential cation channel subfamily V member 3,19109,70,1.20 [0.81-1.76],0.3638395147490235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC1,Hamartin,19160,71,0.98 [0.72-1.34],0.8976020221056431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC22D1,TSC22 domain family protein 1,19678,72,0.73 [0.51-1.06],0.0945902541773153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSHB,Thyrotropin subunit beta,22636,82,1.11 [0.89-1.39],0.3556111505291849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSLP,Thymic stromal lymphopoietin,22232,80,0.92 [0.66-1.30],0.6512771512341774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSNAX,Translin-associated protein X,19109,70,1.45 [0.84-2.49],0.1804984311618504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN1,Tetraspanin-1,22232,80,0.83 [0.39-1.75],0.6257164577419707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN15,Tetraspanin-15,19109,70,1.12 [0.74-1.68],0.6013319820615795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN7,Tetraspanin-7,19101,70,0.87 [0.66-1.16],0.3509889401581907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN8,Tetraspanin-8,19608,71,0.98 [0.79-1.22],0.8536286827077342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPYL1,Testis-specific Y-encoded-like protein 1,19160,71,0.95 [0.54-1.69],0.8723429754469632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TST,Thiosulfate sulfurtransferase,22035,79,1.05 [0.80-1.36],0.7430407854888947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTF2,Transcription termination factor 2,19160,69,0.70 [0.42-1.16],0.1621286003945659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTN,Titin,19109,70,1.12 [0.82-1.52],0.4760631151525814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTR,Transthyretin,19512,72,1.12 [0.46-2.76],0.7976099201601619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TUBB3,Tubulin beta-3 chain,19101,70,1.10 [0.48-2.48],0.8256243467950581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,19705,73,0.72 [0.55-0.95],0.0189342853663531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXK,Tyrosine-protein kinase TXK,19329,70,1.13 [0.87-1.46],0.3643866716572046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXLNA,Alpha-taxilin,22486,81,0.85 [0.68-1.06],0.1431151587349834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXN,Thioredoxin,19368,69,1.23 [0.78-1.92],0.3737452804250064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC15,Thioredoxin domain-containing protein 15,22705,82,1.28 [0.63-2.58],0.4925680767806326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC5,Thioredoxin domain-containing protein 5,22833,80,0.74 [0.54-1.01],0.0550577990417325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC9,Thioredoxin domain-containing protein 9,19668,71,0.69 [0.43-1.11],0.1250211449547849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNL1,Thioredoxin-like protein 1,19065,70,1.09 [0.88-1.34],0.4179469983516485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22641,79,0.90 [0.58-1.40],0.6459213790085585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYMP,Thymidine phosphorylase,22489,81,0.82 [0.61-1.11],0.1974821235307297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRO3,Tyrosine-protein kinase receptor TYRO3,22636,82,0.66 [0.33-1.31],0.2303918182668722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19160,71,1.03 [0.71-1.49],0.8794345823215853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,22532,81,1.77 [1.04-3.02],0.0368926722306794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2B,Ubiquitin-conjugating enzyme E2 B,19602,71,1.22 [0.60-2.48],0.5903835816116093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19709,73,0.76 [0.52-1.10],0.1485567962300021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19160,71,0.88 [0.58-1.33],0.5404862283655252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBQLN3,Ubiquilin-3,19109,70,1.06 [0.64-1.73],0.8313390317246492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBXN1,UBX domain-containing protein 1,19296,70,0.92 [0.66-1.29],0.6436465551287207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19608,71,0.87 [0.74-1.02],0.0944167851147036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UGDH,UDP-glucose 6-dehydrogenase,19109,70,1.15 [0.95-1.38],0.1480093159077355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UHRF2,E3 ubiquitin-protein ligase UHRF2,19109,70,0.98 [0.52-1.87],0.9563113482649088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ULBP2,UL16-binding protein 2,22486,81,0.84 [0.48-1.47],0.5442081678236657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UMOD,Uromodulin,22841,81,0.85 [0.60-1.21],0.3607950128591458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC5D,Netrin receptor UNC5D,19160,71,1.18 [0.50-2.74],0.7076586385068029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC79,Protein unc-79 homolog,19016,71,0.93 [0.62-1.41],0.7441067008009363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNG,Uracil-DNA glycosylase,19602,71,0.68 [0.34-1.38],0.2839010264597506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPB1,Beta-ureidopropionase,19709,73,1.01 [0.79-1.29],0.9153307250071684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3A,Uroplakin-3a,19101,70,1.07 [0.69-1.67],0.7530830534619647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3BL1,Uroplakin-3b-like protein 1,19301,70,0.90 [0.56-1.43],0.643917703634423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROD,Uroporphyrinogen decarboxylase,19296,70,0.93 [0.67-1.29],0.6653636606097699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROS,Uroporphyrinogen-III synthase,19160,69,1.19 [0.90-1.59],0.228095149432445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USO1,General vesicular transport factor p115,22532,81,0.92 [0.74-1.14],0.433717923936873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP25,Ubiquitin carboxyl-terminal hydrolase 25,19602,71,0.82 [0.60-1.13],0.2293303637891884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP28,Ubiquitin carboxyl-terminal hydrolase 28,19668,71,1.07 [0.61-1.88],0.812231583081992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19109,70,1.02 [0.78-1.33],0.909683027537407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22232,80,0.84 [0.67-1.04],0.1087283882737531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UXS1,UDP-glucuronic acid decarboxylase 1,22124,81,0.75 [0.51-1.11],0.1466243054204189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP5,Vesicle-associated membrane protein 5,22232,80,1.12 [0.81-1.54],0.5058495933291214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP8,Vesicle-associated membrane protein 8,19160,71,0.84 [0.65-1.10],0.2088974302878831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASH1,Tubulinyl-Tyr carboxypeptidase 1,22597,82,0.82 [0.64-1.05],0.1141906769115861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASN,Vasorin,22250,81,1.08 [0.52-2.27],0.829131583214413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,19711,71,0.70 [0.51-0.97],0.033897394111268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22532,81,0.54 [0.20-1.48],0.2296159579265363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAV3,Guanine nucleotide exchange factor VAV3,19101,70,0.83 [0.66-1.06],0.1313588257368506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAM1,Vascular cell adhesion protein 1,22661,82,1.40 [0.68-2.90],0.3624887817239045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAN,Versican core protein,22833,80,0.93 [0.48-1.80],0.8297979815140265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCPKMT,Protein-lysine methyltransferase METTL21D,19016,71,1.08 [0.86-1.37],0.4966215786815546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFA,Vascular endothelial growth factor A,22816,83,0.82 [0.58-1.16],0.2690366614269782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFB,Vascular endothelial growth factor B,19160,71,0.56 [0.25-1.26],0.1619450443079054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFC,Vascular endothelial growth factor C,22705,82,0.89 [0.63-1.25],0.502428651309728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFD,Vascular endothelial growth factor D,22845,83,1.67 [0.94-2.96],0.0831082799161895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,19678,72,0.44 [0.21-0.94],0.0341664506087711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIM,Vimentin,22232,80,1.15 [0.96-1.38],0.139941933001873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIPR1,Vasoactive intestinal polypeptide receptor 1,19209,70,1.05 [0.44-2.52],0.9150976821571666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIT,Vitrin,19709,73,0.88 [0.48-1.64],0.6895856179451076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VMO1,Vitelline membrane outer layer protein 1 homolog,22532,81,1.29 [0.94-1.77],0.1099612671796275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN1,Pantetheinase,19711,71,0.96 [0.70-1.30],0.781182096721509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN2,Vascular non-inflammatory molecule 2,22532,81,1.12 [0.72-1.75],0.6162994849790655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19329,70,0.93 [0.65-1.32],0.6689166410246701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS37A,Vacuolar protein sorting-associated protein 37A,22532,81,0.81 [0.63-1.04],0.1028432756320077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS4B,Vacuolar protein sorting-associated protein 4B,19602,71,0.85 [0.67-1.09],0.1935299025991223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS53,Vacuolar protein sorting-associated protein 53 homolog,22532,81,0.82 [0.63-1.07],0.1520388788525622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10,V-set and immunoglobulin domain-containing protein 10,19602,71,1.51 [0.94-2.42],0.0863902216586275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19109,70,0.88 [0.43-1.81],0.7313314426827406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG2,V-set and immunoglobulin domain-containing protein 2,19602,71,0.95 [0.63-1.41],0.7812262911572301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG4,V-set and immunoglobulin domain-containing protein 4,22608,79,0.89 [0.52-1.53],0.6821876749001685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22601,82,1.01 [0.74-1.39],0.9325195643762852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,19668,71,0.43 [0.22-0.83],0.0113333303497136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM1,V-set and transmembrane domain-containing protein 1,22073,79,1.27 [0.86-1.88],0.2217271761042223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2B,V-set and transmembrane domain-containing protein 2B,19329,70,1.16 [0.72-1.85],0.5469534986340525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22232,80,1.09 [0.79-1.51],0.5825126834290583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22833,80,0.94 [0.72-1.24],0.6641043321072884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22124,81,1.81 [1.06-3.08],0.0303238925572173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19296,70,0.86 [0.57-1.29],0.4593561946695167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA1,von Willebrand factor A domain-containing protein 1,22798,83,0.81 [0.51-1.29],0.3737419904631942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,19016,71,0.63 [0.40-0.98],0.0394261524927684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2,Brorin,22403,81,0.80 [0.48-1.35],0.4125734050616255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2L,von Willebrand factor C domain-containing protein 2-like,19678,72,0.87 [0.51-1.50],0.6207375701801127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWF,von Willebrand factor,22905,81,1.04 [0.79-1.35],0.799362424723862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WARS,"Tryptophan--tRNA ligase, cytoplasmic",22641,79,1.18 [0.70-2.00],0.5339867871417001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WAS,Wiskott-Aldrich syndrome protein,22210,82,1.04 [0.78-1.39],0.7753167510567821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF1,Wiskott-Aldrich syndrome protein family member 1,22232,80,0.90 [0.72-1.13],0.3616315179712356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF3,Wiskott-Aldrich syndrome protein family member 3,22073,79,0.83 [0.66-1.03],0.0904498455879272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASHC3,WASH complex subunit 3,19668,71,0.85 [0.62-1.17],0.3320385796890232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASL,Neural Wiskott-Aldrich syndrome protein,19160,71,1.03 [0.72-1.47],0.8726005109900019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WDR46,WD repeat-containing protein 46,19602,71,0.93 [0.49-1.76],0.820530188713715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC1,WAP four-disulfide core domain protein 1,19217,71,0.68 [0.39-1.19],0.1757387222663011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC12,WAP four-disulfide core domain protein 12,22809,83,1.17 [0.87-1.57],0.2942727468060904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC2,WAP four-disulfide core domain protein 2,21468,78,0.93 [0.52-1.67],0.81212301111448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22424,81,0.91 [0.56-1.48],0.7061788543174706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22672,82,0.84 [0.48-1.49],0.5564164687759511
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WIF1,Wnt inhibitory factor 1,22837,83,0.75 [0.42-1.32],0.3104308342811176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WNT9A,Protein Wnt-9a,22210,82,0.48 [0.23-1.01],0.0530426388058944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22486,81,0.97 [0.68-1.40],0.8862575449968456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XCL1,Lymphotactin,22837,83,0.93 [0.65-1.33],0.6934091258462785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XG,Glycoprotein Xg,22791,81,1.10 [0.56-2.14],0.7891332149992942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XIAP,E3 ubiquitin-protein ligase XIAP,19160,71,0.82 [0.54-1.24],0.3514857382125526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XPNPEP2,Xaa-Pro aminopeptidase 2,22705,82,1.04 [0.83-1.30],0.745447642582457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XRCC4,DNA repair protein XRCC4,22073,79,0.85 [0.48-1.49],0.5661314683969056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YAP1,Transcriptional coactivator YAP1,19668,71,0.71 [0.29-1.72],0.4489051254220949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19608,71,0.92 [0.79-1.07],0.2824041421783018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YES1,Tyrosine-protein kinase Yes,22532,81,0.85 [0.71-1.01],0.060951643181796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YJU2,Splicing factor YJU2,19602,71,1.20 [0.62-2.32],0.5822891819892104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,19109,70,1.55 [1.11-2.18],0.0103328125406376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YTHDF3,YTH domain-containing family protein 3,22210,82,0.98 [0.77-1.23],0.8340321990271393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YWHAQ,14-3-3 protein theta,19296,70,0.88 [0.64-1.21],0.4270822991088705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YY1,Transcriptional repressor protein YY1,19160,71,1.21 [0.55-2.64],0.6370532662099614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBP1,Z-DNA-binding protein 1,19160,71,0.89 [0.49-1.63],0.7159535183130562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB16,Zinc finger and BTB domain-containing protein 16,22124,81,0.81 [0.60-1.10],0.1797042713324917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB17,Zinc finger and BTB domain-containing protein 17,22232,80,1.13 [0.72-1.77],0.5953258223936393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19109,70,1.28 [0.97-1.69],0.0858426188423413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZFYVE19,Abscission/NoCut checkpoint regulator,19608,71,0.90 [0.70-1.16],0.4073158478614541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZHX2,Zinc fingers and homeoboxes protein 2,19668,71,1.09 [0.59-2.01],0.7851068841279578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF174,Zinc finger protein 174,19160,71,1.24 [0.77-1.99],0.382933692089344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF75D,Zinc finger protein 75D,19329,70,1.15 [0.84-1.59],0.388737198879263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF830,Zinc finger protein 830,19602,71,0.89 [0.65-1.21],0.4614307923121902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRD2,Protein ZNRD2,19608,71,1.02 [0.73-1.42],0.9131109606211634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19602,71,0.81 [0.52-1.26],0.3501135130490993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP3,Zona pellucida sperm-binding protein 3,19209,70,1.01 [0.92-1.10],0.887017718572449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP4,Zona pellucida sperm-binding protein 4,19016,71,0.96 [0.48-1.92],0.9166155438949352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZPR1,Zinc finger protein ZPR1,19101,70,0.91 [0.70-1.19],0.4905215395781497
